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Abstract 
In vivo characterization of RNA cis-regulators in bacteria 
Arianne M. Babina 
Advisor: Michelle M. Meyer, Ph.D. 
Bacteria commonly utilize cis-acting mRNA structures that bind specific molecules to 
control gene expression in response to changing cellular conditions. Examples of these 
ligand-sensing RNA cis-regulators are found throughout the bacterial world and include 
riboswitches, which interact with small metabolites to modulate the expression of 
fundamental metabolic genes, and the RNA structures that bind select ribosomal 
proteins to regulate entire ribosomal protein operons. Despite advances in both non-
coding RNA discovery and validation, many predicted regulatory RNA motifs remain 
uncharacterized and little work has examined how RNA cis-regulators behave within 
their physiological context in the cell. Furthermore, it is not well understood how 
structured RNA regulators emerge and are maintained within bacterial genomes. In this 
thesis, I validate the biological function of a conserved RNA cis-regulator of ribosomal 
protein synthesis previously discovered by my group using bioinformatic approaches. I 
then investigate how bacteria respond to the loss of two different cis-regulatory RNA 
structures. Using Bacillus subtilis as a model organism, I introduce point mutations into 
the native loci of the ribosomal protein L20-interacting RNA cis-regulator and the tandem 
glycine riboswitch and assay the strains for fitness defects. I find that disrupting these 
regulatory RNA structures results in severe mutant phenotypes, especially under harsh 
conditions such as low temperatures or high glycine concentrations. Together, this body 
of work highlights the advantages of examining RNA behavior within its biological 
context and emphasizes the important role RNA cis-regulators play in overall organismal 
 ii 
viability. My studies shed light on the selective pressures that impact structured RNA 
evolution in vivo and reinforce the potential of cis-regulatory RNAs as novel antimicrobial 
targets. 
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Awake, arise, or be for ever fall’n! 
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Do I dare 
Disturb the universe? 
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Chapter 1 
Introduction to RNA cis-regulators in bacteria 
In bacteria, transcription and translation occur simultaneously (Proshkin et al. 
2010; McGary and Nudler 2013). As a result, bacteria have evolved a number of ways to 
exploit the close linkage of these two important processes to efficiently control gene 
expression for rapid adaptation to changes within their environments. One manner in 
which bacteria regulate gene expression is through the use of messenger RNA (mRNA) 
cis-regulators, RNA motifs that are often structured and mediate the expression of the 
transcripts in which they are contained. 
Structural features of bacterial mRNA transcripts play integral roles in modulating 
transcription and translation efficiency and mRNA degradation. During transcription, the 
nascent mRNA can base pair with itself to form secondary structures that induce 
pausing or termination of the actively transcribing RNA polymerase (Gusarov and Nudler 
1999; Yarnell and Roberts 1999), prevent ribosome access and translation initiation, 
and/or stall concurrently translating ribosomes. Transcript conformations stabilized by 
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the presence of a paused RNA polymerase or ribosome can protect the mRNA from 
premature interactions with transcription termination factors (such as Rho) or nucleases. 
Alterations in mRNA folding and stability in response to changing cellular conditions 
such as temperature and pH can influence transcription, translation, and degradation 
rates and allow for condition-specific gene expression patterns (for review see: (Meyer 
2017)).   
Certain mRNA sequences can adopt complex three-dimensional shapes to 
modulate downstream expression in response to interactions with specific molecules. 
These structured RNA “sensors” are commonly employed by bacterial genomes to 
regulate fundamental processes, such as the production of ribosomal components and 
metabolic pathways essential for survival or pathogenesis. The best-characterized 
examples of bacterial RNA cis-regulators that respond to ligand-binding interactions are 
those that control ribosomal protein synthesis and riboswitches.  
 
1.1 RNA cis-regulators of ribosomal protein synthesis 
1.1.1 The prokaryotic ribosome 
The ribosome is a highly complex molecular machine that plays an essential role 
in protein biosynthesis in all living organisms. The prokaryotic 70S ribosome consists of 
two subunits, each of which is composed of ribosomal RNA (rRNA) and many ribosomal 
proteins. The small 30S ribosomal subunit, which interacts with the mRNA to be 
translated, consists of the 16S rRNA and approximately 21 ribosomal proteins. The large 
50S subunit, which participates in the polymerization of nascent polypeptide chains, is 
composed of the 5S and 23S rRNAs and about 33 different ribosomal proteins (for 
review see: (Kaczanowska and Rydén-Aulin 2007; Shajani et al. 2011)). In rapidly 
dividing Escherichia coli, as much as 40% of total cellular dry mass is comprised of 
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ribosomes and their associated cofactors (Tissieres et al. 1959; Bremer and Dennis 
1996) and ribosome production consumes about 40% of the cell’s total energy (Nierhaus 
1991). Because of this enormous energy expense and the importance of appropriate 
component stoichiometry in ribosome biosynthesis and function, the production of 
individual ribosomal components and extra-ribosomal cofactors is highly regulated and 
tightly coordinated (Harvey 1970; Bremer and Dennis 1996).  
 
1.1.2 Regulation of ribosomal protein synthesis in bacteria  
One manner in which bacteria maintain the delicate balance between rRNA, 
ribosomal proteins, and extra-ribosomal cofactors to ensure proper and efficient 
ribosome production is through the autogenous regulation of ribosomal protein synthesis 
(Nomura et al. 1980, 1984; Zengel and Lindahl 1994). In bacterial genomes, the genes 
  
 
 
Figure 1.1. Autogenous regulation of ribosomal protein synthesis in bacteria. During 
ribosome assembly, ribosomal proteins typically bind to specific sites on rRNA. When rRNAs are 
saturated with bound proteins or when ribosomal proteins are in excess, select ribosomal proteins 
can interact with RNA structures located within their operon transcripts to inhibit further ribosomal 
protein expression at the transcriptional or translational level. 		
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coding for ribosomal proteins exist as single copies and are clustered together in several 
large polycistronic operons. When cells are rapidly dividing, rRNA and ribosomal 
proteins are produced en masse to satisfy the cells’ increasing need for active protein 
synthesis. During ribosome assembly, ribosomal proteins preferentially bind to their 
target rRNAs. However, when rapid ribosome synthesis is no longer needed and/or 
rRNA-binding sites are saturated with bound proteins, select ribosomal proteins will bind 
to structured non-coding RNA motifs that are typically located in the 5’-untranslated 
regions (UTRs) of their own operon transcripts (Figure 1.1). These interactions are 
highly specific and induce conformational changes within the mRNA that repress 
transcript expression at the transcriptional or translational level. In most instances, the 
cis-regulatory RNA elements are molecular mimics of rRNA structure and their binding 
partners are primary rRNA-binding ribosomal proteins (Fu et al. 2013). While most of 
these RNA cis-regulators respond to a single effector protein, some require interactions 
with a complex of ribosomal proteins to carry out their regulatory function, such as the 
RNA structures that interact with the S6:S18 heterodimer (Matelska et al. 2013; Fu et al. 
2014; Babina et al. 2015) or the pentameric L10(L12)4 complex (Iben and Draper 2008; 
Yakhnin et al. 2015). 
 
1.1.3 Diversity and distribution of ribosomal protein RNA cis-regulators 
This RNA-based negative feedback regulation has been extensively 
characterized in the model Gram-negative bacterium, E. coli. Fifteen distinct RNA cis-
regulatory elements have been found to control the synthesis of over half of the 
ribosomal proteins within this organism (Figure 1.2) (Zengel and Lindahl 1994; Fu et al. 
2013; Matelska et al. 2013; Fu et al. 2014; Aseev et al. 2015, 2016). These cis-
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regulatory RNA structures exhibit a great deal of variation in size and complexity and 
utilize different mechanisms to inhibit gene expression.  
For example, the S4-interacting and S15-interacting RNA regulatory elements 
found in E. coli contain complex pseudoknotted structures and inhibit translation of their 
corresponding operons via ribosomal entrapment (Jinks-Robertson and Nomura 1982; 
Thomas et al. 1987; Tang and Draper 1989; Portier et al. 1990; Philippe et al. 1990, 
1993, 1995; Baker and Draper 1995). Conformational changes of the mRNA occurring 
upon protein binding trap the 30S ribosomal subunit, forming a ternary complex that 
impedes translation initiation. The S1-interacting RNA is proposed to control expression 
 
 
Figure 1.2. Ribosomal protein operon organization and regulation in E. coli. Gene names are 
given below each arrow and ribosomal protein product names are given above each arrow. Red 
arrows represent experimentally validated regulatory RNA structures; the two RNA structures that 
interact with ribosomal protein L20 are represented by a single arrow. Green arrows represent 
genes that are autogenously regulated; dark green arrows indicate the effector proteins 
responsible for regulation. Dark gray arrows are genes with reported autogenous regulation and 
white arrows indicate genes with no known autogenous regulation. Light gray arrows are 
confirmed genes not subject to autogenous regulation. Double slashes indicate breaks in genome 
sequence. Adapted from (Fu et al. 2013). 	
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of its own transcript using a similar mechanism, although its three-helix structure is 
considerably less complex (Boni and Artamonova 2000; Boni et al. 2001). The L1-
interacting RNA consists of a simple stem-loop with an internal bulge that is a direct 
mimic of the L1-binding site on the 23S rRNA. L1 binding to the mRNA inhibits 
translation through a ribosome displacement mechanism in which the 30S subunit is 
blocked from accessing the ribosome-binding site on the transcript (Dean and Nomura 
1980; Baughman and Nomura 1983). The large L4-interacting RNA regulatory element 
contains multiple helices and uniquely regulates expression of the operon it precedes 
using both translation inhibition and NusA-dependent transcription termination 
mechanisms (Yates and Nomura 1980; Lindahl et al. 1983; Freedman et al. 1987; Shen 
et al. 1988; Zengel and Lindahl 1992, 1994; Sha et al. 1995; Zengel and Lindahl 1996; 
Zengel et al. 2002). 
Four of the ribosomal protein RNA cis-regulators found in E. coli (interacting with 
ribosomal proteins S2, S6:S18, L1, and L10(L12)4), are widely distributed across most 
bacterial phyla (Figure 1.3). All bacterial phyla, except Acidobacteria, possess at least 
one of these cis-regulatory RNA structures (Fu et al. 2013; Matelska et al. 2013; Fu et al. 
2014), setting the precedent that the autogenous regulation of ribosomal protein 
synthesis is nearly universal in bacteria. The wide distribution and conservation of these 
specific RNA elements suggests vertical inheritance from an ancient ancestor. This is 
further supported by the fact that examples of these conserved RNA structures are able 
to interact with corresponding ribosomal protein homologs from different bacterial 
species (Köhrer et al. 1998). The remaining eleven ribosomal protein RNA cis-regulators 
found in E. coli are relegated to only a few orders of Gammaproteobacteria (Fu et al. 
2013). 
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Recent structure-based homology searches and phylogenetic analyses have 
identified several independently derived RNA structures that perform analogous 
regulatory functions in different bacterial phyla (Deiorio-Haggar et al. 2013; Slinger et al. 
2014). While some features that mimic rRNA protein-binding sites are conserved, these 
RNA regulators are narrowly distributed to select phyla and share little to no sequence 
and/or structural similarity to the regulatory RNAs found in E. coli that interact with 
homologous ribosomal proteins (Figure 1.3). The RNA structures that interact with 
ribosomal protein S15 are perhaps the most striking illustration of this diversity (Figure 
		
Figure 1.3. Distribution of ribosomal protein regulatory RNA structures in bacterial phyla. 
Distributions were compiled from alignments for twelve of the fifteen RNA structures controlling 
ribosomal protein biosynthesis in E. coli. Different shapes within the same column represent 
distinct RNA structures that interact with and/or precede the gene encoding the indicated 
ribosomal protein. Adapted from (Fu et al. 2013). 	
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1.4). Across different groups of bacteria, four distinct S15-interacting regulatory RNAs 
have been experimentally validated and two additional structures have been predicted 
(Philippe et al. 1990; Scott and Williamson 2001; Serganov et al. 2003; Slinger et al. 
2014; Slinger 2016). 
  More examples of these independently derived RNA cis-regulators can be found 
in the Gram-positive bacterium Bacillus subtilis. This organism contains the four widely 
distributed cis-regulatory RNA structures as well as three that are specific to the Bacilli 
class: the RNA structures interacting with ribosomal proteins L20, S4, and S15 (Fu et al. 
	
 
Figure 1.4. The diversity of the S15-interacting RNA cis-regulator. The RNA structures that 
regulate gene expression in response to ribosomal protein S15 are narrowly distributed to select 
bacterial phyla. The regulatory structures found in E. coli, Rhizobium radiobacter, Geobacillus 
stearothermophilus, and Thermus thermophilus have been experimentally verified; those found in 
Mycobacterium tuberculosis and Chlamydia trachomatis have been computationally predicted but 
have yet to be biologically validated (Slinger et al. 2014). Adapted from (Slinger 2016). 	
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2013; Matelska et al. 2013; Deiorio-Haggar et al. 2013; Fu et al. 2014). Unlike in E. coli, 
the B. subtilis S4-interacting RNA is a multi-helical structure that does not form a 
pseudoknot and represses protein synthesis shortly after transcription initiation (Grundy 
and Henkin 1991, 1992). The B. subtilis L20-interacting RNA is composed of three 
helices and controls the expression of its operon via the formation of a Rho-independent 
transcription terminator (Choonee et al. 2007). Conversely, there are two L20-interacting 
RNA cis-regulators in E. coli that regulate downstream gene expression at the 
translational level; one structure consists of a single bulged helix and the other contains 
a long range pseudoknot (Lesage et al. 1990, 1992, Guillier et al. 2005a, 2005b). 
Moreover, although the protein-binding site of the L10(L12)4-interacting RNA is 
conserved between E. coli and B. subtilis, the regulatory mechanism of action is not (Fu 
et al. 2013). In E. coli, this RNA regulator appears to act post-transcriptionally (Johnsen 
et al. 1982; Christensen et al. 1984), whereas in Firmicutes, Cyanobacteria, and 
Fusobacteria, the L10(L12)4-binding RNA structure is followed by an Rho-independent 
transcription terminator stem (Iben and Draper 2008; Yakhnin et al. 2015). Several 
additional ribosomal protein regulatory RNA structures specific to a subset of Firmicutes 
species, including Bacilli, have been computationally predicted but have yet to be 
experimentally validated (Yao et al. 2007).  
 
1.2 Riboswitches 
1.2.1 Anatomy of a riboswitch 
Though similar to RNA cis-regulators of ribosomal protein synthesis, riboswitches 
are structured mRNA elements commonly found in the 5’-UTRs of bacterial transcripts 
that control gene expression upon interactions with small molecule ligands, rather than 
in response to proteins. Riboswitches are often more complex than their ribosomal 
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protein-binding counterparts. They typically consist of a ligand-binding domain, or 
aptamer, followed by an expression platform that mediates conformational changes 
occurring upon ligand binding into a gene control response (Figure 1.5A). Riboswitches 
regulate genes important for central biochemical pathways, such as the metabolism and 
transport of amino acids, nucleic acids, coenzymes, and sulfur. These cis-regulatory 
RNAs commonly control expression at the transcriptional or translational level by 
modulating the stability of terminator/antiterminator structures (Figure 1.5B) or 
accessibility of ribosome-binding sites (Figure 1.5C). However, some riboswitches also 
utilize antisense RNAs, alternative splicing, and RNA degradation mechanisms to 
		
Figure 1.5. Overview of riboswitch structure and mechanisms of action. (A) A typical 
riboswitch is located in the 5’-UTR of an mRNA transcript and is composed of a ligand-binding 
domain, or aptamer, followed by an expression platform. (B) Transcriptional regulation by 
riboswitches. Ligand binding to the aptamer domain induces conformational changes of the 
expression platform that can destabilize a terminator stem to allow downstream expression (“on” 
switch, (i)) or stabilize a terminator to inhibit further transcription (“off” switch (ii)). (C) Translational 
regulation by riboswitches. Interactions between the ligand and aptamer domain result in structural 
reorganization of the expression platform that can expose a ribosome-binding site (RBS) to allow 
ribosome access and translation initiation (“on” switch, (i)) or lead to the sequestration of a RBS to 
prevent translation (“off” switch, (ii)). 	
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regulate gene expression. The majority of riboswitches act as genetic “off” switches by 
inhibiting the production of biosynthetic enzymes, metabolic intermediates, or 
transporters when sufficient quantities are present within a cell. A subset of riboswitches 
function as genetic “on” switches and activate the expression of salvage or degradation 
pathways when their target molecules are present in excess (for review see: (Winkler 
and Breaker 2005; Breaker 2012; Serganov and Nudler 2013)). 
 
1.2.2 Riboswitch diversity 
Riboswitches are classified based on their target ligand as well as the conserved 
architectures of their aptamer domains, which can vary in length and structural 
complexity. Nearly 40 different classes of riboswitches that interact with a diverse array 
of metabolites have been characterized to date (McCown et al. 2017).  Among the 
established riboswitch classes are three that respond to amino acids (glycine, lysine, 
and glutamine) (Mandal et al. 2004; Sudarsan et al. 2003; Ames and Breaker 2011), one 
that interacts with the amino sugar glucosamine-6-phosphate (GlcN6P) (Winkler et al. 
2004), four that bind signaling molecules (cyclic di-GMP (c-di-GMP) (Sudarsan et al. 
2008; Lee et al. 2010), cyclic-di-AMP (c-di-AMP) (Nelson et al. 2013), cyclic-GMP-AMP 
(c-GMP-AMP) (Nelson et al. 2015), and 5-aminoimidazole-4-carboxamide 
ribonucleoside-5’-triphosphate (ZTP) (Kim et al. 2015)), and several that recognize 
various enzyme cofactors, including: S-adenosylmethionine (SAM) (Grundy and Henkin 
1998; Winkler et al. 2003; Breaker 2012; Gayan et al. 2018), thiamine pyrophosphate 
(TPP) (Winkler et al. 2002b), flavin mononucleotide (FMN) (Winkler et al. 2002a), 
adenosyl-cobalamin or coenzyme B12 (AdoCbl) (Nahvi et al. 2004), S-
adenosylhomocysteine (SAH) (Wang et al. 2008; Wang and Breaker 2008), 
molybdenum (Moco) and tungsten (Tuco) cofactors (Regulski et al. 2008), and 
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tetrahydrofolate (THF) (Ames et al. 2010). Four riboswitch classes have been found to 
bind ions (Mg+2, F-, Mn+2, NiCo) (Ramesh and Winkler 2017; Baker et al. 2012; Dambach 
et al. 2015; Furukawa et al. 2015) and several of these regulatory RNAs interact with 
nucleotides or nucleotide derivatives: adenine (Mandal and Breaker 2004), guanine 
(Batey et al. 2004), prequeuosine (preQ1) (Roth et al. 2007; Meyer et al. 2008; McCown 
et al. 2014), and 2’-deoxyguanosine (2’-dG) (Kim et al. 2007). In addition to small 
molecule metabolites, riboswitches that respond to charged tRNAs (T-boxes) to regulate 
amino acid and tRNA synthetase biosynthesis have also been identified (for review see: 
(Green et al. 2010; Zhang and Ferré-D’Amaré 2015)). 
Riboswitch diversity is not limited to the wide variety of target molecules 
recognized. While most riboswitch sequences and structures are well conserved across 
different species, certain ligands can be recognized by several different aptamer 
conformations. The SAM riboswitches best exemplify this variation in aptamer 
composition; at least six distinct riboswitch structures recognize and respond to 
interactions with SAM and/or its derivative SAH (Wang and Breaker 2008; Breaker 2012; 
Gayan et al. 2018). Two different ligand-binding structures have been characterized for 
the c-di-GMP (Sudarsan et al. 2008; Lee et al. 2010), 2’-dG (Kim et al. 2007), and Mg+2 
(Ramesh and Winkler 2017) riboswitch classes and three unique riboswitch aptamer 
conformations have been identified for both the guanidine (Nelson et al. 2017; Sherlock 
et al. 2017; Sherlock and Breaker 2017) and preQ1 (Roth et al. 2007; Meyer et al. 2008; 
McCown et al. 2014) riboswitch classes. 
“Stacking” of riboswitch components adds an additional layer of complexity to 
riboswitch composition and allows for enhanced ligand-binding affinity and/or more 
dynamic genetic control. Tandem arrangements of complete and functionally 
independent riboswitches have been identified in select bacterial genomes. Bacillus 
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anthracis employs a double-tandem TPP riboswitch configuration (Welz and Breaker 
2007) and a triple-tandem c-di-GMP riboswitch system has been characterized in a 
subspecies of Bacillus thuringiensis (Zhou et al. 2016). A tandem arrangement of two 
different SAM riboswitch subtypes (SAM-II/SAM-V) allows both transcriptional and 
translational control of downstream expression in Candidatus pelagibacter ubique 
(Poiata et al. 2009) and a conformation in which a SAM-I riboswitch precedes an AdoCbl 
riboswitch regulates expression in response to either ligand in Bacillus clausii (Nahvi et 
al. 2004). Moreover, the glycine riboswitch found in both B. subtilis and Vibrio cholerae, 
among other bacteria, consists of two homologous glycine-binding aptamers arranged in 
tandem followed by a single expression platform (Mandal et al. 2004); a similar 
architecture also has been proposed for the glutamine riboswitch (Ames and Breaker 
2011). Riboswitches that bind two molecules within a single aptamer structure have also 
been described (Trausch et al. 2011; Gao and Serganov 2014; Ren and Patel 2014). 
 
1.2.3 Phylogenetic distribution of riboswitches 
Because riboswitch-mediated regulation exploits the bacteria-specific coupling of 
transcription and translation, riboswitches are almost exclusively found in bacterial 
genomes. The TPP riboswitch is the only known example that can be found in all three 
domains of life; representatives of this riboswitch class have been identified in bacteria, 
archaea, and eukaryotes, specifically in select plants and fungi (Barrick and Breaker 
2007). The AdoCbl riboswitch is the second most prevalent class in bacteria, followed by 
the SAM-I riboswitch (Barrick and Breaker 2007; McCown et al. 2017). These widely 
distributed RNA structures and the ligands with which they interact are proposed to have 
ancient origins (White 1976; Benner et al. 1989; Breaker 2012). In contrast, evidence 
suggests the narrowly distributed riboswitches that have relatively simple structures 
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and/or multiple aptamer conformations, such as the preQ1 riboswitch, likely resulted 
from independent derivation events. Finally, the instances in which certain riboswitches 
occur at low frequency in select clades may be due to horizontal gene transfer. Overall, 
Firmicutes (Bacilli, Clostridia, Erysipelotrichia, and Negativicutes), Fusobacteria, and 
Gammaproteobacteria employ the largest diversity of riboswitch classes, although 
Gammaproteobacteria contain fewer representatives of each class (Barrick and Breaker 
2007; McCown et al. 2017).  
 
1.3 Discovery and validation of RNA cis-regulators 
The RNA structures responsible for the control of ribosomal protein synthesis are 
among the earliest known examples of ligand-binding cis-regulatory RNA structures in 
bacteria. These autoregulatory RNA elements were first described in the late 1970s 
when overexpression of select ribosomal protein operons did not result in gene dosage 
effects, but rather reduced ribosomal protein production (Fallon et al. 1979; Lindahl and 
Zengel 1979). In the following decades, a number of additional ribosomal protein RNA 
cis-regulators were identified in E. coli using similar molecular genetic approaches 
(Zengel and Lindahl 1994). Correspondingly, the first riboswitches were discovered in 
the early 2000s when the expression of certain mRNAs was found to depend on the 
presence of specific small molecules as well as the sequence of the transcripts’ 5’-UTRs 
(Nou and Kadner 2000; Mironov et al. 2002; Nahvi et al. 2002; Winkler et al. 2002b, 
2002a). 
With the advent of high-throughput sequencing technologies and the concurrent 
advancements made in comparative genomics and RNA structure prediction, a plethora 
of putative RNA cis-regulators have been predicted in diverse bacterial species in recent 
years (Barrick et al. 2004; Weinberg et al. 2007, 2010; Yao et al. 2007; Meyer et al. 
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2009; Xu et al. 2009; Slinger et al. 2014). A number of these RNAs have been 
experimentally validated, however, many remain uncharacterized. As the amount of 
genomic and transcriptomic data available continues to grow, it is increasingly necessary 
to translate computational discoveries into biologically validated RNA structures. 
The majority of RNA cis-regulators are experimentally characterized using a 
combination of in vitro and in vivo techniques. Direct RNA-ligand interactions and 
subsequent binding kinetics are often determined in vitro via filter binding assays (Hall 
and Kranz 1999), electrophoretic mobility shift assays (Hellman and Fried 2009), inline 
or lead-probing (Pan 2001; Lindell et al. 2002; Regulski and Breaker 2008), and 
isothermal titration calorimetry (Batey et al. 2004). Structural features and binding 
determinants of the RNA regulator in both the presence and absence of its target 
molecule are further assessed using secondary structure probing methods, such as 
nuclease cleavage assays (Knapp 1989) and SHAPE (selective 2’-hydroxyl acylation 
analyzed by primer extension) (Wilkinson et al. 2006), and in more advanced instances, 
through X-ray crystallography (Batey et al. 2004) and nuclear magnetic resonance 
(Serganov et al. 2004). Regulatory activity is often examined using in vivo reporter 
systems and mechanism of action is determined through Northern blots (Rio 2015) or 
quantitative RT-PCR (Freeman et al. 1999), sometimes coupled with in vitro transcription 
termination (Artsimovitch and Henkin 2009) and/or translation inhibition assays (Castro-
Roa and Zenkin 2015). 
While the above approaches allow for the successful functional and structural 
characterization of putative RNA cis-regulators, such methods may not always capture 
the actual physiological behavior of an RNA structure. Discrepancies often exist between 
in vitro and in vivo experimental results as well as between regulatory RNA behavior 
within an in vivo reporter assay system versus within its biological context in the cell. 
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Limited work has examined the in vivo function of RNA cis-regulators in the context of 
their native loci and how these RNA elements contribute to overall cell fitness. 
Furthermore, despite the prevalence of RNA cis-regulators within bacterial genomes, 
little is known about how such regulatory RNA structures emerge and actively evolve, 
especially with their corresponding binding partners. 
With that said, this body of work aims to further bridge the gap between the 
computational discovery and experimental verification of regulatory RNA structures to 
gain a more complete understanding of cis-regulatory RNA function and evolution in 
bacteria. This thesis begins with the biological validation of a widely distributed RNA cis-
regulator of ribosomal protein synthesis that was previously identified by my group using 
comparative genomic approaches (Chapter 2; see Appendix for preliminary validation of 
additional predicted RNA regulators). In the subsequent Chapters, I move beyond the 
“discover-validate” binary and combine knowledge from previous in vitro and in vivo 
studies with an elegant knock-out strategy to assess the behavior and fitness 
contributions of two unique cis-regulatory RNAs within the context of their native loci in 
the model organism B. subtilis: the ribosomal protein L20-interacting RNA cis-regulator 
(Chapter 3) and the tandem glycine riboswitch (Chapter 4). 	 	
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Chapter 2 
A conserved S6:S18-interacting RNA cis-regulator 
inhibits translation of Escherichia coli rpsF 
 
The content in this Chapter is adapted from the following publication: 
Babina AM, Soo MW, Fu Y, Meyer MM. 2015. An S6:S18 complex inhibits translation of 
E. coli rpsF. RNA 21: 2039-2046. 
 
Author contributions: 
AMB performed the majority of the experiments, analyzed data, and wrote the 
manuscript. MWS generated select constructs and collected preliminary data. YF laid 
the groundwork for this project with previous in vitro studies. MMM conceived of the 
project, designed experiments, conducted the qRT-PCR analysis, analyzed data, and 
wrote the manuscript.  
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2.1 Introduction 
We, and others, previously reported a conserved RNA structure preceding rpsF, 
which encodes ribosomal protein S6 (Matelska et al. 2013; Fu et al. 2014). The mRNA 
structure is widely distributed to many bacterial species and displays some similarity with 
the S6:S18-binding site on the 16S rRNA. In particular, both RNA structures contain a 
pair of highly conserved bulged cytosines flanked by two helices (Figure 2.1) (Cannone 
et al. 2002). In most bacteria, rpsF is co-localized in the genome with priB, which 
encodes a component of the primosome, and rpsR, which encodes ribosomal protein 
S18. In E. coli, this transcriptional unit also includes rplI, encoding ribosomal protein L9 
(Isono and Kitakawa 1978). However, in many cases (including B. subtilis) rplI is found 
elsewhere in the genome. In the context of ribosome assembly, S6 and S18 form a 
heterodimer prior to interaction with the rRNA-S15 complex (Held et al. 1974; Agalarov 
et al. 2000; Recht and Williamson 2001).  Examples of the conserved RNA structure 
preceding rpsF from E. coli and B. subtilis were found to specifically interact in vitro with 
		
Figure 2.1. An RNA structure preceding rpsF is widely distributed across many bacterial 
phyla. (A) Consensus secondary structure of the RNA motif derived from over 1300 bacterial 
sequences. (B) Binding site for the S6:S18 heterodimer on 16S rRNA. Sequence is derived from 
B. subtilis; nucleotide conservation was determined from 4214 bacterial 16S rRNA sequences 
(Cannone et al. 2002). Black nucleotides are >90% conserved and red nucleotides are >98% 
conserved across bacteria. Nucleotides that make direct contact with S18 in Thermus 
thermophilus are boxed (Agalarov et al. 2000). Adapted from (Fu et al. 2014). 	
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an S6:S18 heterodimer with nM affinity (Matelska et al. 2013; Fu et al. 2014), however 
the B. subtilis homolog also had weak, potentially non-specific, interactions with S18 in 
the absence of S6 (Fu et al. 2014). Additionally, similarities between the conserved RNA 
structure preceding rpsF and the rRNA-binding site of the S6:S18 heterodimer were 
identified. The combination of this in vitro binding data with the proximity of the RNA 
structure to the translation start codon strongly suggests that the conserved RNA 
structure allows regulation of these proteins in many species of bacteria.  
In this work, we demonstrate that an example of the RNA structure from E. coli 
negatively regulates gene expression only in response to overexpression of both S6 and 
S18 using a lacZ reporter. This regulation may be disrupted by mutations to the 
regulatory RNA element that prevent its interaction with the repressor proteins, 
mutations to S18 that prevent interaction with the rRNA, and mutations to both S6 and 
S18 that prevent their interaction with one another. These results indicate that the 
S6:S18 complex is the biologically active effector. Furthermore, assessment of transcript 
levels by quantitative RT-PCR (qRT-PCR) suggests that the mechanism by which this 
RNA regulates gene expression is most likely inhibition of translation. Thus, this mRNA 
structure joins a collection of mRNA structures in E. coli that together, allow the fine-
tuning of ribosomal protein levels across multiple transcriptional units.  
 
2.2 Results and Discussion 
2.2.1 rpsF_leader is a regulatory element 
 To assess the regulatory ability of the mRNA sequence preceding the rpsF gene 
in E. coli (rpsF_leader), we constructed a translational fusion between the RNA 
structure, including the first nine codons of rpsF, and lacZ, under transcriptional control 
of the IPTG-inducible Lac promoter (Macia̧g et al. 2011; Slinger et al. 2014). To supply 
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potential exogenous protein regulatory 
partners, we amplified portions of the rpsF operon and overexpressed them under the 
control of an arabinose-inducible promoter on pBAD33 (Figure 2.2A). These plasmids 
were co-transformed and the β-galactosidase activity of individual colonies was 
quantified with potential binding partners induced (+arabinose) and uninduced (-
arabinose) (Figure 2.2B). The assays were conducted with cells harvested during 
Figure 2.2. Regulatory activity of the 
rpsF_leader in response to rpsF operon 
overexpression. (A) Portions of the rpsF 
operon assessed in this study. (B) β-
galactosidase activity (in Miller Units) of i: 
(left axis) cells with no lacZ reporter 
transcript induced (no IPTG); ii: (left axis) 
cells with the rpsF’-‘lacZ transcript induced 
(+IPTG) and different portions of an 
exogenous rpsF-priB-rpsR transcript 
(including an empty vector control) induced 
(+arabinose) and uninduced (-arabinose); 
iii: (right axis) cells with the rpsO’-‘lacZ 
transcript induced (+IPTG) with the empty 
vector and the rpsF-priB-rpsR transcript 
induced and uninduced (±arabinose). 
Values reported represent the mean of 
three or more independent experimental 
replicates. Error bars represent the 
standard error of the mean across 
experimental replicates. (C) Fold 
repression of the rpsF’-‘lacZ reporter 
construct derived from data in B. Fold 
repression is calculated from matched 
pairs of cultures as: (Miller Units  
–arabinose)/(Miller Units +arabinose). 
Values reported represent the mean of this 
calculation from matched pairs of three or 
more independent experimental replicates. 
Error bars represent standard error of the 
mean for this calculation across 
experimental replicates. (D) qRT-PCR 
quantification of the native rpsF-priB-rpsR-
rplI transcript (rplI), overexpressed 
transcript (rpsF), and reporter transcript 
(lacZ) relative to the tus control transcript. 
Values reported represent the mean of 
three or more independent biological 
replicates. Error bars represent standard 
error of the mean across biological 
replicates. 	
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logarithmic phase growth (OD600 = 0.4 to 0.8) when the overexpressed protein-binding 
partners had been induced (+arabinose) for 2-3 hours, and the reporter construct (lacZ) 
induced for 30 minutes. β-galactosidase activity of cells where the lacZ transcript is 
uninduced is negligible (Figure 2.2Bi).  
Using this system, overexpression of each individual component of the rpsF 
operon: rpsF encoding S6, priB encoding a component of the primosome, and rpsR 
encoding S18, results in little to no change in β-galactosidase activity (~1-fold 
repression) compared to the empty vector control (pBAD33) (Figure 2.2C). Upon 
expression of the first three genes of the rpsF operon (rpsF-priB-rpsR), we observe a 
large decrease in β-galactosidase activity (~4-fold repression). To control for potential 
global changes in translational efficiency that may be due to ribosome defects 
associated with overexpression of S6 and S18, we also examined the β-galactosidase 
activity of a similar lacZ fusion with an RNA structure not expected to interact with S6 or 
S18, that preceding ribosomal protein S15 in E. coli (rpsO’-‘lacZ) (Philippe et al. 1993; 
Slinger et al. 2014). While the rpsO’-‘lacZ fusion results in higher β-galactosidase activity 
in comparison to the rpsF_leader-lacZ constructs (Figure 2.2B), there is no significant 
change in β-galactosidase activity upon expression of the rpsF-priB-rpsR (S6:S18) 
construct compared to pBAD33 lacking any insert (empty vector) (Figure 2.2C). Thus, 
overexpression of both S6 and S18 (rpsF-priB-rpsR) is necessary to regulate gene 
expression, and the observed change in gene expression is specific to the rpsF_leader. 
 
2.2.2 rpsF_leader inhibits translation  
 The E. coli example of the rpsF_leader contains a putative Shine-Dalgarno (SD) 
sequence within the structure, suggesting that the mechanism of action for this RNA is 
through inhibition of translation initiation. To examine the mechanism of regulation, we 
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measured mRNA levels in our reporter strains via qRT-PCR to determine whether 
transcript levels are significantly altered under the conditions where we observe changes 
in reporter gene expression. The tus gene (terminus utilization substance) was used as 
a control transcript instead of a ribosomal protein or rRNA control transcript, as they 
might be affected by the overexpression of the rpsF-priB-rpsR fragment (Sykes et al. 
2010). We measured levels of the overexpressed transcript (primers within rpsF), the 
reporter transcript (primers within lacZ), and the native transcript (primers within rplI) 
relative to tus transcript. We found that levels of the lacZ transcript do not change 
relative to the tus transcript under the +arabinose condition where we observe changes 
in β-galactosidase activity (Figure 2.2D). In contrast, while it is clear that the 
overexpression constructs increase rpsF transcript levels approximately 10-fold upon 
induction with arabinose as expected, the rplI transcript (corresponding to the native 
rpsF-priB-rpsR-rplI transcript) is reduced approximately 4.5-fold under these conditions. 
These results indicate that while the changes in β-galactosidase activity we observe are 
due to differences in translation, the native transcript is subject to additional regulation 
and is either not produced, terminates prematurely, or is degraded more rapidly under 
these conditions.  
 
2.2.3 Mutations to rpsF_leader affect expression and regulatory capacity 
 To determine whether mutations to the RNA that prevent protein binding could 
abolish regulation, we examined six mutant RNAs (Figure 2.3A). The M1 mutation 
disrupts the H1 stem as well as the putative SD sequence. This mutation in the 
homologous B. subtilis RNA was previously shown to reduce protein binding affinity 
using in vitro electrophoretic mobility shift assays (EMSAs) (Fu et al. 2014). During our in 
vivo studies, we find that this mutation results in low β-galactosidase activity in both the 
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presence and absence of exogenous 
protein (Figure 2.3B). This indicates that 
this region is important for translational 
efficiency and supports our prediction 
that the H1 stem may contain the SD 
sequence. The overall low β-
galactosidase activity of M1 makes any 
potential regulatory activity difficult or 
impossible to determine. 
 The M2 mutation is not directly in 
the proposed protein-binding region but is within positions that are predicted to pair with 
the SD sequence. This mutation in the homologous B. subtilis RNA completely abolished 
Figure 2.3. Regulatory capacity of 
rpsF_leader mutants. (A) The presumed 
secondary structure of the rpsF 5’-UTR used 
for reporter studies with mutations M1-M6. 
The transcription start site (Macia g et al. 
2001), translational start, and putative Shine-
Dalgarno (SD) sequence are indicated. (B) β-
galactosidase activity (in Miller Units) of cells 
carrying plasmids with the unmutated 
rpsF_leader (WT) or each mutant RNA (M1-
M6) and the rpsF-priB-rpsR overexpression 
plasmid or the empty vector (pBAD33) under 
induced and uninduced (±arabinose) 
conditions. Values reported represent the 
mean of three or more independent 
experimental replicates. Error bars represent 
the standard error of the mean across 
experimental replicates. (C) Fold repression 
as calculated in Figure 2.2C of the 
unmutated rpsF_leader (WT) and each 
mutant RNA (M1-M6). Values reported 
represent the mean of this calculation from 
matched pairs of three or more independent 
experimental replicates. Error bars represent 
standard error of the mean for this calculation 
across experimental replicates. 	
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protein binding in vitro (Fu et al. 2014). Consistent with these data, we find that this 
mutation to the E. coli rpsF_leader almost completely abolishes regulation. Further 
disruption of this stem with the M3 mutation yields similar results, suggesting that the 
base pairing in this region is important for protein binding and consequent regulation 
(Figure 2.3C). 
 The M4 mutation is directly within the proposed protein-binding site, changing 
two highly conserved cytosines to adenines (Matelska et al. 2013; Fu et al. 2014). 
During in vitro studies of the homologous B. subtilis RNA, this mutation significantly 
inhibited protein binding. A more severe mutation at the same position (AAA rather than 
AAG) in the E. coli RNA had a similar effect during in vitro binding assays (Matelska et 
al. 2013). We find that this mutation completely abolishes the demonstrated regulation in 
vivo (Figure 2.3C). This is consistent with its location directly within the protein-binding 
region.   
 The M5 mutation disrupts the highly conserved H2 stem of the rpsF_leader 
secondary structure. Mutations to this region in the homologous B. subtilis RNA 
significantly impaired RNA-protein interactions in vitro (Fu et al. 2014). In agreement with 
these data, this mutation reduces repression of β-galactosidase activity to about half of 
that observed with the wild-type rpsF_leader (~1.8-fold repression). The low basal 
(unrepressed) β-galactosidase activity of the M5 mutant in comparison to the wild-type 
rpsF_leader and other mutant constructs (Figure 2.3B) does not appear to be due to 
changes in transcript levels (data not shown), but rather to translational efficiency. The 
M6 compensatory mutation to the H2 stem almost fully restores basal β-galactosidase 
activity and regulation to near wild-type levels (~3.5-fold repression) (Figure 2.3B,C). 
This further confirms our previous secondary structure predictions and indicates that the 
base pairing in the H2 stem is important for regulatory activity. 
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2.2.4 S6 and S18 residues required for regulation 
 The S6:S18 complex is expected to be the biologically active regulator that 
interacts with the rpsF_leader. During ribosome assembly, S6 and S18 form a 
heterodimer prior to assembly with the 16S rRNA-S15 complex (Held et al. 1974; Recht 
and Williamson 2001). The rpsF_leader shows significant sequence and structural 
similarities with the S18-binding site on the rRNA (Figure 2.1), and tertiary structure 
modeling indicates that the majority of RNA-protein contacts are likely with S18 
(Matelska et al. 2013). In vitro studies with the B. subtilis rpsF_leader homolog show 
weak and likely non-specific interactions between S18 and the rpsF_leader (Fu et al. 
2014), and our β-galactosidase assay results (Figure 2.2B,C) indicate that 
overexpression of both S6 and S18 is required for inhibition.  
To assess the role S18 has in the mRNA-protein regulatory interactions, we 
altered two positively charged amino acids in S18 (within the rpsF-priB-rpsR construct) 
that are expected to interact with the conserved pair of cytosines in both the rRNA and  
Figure 2.4. rpsF_leader regulation in response to S6:S18 protein mutations. (A) Rendering of 
the S6:S18 heterodimer in complex with the 16S rRNA (coordinates derived from 2QAL 
(Borovinskaya et al. 2007)). The rRNA segment (660-678; 713-739) is gray, interacting bases 
C719 and C720 are highlighted in yellow, S18 is shown in blue, amino acids mutated at the 
S18:rRNA interface (K60, R61, and R63) are indicated in purple, amino acids mutated at the 
S6:S18 interface (Y23 and K24) are orange. S6 is displayed in green, and the amino acids 
mutated at the S6:S18 interface are highlighted in red. For individual amino acids mutated at the 
S6:S18 interface (R44, Y48, P49 and R85) side chains are displayed, for the additional amino 
acids altered in the ‘A-loop’ mutant (44-49 all mutated to alanine) only the backbone is colored. 
Negative control mutations (S6 E22 and S18 R48) are highlighted in cyan. (B) β-galactosidase 
activity (in Miller Units) of cells carrying the rpsF-priB-rpsR overexpression construct with 
mutations to the S18 RNA-binding region with protein induced and uninduced (±arabinose). For 
comparison, data for the unmutated construct (WT) and empty vector (--) are included. Values 
reported represent the mean of three or more independent experimental replicates. Error bars 
represent the standard error of the mean across experimental replicates. (C) Fold repression for 
S18 RNA-binding site mutations (data in B) calculated as described in Figure 2.2C. ** indicates a 
statistically significant change (p<0.01) from the wild-type construct. (D) β-galactosidase activity 
(in Miller Units) of cells carrying the rpsF-priB-rpsR overexpression construct with mutations made 
to the S6:S18 interface. For comparison, data for the unmutated construct (WT) and empty vector 
(--) are included. Values reported represent the mean of three or more independent experimental 
replicates. Error bars represent standard error of the mean across experimental replicates.   
(E) Fold repression for S6:S18 interface mutations (data in D) calculated as described in Figure 
2.2C. Asterisks indicate a statistically significant change from the wild-type construct: ** indicates 
p<0.01 and * indicates p<0.05. 	
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rpsF_leader (lysine 60 and arginine 63 to alanine) (Figure 2.4A). These amino acids 
form hydrogen bonds with the conserved cytosines in the loop region adjacent to Helix 
23a of the rRNA (C719 and C720) (Figure 2.1B) (Agalarov et al. 2000) that are mimicked 
in the mRNA structure by the conserved pair of cytosines mutated in M4 (Figure 2.3A). 
During in vitro studies, mutating these amino acids resulted in either significant reduction 
in binding affinity (K60A) or complete loss of saturated binding (R63A) (Matelska et al. 
2013). In our assays, both of these mutants significantly reduce regulation (~2-fold 
repression, p<0.01) (Figure 2.4B,C). Additionally, mutating arginine 61 to an alanine, a 
residue that is implicated in both S18-rRNA interactions and S6:S18 dimer interactions in 
a Thermus thermophilus structure of the S15:S6:S18:rRNA complex (Agalarov et al. 
2000), but only appears to contact the RNA in crystal structures of the E. coli ribosome 
(Borovinskaya et al. 2007), decreases regulatory activity (~2.9-fold repression, p<0.01). 
This supports the conclusion that S18 contacts with the mRNA are critical for binding 
and subsequent regulatory activity. Arginine 48 was also mutated to an alanine as a 
negative control. R48 is not known to directly contribute to S18-rRNA or S6:S18 protein-
protein interactions, and this mutation to S18 did not affect regulation. 
To further assess whether the S6:S18 heterodimer is the biologically relevant 
effector, we mutated residues in both S6 and S18 (within the rpsF-priB-rpsR construct) 
to disrupt S6:S18 dimer interactions and consequent regulation. However, the interface 
of S6 and S18 proved difficult to completely disrupt using mutations to a single protein. 
Mutations to S18, tyrosine 23 and lysine 24 to alanine, individually had little or no effect 
on regulation. However, combining these mutations results in a modest, but significant 
(p<0.01) decrease in β-galactosidase activity (2.5-fold repression).  On the 
complementary S6 surface, individual and combined mutations of S6 arginine 44 and 
tyrosine 48 to alanine had little effect on binding (Figure 2.4D,E). Mutations of proline 49 
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and arginine 85 to alanine, and replacing residues 44-49 (RQLAYP) with alanine (‘A-
loop’) all had modest, but significant effects on repression (decreasing to about ~3-fold, 
p<0.05). However, combining the S6 ‘A-loop’ mutation with the S18 Y23A/K24A 
mutation did strongly impact regulation (1.5-fold repression, p<<0.001), indicating that 
disruption of the S6:S18 interface can disrupt regulation. A negative control mutation to 
S6, glutamate 22 to alanine, showed no change in repression.  
We suspect the robustness of the protein-protein interaction is due to several 
factors. First, our overexpressed mutant proteins are competing with endogenous 
protein levels, and we may see less of an effect due to this competition. Second, the 
nature of the S6:S18 protein-protein interaction may be somewhat plastic and robust to 
our mutagenesis efforts. The structures of the T. thermophilus S15:S6:S18:rRNA 
complex and the complete E. coli ribosome are not identical, leading to slightly varying 
determinations of which residues are most critical for this interaction (Agalarov et al. 
2000; Borovinskaya et al. 2007). In particular the N-terminal portion of S18 that contacts 
S6 is not resolved in the T. thermophilus complex, suggesting that there may be some 
flexibility in the S6:S18 interaction. That our combined S6 ‘A-loop’ and S18 Y23A/K24A 
mutations had the strongest impact on regulation indicates that the first of these two 
factors is likely playing a significant role, and supports our conclusion that the active 
complex is the S6:S18 heterodimer.  
 
2.3 Conclusions 
 In this work we show that in E. coli, the rpsF_leader RNA is a regulatory element 
that inhibits the translation of rpsF. Changes in β-galactosidase activity are not 
accompanied by corresponding changes in the level of lacZ transcript. However, the 
native transcript does show significant reduction under conditions where β-galactosidase 
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activity is reduced, suggesting that it is subject to additional regulation. Due to past 
associations of reduced translation with more rapid transcript degradation (Deana and 
Belasco 2005), we strongly suspect this mechanism may play a significant role in 
amplifying the relatively modest 4-fold repression we observe. 
Our mutagenesis studies indicate that the biologically relevant effector is the 
S6:S18 heterodimer. Unlike many regulators of ribosomal protein synthesis, the 
rpsF_leader does not respond to a primary rRNA-binding protein, but rather a complex 
of secondary rRNA-binding proteins. This situation is relatively rare, as most 
characterized regulators to date interact with primary rRNA-binding proteins, although 
there are a few exceptions (e.g. S2, L25 (Aseev et al. 2008, 2015)). The closest 
comparison to this situation is the rplJ-rplL regulator that interacts with either L10 or the 
L10(L12)4 complex (Yates et al. 1981).  
The rpsF_leader is one of the few RNA structures responsible for ribosomal 
protein regulation that is widely distributed across many bacterial phyla (Matelska et al. 
2013; Fu et al. 2014). For other such widely distributed regulators, the same protein-
binding site may be utilized for different mechanisms of gene regulation. For example as 
mentioned in Chapter 1, the L10(L12)4-interacting regulatory mRNA inhibits translation 
initiation in E. coli (Johnsen et al. 1982; Christensen et al. 1984), whereas in B. subtilis 
the conserved L10(L12)4 mRNA-binding site regulates transcription attenuation (Iben 
and Draper 2008; Yakhnin et al. 2015). This is similar to many riboswitch aptamers 
where the same recognizable aptamer may utilize different expression platforms in 
different species (Barrick and Breaker 2007). Therefore, it would not be unlikely for the 
rpsF_leader to utilize distinct mechanisms for regulation in diverse species of bacteria. 
Confirmation of the biological activity of the rpsF_leader mRNA structure allows it to join 
a still growing canon of RNA regulatory structures in bacteria that allow regulation of 
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ribosomal protein synthesis, but utilize a wide variety of mechanisms and have very 
different distribution patterns across bacterial phyla. 
 
2.4 Materials and Methods 
2.4.1 Plasmid construction 
 The lacZ reporter plasmid is a modified version of the pLac-ThiM#2-tetA-gfpuv 
plasmid previously described (Muranaka et al. 2009; Slinger et al. 2014), in which the 
tetA-gfpuv construct is replaced with a lacZ gene using SalI and XbaI restriction sites. 
The fragment corresponding to the RNA and the first 9 codons of rpsF (NC_000913.3: 
4425023-4425144) was PCR-amplified from genomic DNA extracted from E. coli strain 
XL1-Blue (Agilent Technologies) and cloned between the EcoRI and SalI sites, to 
generate an RNA-lacZ translational fusion (Table 2.1). To construct the pBAD33 (ATCC 
87402) overexpression plasmids, genomic fragments corresponding to portions of the 
rpsF operon (NC_000913.3 rpsF: 4425118-4425513; priB: 4425520-4425834; rpsR: 
4425839-4426066; rpsF-priB-rpsR: 4425118-4426066) were PCR-amplified from 
genomic DNA from E. coli and cloned between the XbaI and SacI sites. To enable 
efficient translation, a Shine-Dalgarno sequence (5’-AGGAGGTTTTAAA) was appended 
to the 5’ end of each genomic fragment. Mutant RNA and protein plasmids were created 
by site-directed mutagenesis from the original plasmids (Table 2.1). All plasmid 
sequences were confirmed by Sanger sequencing. 
 
2.4.2 β-galactosidase activity assays 
To generate strains for β-galactosidase activity analysis, a reporter plasmid and a 
protein overexpression plasmid were co-transformed into E. coli strain NCM534 (F-, 
Δ(araD-araB)714, Δ(lacA-lacZ)880(::FRT), lacIp-4000(lacIQ), zah-2225::FRT, λ-, ΔaraEp-
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532::FRT, φPcp18araE533, rph-1) (E. coli Genetic Stock Center, strain #: 8256). For each 
independent assay, a single colony was chosen and grown overnight at 37ºC with 
shaking (225 rpm) in 1.5 mL LB + ampicillin (100 µg/mL) + chloramphenicol (35 µg/mL). 
This culture was used to inoculate two separate pre-warmed 1.5 mL cultures, one 
containing 15 mM L-arabinose (+arabinose) to induce protein overexpression and one 
without any sugar added (-arabinose, protein not induced), to a starting OD600 of 
approximately 0.05-0.1. Cultures were grown at 37ºC with shaking (225 rpm) until an 
OD600 of approximately 0.4-0.6 was reached. IPTG (1 mM) was added to both cultures to 
induce transcription of the reporter transcript. The induced cultures were incubated for 
30 minutes at 37ºC with shaking (225 rpm). Spectinomycin (100 µg/mL) was added to 
each culture following the 30-minute incubation to inhibit further translation. Cells (1 mL) 
were harvested and re-suspended in 1 mL Z buffer (50 mM Na2HPO4, 40 mM NaH2PO4, 
10 mM KCl, 1 mM MgSO4, 50 mM 2-Mercaptoethanol) + 100 µg/mL spectinomycin. 
OD600 readings were recorded as cell suspensions in Z buffer. Samples that had an 
OD600 reading of 0.4 or lower at time of harvest were discarded. β-galactosidase activity 
assays were performed as previously described using 30 µl of cell suspensions and 
Miller Units were calculated as follows (Miller 1992): 
Miller Units = 1000 ∗  !!"#∆! !"#.  ∗ !!"" ∗ !"#.(!") 
To determine the fold repression for each sample, the Miller Units of the -arabinose 
(protein not induced) culture were divided by that of the corresponding +arabinose 
(protein induced) culture. The values reported represent 5 or more independent 
replicates for wild type, mutant rpsF_leader, and protein overexpression co-transformed 
strains, and 3 independent replicates for the uninduced (-IPTG) and rpsO’-‘lacZ control 
assays. Error bars represent standard error of the mean across biological replicates. To 
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determine significance, the fold repression of samples was compared using a Welch’s T-
test in Microsoft Excel. 
 
2.4.3 Quantitative RT-PCR 
 Total RNA was extracted using Trizol (Life Technologies) from +/- arabinose 
cultures grown essentially as described. Contaminating DNA was removed from 10 µg of 
total RNA by RQ1 DNase digestion at 37ºC for 4 hours (Promega) followed by phenol-
chloroform extraction and ethanol precipitation.  Reverse transcription reactions were 
conducted with random hexamers using SuperScript III (Life Technologies) on 2.5 µg of 
DNase-treated RNA according to the manufacturer’s instructions. The resulting cDNA 
was used as template for qPCR using an Applied Biosystems 7500 Fast Real-Time PCR 
system (SYBR Green detection, ThermoFisher Scientific). qPCR primers targeting the 
lacZ reporter, the overexpression construct (rpsF), and the native transcript (rplI) were 
used to quantify transcript levels in each sample. Quantification of tus was used as a 
normalization control (Table 2.1). Equivalent experiments were conducted on reactions 
lacking reverse transcriptase to ensure that DNase digestion removed all contaminating 
DNA. Each condition is represented by three independent biological replicates, and 
qPCR was conducted with three technical replicates for each biological replicate. 
Standard error reported represents variance among biological replicates. 
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Name Sequence (5'-3') Notes 
627 
 
CGCGGAATTCGCGTCATTTTTCAGCCG
ACCTTTAAC 
 
Primer for cloning rpsF_leader 
into modified pLac reporter vector 
(Slinger et al. 2014); EcoRI 
restriction site in bold 
628 
 
ACGCGTCGACCATAAAAACGATTTCGTA
ATGACGCAT 
 
Primer for cloning rpsF_leader 
into modified pLac reporter vector 
(Slinger et al. 2014); SalI 
restriction site in bold 
629 CAAGAGCTCAGGAGGTTTTAAAATGCGT
CATTACGAAATCGTTTTTATG 
 
Primer for cloning rpsF into 
pBAD33 protein overexpression 
vector; SacI restriction site in 
bold; SD sequence is underlined 
630 CAATCTAGATTACTCTTCAGAATCCCCA
GCTTCAGC 
 
Primer for cloning rpsF into 
pBAD33 protein overexpression 
vector; XbaI restriction site in 
bold 
782 CAAGAGCTCAGGAGGTTTTAAAATGACC
AACCGTCTGGTG 
 
Primer for cloning priB into 
pBAD33 protein overexpression 
vector; SacI restriction site in 
bold; SD sequence is underlined 
783 CAATCTAGACTAGTCTCCAGAATCTATC
AATTCAAT 
 
Primer for cloning priB into 
pBAD33 protein overexpression 
vector; XbaI restriction site in 
bold 
631 CAAGAGCTCAGGAGGTTTTAAAATGGC
ACGTTATTTCCGTCGTCGC 
 
Primer for cloning rpsR into 
pBAD33 protein overexpression 
vector; SacI restriction site in 
bold; SD sequence is underlined 
632 CAATCTAGATTACTGATGGCGATCAGTG
TACGG 
 
Primer for cloning rpsR into 
pBAD33 protein overexpression 
vector; XbaI restriction site in 
bold 
667 CTGAATAATCCGTATCGAGCAATTCG Mutagenesis primer for 
rpsF_leader M1 
668 CGAATTGCTCGATACGGATTATTCAG Mutagenesis primer for 
rpsF_leader M1 
669 CCTTTAACACGTTCGATGCCTCCCCGG
G 
 
Mutagenesis primer for 
rpsF_leader M2 
670 CCCGGGGAGGCATCGAACGTGTTAAAG
G 
 
Mutagenesis primer for 
rpsF_leader M2 
1135 GACCTTTAACACGTTGGAAGCCTCCCC
GGGATTC 
Mutagenesis primer for 
rpsF_leader M3 
Table 2.1. Oligonucleotides used in this study. 
For primer pairs, the forward primer is listed first and the reverse primer is listed second. 
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1136 GAATCCCGGGGAGGCTTCCAACGTGTT
AAAGGTC 
Mutagenesis primer for 
rpsF_leader M3 
671 GGAGGCTGAATAATAAGTAAGGAGCAA
TTCG 
Mutagenesis primer for 
rpsF_leader M4 
672 CGAATTGCTCCTTACTTATTATTCAGCCT
CC 
Mutagenesis primer for 
rpsF_leader M4 
1137 GCTGACCCAGACAGGCAGCTGAATAAT
CCGTAAG 
Mutagenesis primer for 
rpsF_leader M5 
1138 CTTACGGATTATTCAGCTGCCTGTCTGG
GTCAGC 
Mutagenesis primer for 
rpsF_leader M5 
1139 TAACACGTTCCTTGCTGCCCCGGGATTC
G 
Mutagenesis primer for 
rpsF_leader M6; use M5 as 
template 
1140 CGAATCCCGGGGCAGCAAGGAACGTGT
TA 
Mutagenesis primer for 
rpsF_leader M6; use M5 as 
template 
710 CTGGCTCGCGCTATCGCGCGCGCTCGC
TACCTG 
Mutagenesis primer for S18 
K60A 
711 CAGGTAGCGAGCGCGCGCGATAGCGC
GAGCCAG 
Mutagenesis primer for S18 
K60A 
708 CTATCAAACGCGCTGCGTACCTGTCCCT
GCTG 
Mutagenesis primer for S18 
R63A 
709 CAGCAGGGACAGGTACGCAGCGCGTTT
GATAG 
Mutagenesis primer for S18 
R63A 
1133 GCTCGCGCTATCAAAGCCGCTCGCTAC
CTGTC 
Mutagenesis primer for S18 
R61A 
1134 GACAGGTAGCGAGCGGCTTTGATAGCG
CGAGC 
Mutagenesis primer for S18 
R61A 
1131 GCCGTATCACCGGTACCGCTGCAAAAT
ACCAGCGT 
Mutagenesis primer for S18 
R48A 
1132 ACGCTGGTATTTTGCAGCGGTACCGGT
GATACGGC 
Mutagenesis primer for S18 
R48A 
852 GACTGGGGCCGCGCTCAGCTGGCTTAC
C 
Mutagenesis primer for S6 R44A 
853 GGTAAGCCAGCTGAGCGCGGCCCCAGT
C 
Mutagenesis primer for S6 R44A 
1213 CAGCTGGCTGCCCCGATCAAC Mutagenesis primer for S6 Y48A 
1214 GTTGATCGGGGCAGCCAGCTG Mutagenesis primer for S6 Y48A 
1245 CGTCAGCTGGCTTACGCGATCAACAAA
CTG 
Mutagenesis primer for S6 P49A 
1246 CAGTTTGTTGATCGCGTAAGCCAGCTGA
CG 
Mutagenesis primer for S6 P49A 
1243 GATGCCGTTATCGCCAGCATGGTTATG Mutagenesis primer for S6 R85A 
1244 CATAACCATGCTGGCGATAACGGCATC Mutagenesis primer for S6 R85A 
1241 CGCGCTGCGGCGGCTGCCGCGATCAA
CAAACTGCAC 
Mutagenesis primer for S6 ‘A-
loop’ 
1242 GATCGCGGCAGCCGCCGCAGCGCGGC
CCCAGTCTTC 
Mutagenesis primer for S6 ‘A-
loop’ 	 	
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1141 GTTCCGGGCATGATCGCGCGCTACACT
GCTGC 
Mutagenesis primer for S6 E22A 
1142 GCAGCAGTGTAGCGCGCGATCATGCCC
GGAAC 
Mutagenesis primer for S6 E22A 
1235 CAAGAGATCGACGCTAAAGATATCGC Mutagenesis primer for S18 
Y23A 
1236 AGCGATATCTTTAGCGTCGATCTCTTG Mutagenesis primer for S18 
Y23A 
1237 GAGATCGACTATGCAGATATCGCTACG Mutagenesis primer for S18 
K24A 
1238 CGTAGCGATATCTGCATAGTCGATCTC Mutagenesis primer for S18 
K24A 
1239 GAGATCGACGCTGCAGATATCGCTACG
CTGAAAAAC 
Mutagenesis primer for S18 
Y23A K24A 
1240 AGCGATATCTGCAGCGTCGATCTCTTGA
ACGCC 
Mutagenesis primer for S18 
Y23A K24A 
1204 TACCTGTTCCGTCATAGCGA Primer for qRT-PCR targeting the 
lacZ reporter 
1205 CTGTTTACCTTGTGGAGCGA Primer for qRT-PCR targeting the 
lacZ reporter 
1218 GGCTTACCCGATCAACAAAC Primer for qRT-PCR targeting the 
rpsF overexpression construct 
1219 CGGAAGGTAGTTTCCAGCTC Primer for qRT-PCR targeting the 
rpsF overexpression construct 
1127 TACCATCGCGTCTAAAGCTG Primer for qRT-PCR targeting the 
rplI native transcript 
1128 TTCGCTCTTAGCCACTTCAA Primer for qRT-PCR targeting the 
rplI native transcript 
981 TGTTTTCGAAGCGACAGATG Primer for qRT-PCR targeting the 
tus normalization control 
982 TTTCGAGGCCGAGAATTTTA  Primer for qRT-PCR targeting the 
tus normalization control 		 	
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3.1 Introduction 
Since the late 1970s, a number of ribosomal protein RNA cis-regulators have 
been identified and experimentally validated in bacteria and, as detailed in Chapters 1 
and 2, the methods for characterizing these RNA-protein regulatory interactions are well 
established. These studies and techniques have greatly improved our knowledge of the 
structures and mechanisms responsible for the RNA-based autoregulation of ribosomal 
protein synthesis in bacteria. However, our understanding of the selective pressures that 
drive the emergence and maintenance of ribosomal protein RNA cis-regulators within 
bacterial genomes remains limited. The presence of both highly conserved and 
independently derived cis-regulatory RNA structures suggests there exists significant 
evolutionary pressure to regulate ribosomal protein synthesis in this manner. 
Additionally, although it is well known that overexpressing select ribosomal proteins 
inhibits bacterial growth, these observations are typically from studies that induced 
protein overexpression using multiple gene copies, plasmids, and/or strong promoters 
(Dean and Nomura 1980; Sykes et al. 2010). Little to no work has investigated the 
impacts of simply removing ribosomal protein autoregulation in bacteria.  
To measure the fitness advantages ribosomal protein regulatory RNA structures 
confer to an organism, we introduced point mutations into the native locus of the L20-
interacting RNA cis-regulator in the B. subtilis genome to disrupt ribosomal protein 
binding and regulation, and subsequently assayed the strains for mutant phenotypes. B. 
subtilis is a good model organism for examining RNA cis-regulators within the context of 
their native loci. This bacterium utilizes a variety of cis-regulatory RNA structures to 
control gene expression (Barrick and Breaker 2007; Fu et al. 2013; Deiorio-Haggar et al. 
2013; McCown et al. 2017), it is naturally competent during late log phase growth 
(Dubnau 1991), and it is highly amenable to manipulation of its genome via homologous 
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recombination (Fernández et al. 2000). Furthermore, the L20-interacting regulatory RNA 
found in B. subtilis is a good subject for this study as its structure and mechanism of 
action are well characterized. As mentioned in Chapter 1, this RNA structure is narrowly 
distributed to the Firmicutes phylum and it regulates expression of the infC-rpmI-rplT 
operon (encoding translation initiation factor IF3 and large subunit ribosomal proteins 
L35 and L20, respectively) at the transcriptional level using a Rho-independent 
terminator that is stabilized upon L20 binding (Choonee et al. 2007; Bruscella et al. 
2011; Deiorio-Haggar et al. 2013). 
We find that removing RNA-mediated autoregulation results in elevated transcript 
levels of downstream genes and causes cold-sensitive defects in growth, rRNA 
processing, and ribosome subunit sedimentation. Our results suggest that improper 
regulation of ribosomal protein expression compromises ribosome biosynthesis and 
demonstrate the significant role cis-regulatory RNA structures have in proper ribosome 
production and overall organismal fitness. This work gives insight into why RNA-based 
regulation of ribosomal proteins is so prevalent across diverse bacterial species and 
sheds light on the selective forces that govern structured RNA evolution and 
conservation. 
 
3.2 Results 
3.2.1 Reporter assays confirm behavior of L20-interacting RNA mutations 
 We first verified the impact of specific mutations on the regulatory activity of the 
L20-interacting RNA and downstream gene expression using β-galactosidase reporter 
assays in B. subtilis (Figure 3.1A). Assays were conducted during log phase growth 
while overexpressing the entire infC operon from a plasmid, or with an empty plasmid. 
An ~11-fold reduction in β-galactosidase activity was observed for the wild-type L20- 
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interacting RNA construct when the infC operon was overexpressed (Figure 3.1B,C). 
This fold repression is comparable to what has been previously measured for the L20-
interacting RNA (Choonee et al. 2007; Bruscella et al. 2011). 
Mutations M1 and M2 disrupt the previously identified and highly conserved L20-
binding site at the junction of Helices H1 and H2 (Figure 3.1A) (Choonee et al. 2007; 
Deiorio-Haggar et al. 2013). Both mutations relieve the repression observed with the 
wild-type RNA construct when the infC operon is overexpressed (Figure 3.1B,C). 
Mutation M3 targets the loop region of Helix H3 and serves as a control. Previous 
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Figure 3.1. Regulatory activity of the  
B. subtilis L20-interacting RNA 
mutants examined in this study.  
(A) Secondary structure of the L20-
interacting RNA in its protein-bound form 
with mutations M1-M4. The L20-binding 
site is in bold. Helix H4 is the Rho-
independent transcription terminator that 
forms upon L20 binding. Nucleotides are 
numbered from the transcript start site 
from the second infC operon promoter, 
+1 (Choonee et al. 2007). (B) β-
galactosidase activity (in Miller Units) of 
the L20-interacting RNA mutant 
constructs with overexpression of the 
infC operon or empty plasmid during log 
phase growth at 37ºC. The values 
reported represent the mean of three or 
more independent experimental 
replicates; error bars represent standard 
error of the mean across biological 
replicates. (C) Fold repression of the 
L20-interacting RNA reporter constructs 
derived from the data in B. Fold 
repression was calculated for each 
reporter construct as follows: (Mean 
Miller Units of empty plasmid 
strain)/(Mean Miller Units of infC operon 
overexpression strain). Error bars 
represent standard error of the mean 
propagated from the values in B using 
standard calculations (Taylor 1997).  	
 40 
nuclease probing analyses suggest that Helix H3 is not involved in L20-binding 
interactions (Choonee et al. 2007), and this stem is only present in ~75% of examples of 
this RNA (Deiorio-Haggar et al. 2013). As anticipated, regulation was retained for the M3 
mutant construct (~5-fold repression) (Figure 3.1B,C). 
Finally, the M4 mutation is designed to destabilize the stem of the Rho-
independent terminator that forms upon L20 binding (Figure 3.1A). This mutation 
resulted in elevated constitutive expression. The activity measured for the M4 mutant 
under both unrepressed (empty plasmid) and repressed (infC operon overexpression) 
conditions was substantially higher than that obtained with the wild-type RNA (Figure 
3.1B,C). Regulatory activity with the M4 mutant RNA was significantly reduced (~2.5-fold 
repression upon infC operon overexpression). 
 
3.2.2 L20-interacting RNA mutant recombinant strains are cold-sensitive 
 To investigate the effects mutations to the L20-interacting RNA and the loss of 
infC ribosomal protein operon regulation have on B. subtilis fitness, we replaced the 
native copy of the L20-interacting RNA within the B. subtilis 168 genome with either a 
wild-type or mutant recombinant version via homologous recombination (Figure 3.2A). 
Growth curves were performed to measure recombinant strain fitness, as translation 
efficiency and consequently ribosome quality and quantity can be inferred from log 
phase growth (Harvey 1970; Scott et al. 2014). Strains were assayed in nutrient-rich 
2XYT medium at both 37ºC and 15ºC because sensitivity to low temperatures can be 
indicative of defects in ribosome assembly, composition, and/or function (Guthrie et al. 
1969; Tai et al. 1969; Feunteun et al. 1974a; Isono and Krauss 1976; Isono et al. 1977; 
Charollais et al. 2004; Bharat and Brown 2014; Choudhury and Flower 2015).  
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The M1, M3, and M4 mutant 
recombinant strains grew similarly to, if not better than, the wild-type recombinant strain 
at 37ºC, with doubling times of 69, 60, and 68 minutes, respectively, in comparison to a 
doubling time of 68 minutes for the wild-type recombinant strain (Figure 3.2B,D). The M2 
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sequence, and two ~500 bp regions 
flanking the promoter and regulatory 
RNA locus were PCR-amplified from B. 
subtilis 168 genomic DNA. A PCR 
product in which an erythromycin 
resistance cassette (erm) was introduced 
immediately upstream of the second infC 
operon promoter was generated, sub-
cloned, and transformed into B. subtilis 
168. Integration of the PCR constructs at 
the infC locus via double-crossover 
homologous recombination replaced the 
native L20-interacting RNA with a wild-
type or mutant recombinant version. 
Growth curves for each recombinant 
strain in 2XYT at 37ºC (B) and 15ºC (C). 
Growth assays were performed three or 
more times for each strain. 
Representative curves are shown. (D) 
Doubling times (min) of L20-interacting 
RNA recombinant strains grown in 2XYT 
at 37ºC and 15ºC. Values were 
calculated from log phase OD600 values 
and are the mean of three or more 
independent experimental replicates; ± 
indicates the standard error of the mean 
across biological replicates. Numbers in 
parentheses denote mutant recombinant 
strain doubling time relative to that of the 
wild-type recombinant (WT) strain at the 
corresponding temperature. Asterisks (*) 
indicate mutant recombinant strains that 
grew significantly slower than the wild-
type recombinant at the corresponding 
temperature. Daggers (†) indicate mutant 
recombinant strains that grew 
significantly faster than the wild-type 
recombinant at the corresponding 
temperature (p<0.05). 168, parental 
strain. 
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protein-binding mutant recombinant strain grew approximately 1.3 times slower than the 
wild-type recombinant at 37ºC, with a doubling time of 91 minutes. The M2 regulatory 
mutant recombinant strain was consistently unstable and difficult to maintain. While it is 
possible that additional mutations elsewhere in the genome contribute to the instability 
and slow growth exhibited by this strain, this growth defect at 37ºC was observed for 
multiple M2 mutant recombinant strains generated from independent transformation 
events. 
In contrast, all three mutant recombinant strains in which the regulatory activity of 
the L20-interacting RNA was compromised (M1, M2, M4) grew approximately 1.4 times 
slower than the wild-type recombinant at 15ºC, whereas the M3 control mutant 
recombinant strain grew comparably to the wild-type recombinant at this temperature 
(Figure 3.2C,D). This significant cold-temperature sensitive growth defect suggests that 
improper infC operon regulation likely affects ribosome production. 
The 168 parental strain did not demonstrate any cold temperature-sensitive 
growth defects; rather, it consistently grew faster than the wild-type recombinant strain at 
both 37ºC and 15ºC. This difference is likely due to the presence of the erythromycin 
resistance cassette within the wild-type recombinant strain and/or the use of antibiotic in 
the recombinant strain medium. Consequently, the doubling times of the 168 parental 
strain are included in Figure 3.2D for reference, but the strain is not shown in the 
representative growth curves. 
 
3.2.3 Position of erythromycin resistance cassette does not influence 
recombinant strain phenotype 
Following construction of our recombinant strains, we noticed that we failed to 
properly incorporate  the  first  infC operon  promoter into  our native  locus  recombinant  
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strain design. In B. subtilis, the infC operon is under the control of two promoters. 
Transcription from the first promoter adds 58 nucleotides to the 5’ end of the infC operon 
transcript, which contains an RNase Y cleavage site that ultimately allows for increased 
expression of ribosomal proteins L35 and L20 relative to IF3 (Bruscella et al. 2011). In 
 
 
Figure 3.3. Construction of re-designed L20-interacting RNA recombinant strains.  
(A) Re-designed L20-interacting RNA recombinant strain constructs. New PCR products were 
constructed to preserve the native organization of the two infC operon promoters (Pinfc1 and Pinfc2). 
Re-designed recombinant strains were generated as described in Figure 3.2A, except the erm 
cassette was introduced into the intergenic region immediately upstream of the first infC operon 
promoter and two transcription terminators were appended onto the 3’ end of the erm cassette to 
prevent potential read-through from the erm promoter (red arrow). (B) Northern blot analysis of 
total log phase RNA from original (WT, M1) and re-designed (WT.2, M1.2) recombinant L20-
interacting RNA strains grown in 2XYT at 37ºC. The membrane was hybridized with 
oligonucleotide probes complementary to the L20-interacting RNA leader (left) and the 
erythromycin (erm) resistance cassette (right) (Table 3.1). In vitro transcribed RNAs corresponding 
to the full length (ctrl FL) and terminated (ctrl T) infC-rpmI-rplT operon transcripts were included as 
size standards. Transcripts 4 and 5 (see Northern blot transcript legend) are potential transcripts 
that cannot be distinguished on the blots shown; transcript 4 may also be present in the original 
recombinant strains (WT, M1) on the L20 RNA leader blot (left). 168, parental strain. 
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our original recombinant strain design, we introduced the erythromycin resistance (erm) 
cassette immediately upstream of the second infC operon promoter, displacing the 
position of the first infC operon promoter (Figure 3.2A). Consequently, Northern blots 
revealed extra transcript originating from read-through from the displaced promoter 
and/or the erm cassette promoter in the recombinant strains, and this was confirmed 
with 5’-RACE (Figure 3.3B, Northern blot transcript 3). 
To determine if disrupting the context of the two promoters and the resulting 
expression of the extra transcript influenced strain phenotype, we re-designed our wild- 
type recombinant and M1 mutant recombinant strains to more accurately reflect the 
native organization of the infC operon promoter region within the B. subtilis genome. In 
the re-designed recombinant strains, we appended two terminators onto the 3’ end of 
the erm cassette coding sequence to prevent potential read-through from the erm 
promoter and inserted the erm cassette into the intergenic region immediately upstream 
of the first infC operon promoter (Figure 3.3A). The extra transcript previously observed 
in our original recombinant strains was not detected in our re-designed recombinant 
strains, suggesting that the native organization of the infC operon promoter region was 
restored (Figure 3.3B, Northern blot transcript 3). Consistent with our previous growth 
assay results, the re-designed M1 mutant recombinant strain (M1.2) exhibited cold-
sensitive growth defects similar to that of the original M1 regulatory mutant recombinant 
strain (Figure 3.4). Therefore, we continued to use the original recombinant strains we 
constructed for all subsequent experiments.  
It should be noted that although similar trends in growth were observed for both 
recombinant strain designs during the growth assays, the re-designed recombinant 
strains grew slower than the original recombinant strains at both 37ºC and 15ºC. This is 
likely due to differences in erm cassette expression. Transcription from the displaced 
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first infC operon promoter greatly increased expression of the erm cassette in the 
original recombinant strains relative to that of the re-designed recombinant strains 
(Figure 3.3B, Northern blot transcripts 4-6). All growth assays were performed in 
medium containing a final concentration of 0.5 µg/mL erythromycin; thus, the slower 
doubling times calculated for the re-designed recombinant strains may be due to an 
increased sensitivity to erythromycin.  
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Figure 3.4. Comparison of original (WT, 
M1) and re-designed (WT.2, M1.2) L20-
interacting RNA recombinant strain 
growth. Growth curves for each 
recombinant strain grown in 2XYT at 37ºC 
(A) and 15ºC (B). Growth assays were 
performed two or more times for each 
strain. Representative curves are shown. 
(C) Doubling times (min) of original and re-
designed L20-interacting RNA recombinant 
strains grown in 2XYT at 37ºC and 15ºC. 
Values were calculated from log phase 
OD600 values and are the mean of two or 
more independent experimental replicates; 
± indicates the standard error of the mean 
across biological replicates. Numbers in 
parentheses denote mutant recombinant 
strain doubling time relative to that of the 
appropriate wild-type recombinant (WT or 
WT.2) strain at the corresponding 
temperature. Symbols (*,^,#) indicate 
mutant recombinant strains that grew 
significantly slower than the appropriate 
wild-type recombinant at the corresponding 
temperature; the p values are indicated in 
the figure. 168, parental strain. 	
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3.2.4 Low temperatures exacerbate mutant recombinant strain infC operon mis-
regulation at stationary phase 
 To further assess the origins of the temperature-sensitive phenotype observed 
during the growth assays, we quantified levels of the native infC operon transcript in the 
recombinant strains during both log (OD600 ~0.3-0.7) and early stationary phase (OD600 
~2.0-3.0) at 37ºC and 15ºC in the presence of endogenous L20 protein only. Because 
the L20-interacting RNA utilizes a transcription termination mechanism to regulate infC 
operon expression, we measured transcript levels using quantitative RT-PCR (qRT-
PCR) with primers targeting the rplT (L20) coding region. While these measurements 
cannot capture the instantaneous rates of transcription or translation, the relative levels 
of rplT transcript do give some indication of whether differences in termination occur 
under these conditions, and whether there are likely to be differences in protein levels. 
The M2 and M3 mutant recombinant strains exhibited rplT transcript levels 
comparable to that of the wild-type recombinant during log phase at 37ºC, while the M1 
and M4 mutant recombinant strains demonstrated a ~2.7 and 1.7-fold increase in rplT 
levels, respectively, in comparison to that of the wild-type recombinant strain under 
these conditions (Figure 3.5A).  During early stationary phase at 37ºC, rplT transcript 
levels in all strains were approximately 2-fold higher relative to the nifU internal control 
compared to log phase, and the increased transcript levels measured in the M1 and M4 
mutant recombinant strains were even more prominent (~4.3 and 5-fold increase in rplT 
levels, respectively, compared to the wild-type recombinant). Under these conditions, 
rplT levels in the M2 mutant recombinant strain remained consistent with those in the 
wild-type recombinant, and the M3 control mutant recombinant strain displayed a ~2.5-
fold decrease in rplT levels relative to the wild-type recombinant strain. The β-
galactosidase activities measured for each L20-interacting RNA reporter in the
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absence of infC operon 
overexpression (empty plasmid) 
largely reflect the relative transcript 
levels measured at 37ºC for each 
native locus recombinant strain using 
qRT-PCR (Figure 3.1B). Overall, the 
differences in rplT transcript levels measured at 37ºC do not appear to influence or 
correlate with strain growth at this temperature.  
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Figure 3.5. Recombinant strain infC 
operon transcript levels. qRT-PCR 
quantification of the native rplT transcript in 
each of the recombinant strains grown to 
log and early stationary phase at 37ºC (A) 
and 15ºC (B). For each strain/condition, 
rplT transcript level was normalized to the 
level of housekeeping gene nifU (Reiter et 
al. 2011). Graphs depict relative rplT 
transcript levels in each strain compared to 
the rplT level in the wild-type recombinant 
(WT) strain grown to log phase at 37ºC. 
Error bars represent the standard error of 
the mean across three technical replicates. 
Numbers in parentheses denote mutant 
recombinant strain rplT transcript level 
relative to that of the wild-type recombinant 
strain at the corresponding growth phase 
and temperature. (C) qRT-PCR 
quantification of the native rplT transcript in 
the re-designed recombinant strains (WT.2, 
M1.2) grown to log phase at 37ºC, 
normalized and graphed as described 
above. For comparison, data from A for the 
168 parental and original WT and M1 
recombinant strains are included. Numbers 
in parentheses denote mutant recombinant 
strain rplT transcript levels relative to that 
of the corresponding wild-type recombinant 
strain. Consistent with the qRT-PCR 
results from the original recombinant 
strains, the M1.2 recombinant strain 
exhibited elevated rplT levels relative to 
that of the WT.2 recombinant strain. 
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At 15ºC, rplT transcript levels decreased relative to the nifU internal control for all 
strains during both log and early stationary phase in comparison to the transcript levels 
quantified at 37ºC (Figure 3.5B). This is expected, as production of ribosomal 
components decreases during periods of limited growth and/or under poor growth 
conditions (Nomura et al. 1984; Bremer and Dennis 1996; Maguire 2009). However, all 
three regulatory mutant recombinant strains (M1, M2, M4) exhibited a ~2 to 3-fold 
increase in rplT levels during log phase at 15ºC relative to that of the wild-type 
recombinant strain, and these elevated transcript levels were considerably more 
pronounced during early stationary phase at this temperature. Similar to the transcript 
levels quantified at 37ºC, rplT transcript in the M3 control mutant recombinant strain was 
approximately half of that measured in the wild-type recombinant at 15ºC. The qRT-PCR 
data at 15ºC suggest that the compromised negative-feedback regulation in the M1, M2, 
and M4 mutant recombinant strains results in unnecessary constitutive expression of the 
infC ribosomal protein operon. This expression likely impacts strain growth when rapid 
ribosome synthesis is not required, such as during entry into stationary phase and the 
cold temperature conditions assessed in this study. 
 
3.2.5 L20-interacting RNA mutants demonstrate improper rRNA processing at 
low temperatures 
The cold-sensitive phenotype of the L20-interacting RNA regulatory mutant 
recombinant strains suggests that removing the RNA-based regulation of the infC 
operon results in aberrant ribosome assembly. To examine if our regulatory mutant 
recombinant strains are defective in ribosome biosynthesis, we analyzed rRNA 5’ end 
processing in each strain grown to log phase at both 37ºC and 15ºC using primer 
extension.  Ribosome  assembly  and  rRNA  maturation  are  tightly  coupled. Pre-rRNA  
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transcripts are cleaved to their mature 
forms concurrent with ribosomal 
subunit assembly; thus, accumulation 
of precursor rRNA transcripts and/or 
improper rRNA processing can be indicative of defects in ribosome composition 
(Feunteun et al. 1974b; Charollais et al. 2003, 2004; Jain 2008; Choudhury and Flower 
2015).  
Consistent with our previous findings, little to no differences in the 5’ end 
processing of both the 16S and 23S rRNAs were observed for all recombinant strains at 
37ºC (Figure 3.6). The multiple species of closely spaced mature 5’ ends of each rRNA 
(indicated as M(0)) have been previously characterized and are due to differences in 
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Figure 3.6 L20-interacting RNA 
recombinant strain rRNA processing. 
Primer extension analysis of 16S rRNA (A) 
and 23S rRNA (B) from L20-interacting 
RNA recombinant strains grown to log 
phase in 2XYT at 37ºC and 15ºC. 
Sequencing reactions performed with the 
same primers and in vitro transcribed 
RNAs corresponding to portions of the 
unprocessed 5’ ends of both the 16S and 
23S rRNAs were used to identify the 
mature 5’ end of each rRNA, labeled as 
M(0). Sequencing reactions are labeled as 
their complements to allow for direct 
reading. Previously characterized 
precursor species are labeled according to 
the number of extra nucleotides relative to 
M(0) and are included for reference (+76 
for 16S rRNA, +64 for 23S rRNA) (Britton 
et al. 2007; Redko et al. 2008). Asterisks 
(*) indicate regions in which mutant 
recombinant strain rRNA processing differs 
from that of the wild-type recombinant (WT) 
strain. Primer extension analysis was 
conducted with RNA extracted from three 
or more independent biological replicates 
of each strain grown to log phase at both 
37ºC and 15ºC. Representative gels are 
shown. 168, parental strain. 	
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rRNA sequence across the 10 rrn operons encoded within the B. subtilis 168 genome, 
different RNase cleavage sites, and/or other auxiliary processing pathways (Srivastava 
and Schlessinger 1990; Britton et al. 2007; Redko et al. 2008).  
When the strains were grown at 15ºC, multiple extension products longer and 
shorter than those corresponding to the mature 5’ ends of the 16S and 23S rRNAs were 
apparent in the primer extension reactions of the mutant recombinant strains in which 
infC operon regulation was compromised (M1, M2, M4) (Figure 3.6). While the amount 
of extension product corresponding to the mature 5’ ends of both rRNAs (M(0)) was 
comparable to those of the 168 parental, wild-type recombinant, and M3 control mutant 
recombinant strains at this temperature, the extra extension species are likely due to 
improper rRNA processing brought about by aberrant ribosome assembly or an increase 
in rRNA degradation as a result of the cold-sensitive growth defects previously noted. 
Cold-sensitive rRNA processing defects have also been observed in bacterial strains 
lacking specific ribosomal assembly factors (Charollais et al. 2003, 2004; Jain 2008; 
Bharat and Brown 2014; Choudhury and Flower 2015). None of these additional 
extension products were present in the 16S and 23S rRNA primer extension reactions of 
the 168 parental, wild-type recombinant, and M3 control mutant recombinant strains at 
this temperature. These results are consistent with those from our growth assays and 
further suggest that disrupting the RNA-based negative-feedback regulation of the infC 
operon leads to defects in ribosome synthesis or assembly. 
 
3.2.6 Mutations to the L20-interacting RNA affect ribosomal subunit 
sedimentation 
To further characterize the impact disruptions to infC operon regulation have on 
ribosome assembly, we analyzed ribosomal subunit sedimentation profiles of the mutant   
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recombinant strains using sucrose 
density gradient ultracentrifugation. 
Because defects in rRNA processing 
were only apparent in the regulatory 
mutant recombinant strains during 
growth at cold temperatures, sedimentation profiles were generated from extracts of 
cells grown to early log phase at 15ºC. For all strains, the peak corresponding to 
complete 70S ribosomes was reduced relative to that of the 30S and 50S subunits 
(Figure 3.7). This likely reflects a global reduction in active translation due to suboptimal 
growth at 15ºC (Dai et al. 2016). Although the ratio of 30S subunits to 50S subunits 
remained fairly consistent across all strains, a small peak was observed between the 
30S and 50S peaks in the sedimentation profiles of the mutant recombinant strains in 
which the regulatory activity of the L20-interacting RNA was compromised (M1, M2, M4). 
This peak suggests an accumulation of precursor 50S subunit particles in the regulatory 
mutant recombinant strains and is indicative of defects in ribosome biosynthesis. Similar 
peaks corresponding to 50S subunit intermediates have been observed in the 
sedimentation profiles of bacterial strains in which ribosomal assembly factors have 
been deleted (Charollais et al. 2003, 2004; Jain 2008) and/or select ribosomal proteins 
have been overexpressed (Sykes et al. 2010). These data, in combination with the 
Sedimentation
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Figure 3.7. Ribosome sedimentation 
profiles of L20-interacting RNA 
recombinant strains grown at 15ºC. Cells 
were grown in 2XYT at 15ºC with shaking 
(225 rpm) until an OD600 ~0.3-0.4 was 
reached. Ribosomal subunit sedimentation 
profiles were resolved by 10-55% (w/v) 
sucrose density gradients. Arrows indicate 
peaks that are present in the profiles of the 
regulatory mutant recombinant strains, but 
not in those of the control strains.	
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results from our rRNA 5’ end processing assays, indicate that the impact of unregulated 
rplT expression is the formation or accumulation of improper ribosome assembly 
products. 
 
3.3 Discussion 
Many studies have identified, characterized, and compared the structures and 
mechanisms of the RNA elements responsible for the regulation of ribosomal proteins in 
bacteria. Furthermore, as the amount of available genomic data continues to increase, 
additional ribosomal protein cis-regulatory RNAs are being discovered, especially in non-
model species of bacteria. Many of these newly identified regulatory RNA structures are 
distinct from those previously characterized and are narrowly distributed to select 
bacterial phyla or classes. Despite these advances in the field, our understanding of the 
factors that influence the formation, conservation, and adaptive evolution of these 
diverse RNA cis-regulators within bacterial genomes is relatively nonexistent. To 
address these questions, we investigated how mutations to the native locus of the L20-
interacting RNA cis-regulator of ribosomal protein synthesis within the B. subtilis genome 
impact cell fitness. We show that disrupting the regulatory activity of this RNA structure 
results in constitutive downstream expression, reduced growth, aberrant rRNA 
processing, and the accumulation of a 50S ribosomal precursor species at low 
temperatures.  
Differences in rplT transcript levels as measured by qRT-PCR due to mutation 
and/or mis-regulation of the infC operon do not appear to significantly impact 
recombinant strain phenotype at 37ºC. The M1 and M4 regulatory mutant recombinant 
strains exhibited an increase in rplT levels at this temperature, but both strains grew 
comparably to the wild-type recombinant at 37ºC. Although the M2 regulatory mutant 
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recombinant strain demonstrated rplT transcript levels similar to those of the wild-type 
recombinant during both log and early stationary phase at 37ºC, the strain grew 
approximately 1.3 times slower than the wild-type recombinant strain at this temperature. 
Furthermore, despite these differences in rplT transcript levels and growth, all three 
regulatory mutant recombinant strains exhibited rRNA processing comparable to that of 
the wild-type recombinant strain at 37ºC.  
In contrast, rplT expression resulting from the loss of infC operon regulation had 
more severe impacts on regulatory mutant recombinant strain phenotype at 15ºC. The 
M1, M2, and M4 mutant recombinant strains all exhibited elevated constitutive rplT 
transcript levels in comparison to that of the wild-type recombinant at 15ºC, and the 
increased transcript levels were more pronounced during early stationary phase. 
Subsequently, all regulatory mutant recombinant strains demonstrated similar 
temperature-sensitive growth, rRNA processing, and ribosome assembly product 
distribution defects at 15ºC.  
Unlike the mutations that disrupt the function of the L20-interacting RNA 
regulator, the M3 control mutation did not cause any mutant phenotypes. Our β-
galactosidase assays indicate that the M3 reporter construct retained regulatory activity 
and the M3 mutant recombinant strain showed no cold-sensitive growth defects and no 
changes in rRNA processing and ribosomal subunit distribution at 15ºC compared to the 
168 parental and wild-type recombinant strains.  Although rplT transcript levels in the M3 
mutant recombinant strain were lower than that of the wild-type recombinant at both 
37ºC and 15ºC (especially during early stationary phase), the lack of mutant phenotype 
at both temperatures suggests that this under-expression does not significantly impact 
the biological outcome in these conditions. The behavior of the M3 control mutant 
recombinant strain further indicates that the cold-sensitive defects of the L20-interacting 
 54 
RNA M1, M2, and M4 regulatory mutant recombinant strains are primarily the result of 
unnecessary constitutive expression due to compromised infC operon autoregulation. 
Taken together, these results suggest that RNA cis-regulators of ribosomal protein 
synthesis are important for maintaining a balance between ribosomal protein operon 
expression and repression, especially under conditions in which the production of 
ribosomal components is not required, such as during entry into stationary phase or 
periods of slow or suboptimal growth at low temperatures.  
 Sensitivity to cold temperatures, reduced growth, rRNA maturation defects, 
and/or aberrant ribosomal subunit sedimentation profiles are hallmark characteristics of 
bacterial strains that harbor ribosomal protein mutations or deletions (Guthrie et al. 1969; 
Tai et al. 1969; Feunteun et al. 1974b; Isono and Krauss 1976; Isono et al. 1977). These 
phenotypes have also been observed in bacteria defective in specific rRNA helicases, 
rRNA or ribosomal protein modification enzymes, rRNA operon copy number, ribosome 
assembly GTPases, and other assembly and translation cofactors (Charollais et al. 
2003, 2004; Jain 2008; Bharat and Brown 2014; Choudhury and Flower 2015; Gyorfy et 
al. 2015). In this work, we demonstrate that constitutive expression driven by loss of 
autoregulation from subtle point mutations to a cis-regulatory RNA structure within the 
5’-UTR of a ribosomal protein operon transcript has similar impacts on ribosome 
assembly and cell fitness. Our findings reinforce the importance of the coordinated and 
stoichiometric production of ribosomal components for proper ribosome biosynthesis in 
bacteria. While the function of RNA cis-regulators of ribosomal protein synthesis is well 
understood, our study highlights the role of these regulatory RNA elements in optimal 
cell growth and informs us on the factors that influence the formation, evolution, and 
conservation of structured RNA regulators within bacterial genomes. Understanding the 
fitness costs associated with the loss of ribosomal protein RNA cis-regulators sets the 
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stage for the development of novel antimicrobials that target ribosome synthesis and 
assembly.  
 
3.4 Materials and Methods 
3.4.1 β-galactosidase activity assay plasmid and strain construction 
 To generate the protein overexpression plasmid and combat against the growth 
defects previously noted with strains that solely overexpressed L20 (Choonee et al. 
2007), the complete infC-rpmI-rplT operon, including the native infC Shine-Dalgarno 
sequence, was PCR-amplified from B. subtilis 168 genomic DNA (GenBank: AL009126, 
complement of 2952224-2953363) with primers containing EcoRI and PstI restriction 
sites and changing the infC ATT start codon to ATG for stronger expression (Table 3.1). 
After digestion, the PCR product was cloned into the pYH213 plasmid digested with the 
same enzymes, upstream from a PT7A1-lacO IPTG-inducible promoter (Yakhnin et al. 
2015). This plasmid, as well as an empty control plasmid (pAY132) (Yakhnin et al. 
2015), were transformed into B. subtilis 168 as described previously (Yasbin et al. 1975). 
Transformants were screened for resistance to tetracycline (12.5 µg/mL) and verified via 
PCR. 
To generate the infC’-’lacZ reporter constructs, the region containing the second 
native infC operon promoter (the major promoter for infC expression (Choonee et al. 
2007; Bruscella et al. 2011)), the wild-type L20-interacting RNA leader, and Shine-
Dalgarno sequence and first nine codons of infC was PCR-amplified from B. subtilis 168 
genomic DNA (GenBank: AL009126, complement of 2953323-2953586) with primers 
containing EcoRI and BamHI restriction sites and changing the infC ATT start codon to 
ATG for stronger expression (Table 3.1). The PCR product was cloned in-frame as a 
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translational fusion with a lacZ reporter into a modified pDG1728 plasmid digested with 
the same enzymes (Guérout-Fleury et al. 1996; Babina et al. 2017). Mutations to the 
L20-interacting RNA were obtained by site-directed mutagenesis or PCR assembly and 
verified via Sanger sequencing (Table 3.1). Reporter constructs were transformed into 
the above B. subtilis 168 pYH213/pAY132 protein overexpression strains as described 
previously (Jarmer et al. 2002). Transformants were selected on TBAB + 12.5 µg/mL 
tetracycline + 100 µg/mL spectinomycin and screened for proper integration of the lacZ 
reporter constructs into the amyE locus based on sensitivity to erythromycin (0.5 µg/mL) 
and loss of amylase activity (plating on TBAB + 1% starch and staining with Gram’s 
iodine solution, Sigma-Aldrich).  
 
3.4.2 β-galactosidase activity assays  
B. subtilis 168 lacZ reporter strains were grown from single colonies in 2 mL 
2XYT + 12.5 µg/mL tetracycline + 100 µg/mL spectinomycin for 16-18 hours at 37ºC with 
shaking (225 rpm). These cultures (30 µl for the pAY132 strains, 50 µl for the pYH213-
infC-rpmI-rplT strains) were used to inoculate 2 mL 2XYT + 12.5 µg/mL tetracycline + 
100 µg/mL spectinomycin + 1 mM IPTG cultures, which were then grown at 37ºC with 
shaking (225 rpm) until an OD600 ~0.3-0.7 was reached. Cells (1 mL) were harvested 
and re-suspended in 1 mL Z buffer (50 mM Na2HPO4, 40 mM NaH2PO4, 10 mM KCl, 1 
mM MgSO4, 50 mM 2-Mercaptoethanol) + 100 µg/mL spectinomycin. β-galactosidase 
activity assays were performed as previously described using 0.05 mL of cell 
suspensions. Miller Units were calculated as follows (Miller 1992): 
Miller Units = 1000 ∗  !!"#∆! !"#.  ∗ !!"" ∗ !"#.(!") 
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The values reported represent the mean of three or more independent replicates; error 
bars represent standard error of the mean across biological replicates. To determine the 
fold repression for each RNA reporter construct, the mean Miller Units for each empty 
plasmid reporter strain was divided by that of the corresponding infC operon 
overexpression strain. Standard error for the fold repression values were propagated 
from the error calculated for the Miller Units as described previously (Taylor 1997). 
 
3.4.3 L20-interacting RNA native locus recombinant strain construction 
The recombinant strains for the growth assays, qRT-PCR, rRNA processing 
assays, and ribosome sedimentation profiles were generated as described previously 
(Babina et al. 2017). Briefly, the second infC operon promoter, wild-type L20-interacting 
RNA leader, and two ~500 bp regions of homology flanking the promoter and regulatory 
RNA leader region were PCR-amplified from B. subtilis 168 genomic DNA (GenBank: 
AL009126; complement of 2953587-2954227 for the 5’ flanking ~500 bp region of 
homology, complement of 2953142-2953586 for the region containing the promoter, 
RNA leader, and 3’ flanking ~500 bp region of homology). A PCR product in which an 
erythromycin resistance cassette was introduced into the intergenic region immediately 
upstream from the second infC operon promoter was generated and cloned into pCR2.1 
or pCR4 TOPO-TA vector (Invitrogen). Mutations to the L20-interacting RNA were 
obtained via site-directed mutagenesis or PCR assembly (Table 3.1). These constructs 
were then transformed into B. subtilis 168 as described previously and transformants 
were screened for resistance to erythromycin (0.5 µg/mL) (Jarmer et al. 2002). 
Integration of the complete recombinant construct within the infC locus and the presence 
of the L20-interacting RNA mutations of interest were verified via PCR and Sanger 
sequencing. 
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 To generate the re-designed recombinant L20-interacting RNA strains in which 
the first native infC promoter immediately precedes the second infC promoter, new 5’ 
and 3’ ~500 bp regions of homology that flank the infC locus were PCR-amplified from B. 
subtilis 168 genomic DNA (GenBank: AL009126; complement of 2953643-2954227 for 
the 5’ flanking ~500 bp region of homology, complement of 2953142-2953642 for the 
region containing the promoters, regulatory RNA, and 3’ flanking ~500 bp region of 
homology). To prevent read-through from the erythromycin resistance cassette 
promoter, the region containing two Rho-independent terminators was PCR-amplified 
from the pYH213 plasmid (Yakhnin et al. 2015) and appended onto the 3’ end of the 
erythromycin resistance cassette via PCR assembly. Recombinant constructs were 
assembled and transformed into B. subtilis 168 as described above. 
 
3.4.4 Northern blots 
Total RNA was extracted from select B. subtilis 168 strains grown to log phase 
(OD600 ~0.3-0.7) in 20 mL 2XYT (+ 0.5 µg/mL erythromycin for recombinant strains) at 
37ºC with shaking (225 rpm). As a size-standard, template DNA corresponding to both 
the full-length and terminated infC-rpmI-rplT operon transcripts were PCR-amplified from 
B. subtilis 168 genomic DNA using forward primers that contained the T7 promoter 
sequence (GenBank: AL009126; complement of 2952168-2953550 for the full-length 
transcript, complement of 2953394-2953550 for the terminated transcript) (Table 3.1). 
T7 RNA polymerase was used to transcribe RNA from these templates, and transcription 
reactions were ethanol precipitated and re-suspended in TE buffer (Milligan et al. 1987). 
These transcripts (15 ng of full-length transcript, 3 ng of terminated transcript) and 10 µg 
of each total RNA sample were separated on a 0.8% denaturing agarose gel and 
transferred to an Amersham Hybond-N+ membrane (GE Healthcare) overnight, as 
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described previously (Rio 2015). The membrane was UV-crosslinked and pre-hybridized 
in 10 mL Ambion ULTRAhyb ultrasensitive hybridization buffer (Life Technologies) at 
37ºC or 42ºC for ~2-4 hours with rotation. Synthetic oligonucleotide DNA probes (40 
pmol, IDT) complementary to transcript regions of interest were 5’-end labeled with [γ-
32P] ATP (Perkin Elmer) (Regulski and Breaker 2008) and allowed to hybridize to the 
membrane overnight at 37ºC or 42ºC with rotation (Table 3.1). The membrane was 
washed twice with approximately 100 mL 2X SSC (300 mM NaCl, 30 mM trisodium 
citrate [pH 7.0]) + 0.1% SDS at 37ºC or 42ºC for 20 minutes with rotation, exposed to a 
phosphor screen for 16-72 hours, and imaged using a Typhoon FLA 9500 scanner (GE 
Life Sciences). The membrane was then stripped with boiling hot water + 0.1% SDS at 
70ºC with rotation until signal was removed and re-probed for a different transcript as 
described above.  
 
3.4.5 5’-RACE 
 Total RNA was extracted from a log phase (original) wild-type recombinant B. 
subtilis 168 culture grown at 37ºC as described above and 5’-RLM-RACE was 
performed following the Invitrogen GeneRacer protocol with a homemade RNA-linker 
(Weinberg et al. 2009). First-strand synthesis was performed with a gene-specific primer 
complementary to the erythromycin resistance cassette coding region (primer 1401, 
Table 3.1). The resulting cDNA was used as template for PCR with a forward primer 
specific to the RNA-linker and a nested reverse primer specific to the erythromycin 
resistance cassette coding region (primers 9 and 1400, Table 3.1). PCR products were 
cloned into pCR2.1 TOPO-TA vector (Invitrogen) and sequenced to identify transcription 
start sites. 
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3.4.6 Growth assays  
B. subtilis 168 strains were grown from single colonies in 0.5 mL 2XYT (+ 0.5 
µg/mL erythromycin for recombinant strains) in sterile non-treated 24-well cell culture 
plates for 16-18 hours at 37ºC with shaking (225 rpm). These cultures were used to 
inoculate 0.5 mL 2XYT (+ 0.5 µg/mL erythromycin for recombinant strains) cultures to a 
starting OD600 ~0.05 in sterile non-treated 24-well cell culture plates. Plates were 
incubated at 37ºC with shaking (225 rpm) for approximately 24 hours. OD600 values were 
recorded at time points indicated using a SpectraMax M3 Multi-Mode Microplate Reader 
(Molecular Devices). 
For the growth assays at 15ºC, B. subtilis 168 strains were grown from single 
colonies in 2 mL 2XYT (+ 0.5 µg/mL erythromycin for recombinant strains) for 16-18 
hours at 37ºC with shaking (225 rpm). Because cultures were not viable in 24-well plates 
for an extended period of time at 15ºC, these cultures were used to inoculate 25 mL 
2XYT (+ 0.5 µg/mL erythromycin for recombinant strains) cultures to a starting OD600 
~0.05 in sterile 250 mL flasks. Flasks were incubated at 15ºC with shaking (225 rpm) for 
approximately 100 hours. OD600 values were recorded at time points indicated using a 
NanoDrop 2000c (Thermo Fisher Scientific). 
Doubling times were calculated as previously described using exponential phase 
log10(OD600) values (Rubinow 1975). The values reported represent the mean of three or 
more independent replicates; the error reported is the standard error of the mean across 
biological replicates. To determine the significance, mutant recombinant strain doubling 
times were compared to those of the wild-type recombinant strain at the corresponding 
temperature using a Welch’s single-tailed T-test in Microsoft Excel. Values were 
considered significantly different if p<0.05. Representative growth curves are shown. 
 
 61 
3.4.7 Quantitative RT-PCR 
 Total RNA was extracted from early-to-mid log (OD600 ~0.3-0.7) and early 
stationary phase (OD600 ~2.0-3.0) B. subtilis 168 cultures grown in 20 mL 2XYT (+ 0.5 
µg/mL erythromycin for recombinant strains) at both 37ºC and 15ºC with shaking (225 
rpm). Genomic DNA was removed from 5 µg of total RNA by digestion with RQ1 DNase 
(Promega) at 37ºC for 40 minutes, followed by heat inactivation at 98ºC for 2 minutes, 
phenol-chloroform extraction, and ethanol precipitation. Reverse transcription was 
performed using the DNase-treated RNA, random hexamer, and SuperScript III 
according to the manufacturer’s protocol (Invitrogen). qPCR was conducted with the 
resulting cDNA using an ABI 7500 Fast Real-Time PCR system and SYBR green 
detection (ThermoFisher Scientific). infC operon transcript expression was quantified 
using primers targeting the rplT coding region and expression of nifU was used as an 
internal normalization control (Table 3.1) (Reiter et al. 2011). Experiments were repeated 
using reactions lacking reverse transcriptase to confirm removal of genomic DNA. Error 
bars represent the standard error of the mean across three technical replicates 
propagated using previously described calculations (Taylor 1997). 
 
3.4.8 Primer extension assays 
Log phase total RNA was extracted from B. subtilis 168 cultures grown at both 
37ºC and 15ºC as described above. For sequencing reaction templates, regions 
corresponding to the unprocessed 5’ ends of both the 16S and 23S rRNAs from the 
rrnW operon were PCR-amplified from B. subtilis 168 genomic DNA using forward 
primers that included the T7 promoter sequence (Table 3.1). PCR products were gel-
purified, cloned into pCR2.1 TOPO-TA vector (Invitrogen) for sequencing, and RNA was 
transcribed from these constructs using T7 RNA polymerase and purified by 6% 
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denaturing PAGE (Milligan et al. 1987). Synthetic oligonucleotide DNA primers (20 pmol, 
IDT) complementary to the mature 5’ ends of the 16S and 23S rRNAs were 5’-end 
labeled with  [γ-32P] ATP (Perkin Elmer) and purified via 12% denaturing PAGE (Regulski 
and Breaker 2008). 
For the primer extension reactions, 5 µg of total RNA or 1 pmol of in vitro 
transcribed RNA was combined with 1 µl of 32P-labeled primer (~30,000-50,000 cpm/µl) 
for a final volume of 12 µl in water. This mixture was denatured at 75ºC for 4 minutes 
and then flash frozen in a dry ice/ethanol bath for 2 minutes before being transferred to 
ice. SuperScript III (1 µl or 200 U, Invitrogen) and 7 µl of the following master mix were 
then added to each reaction, for a total reaction volume of 20 µl and a final reaction 
concentration of: 50 mM Tris HCl [pH 8.3], 75 mM KCl, 3 mM MgCl2, 5 mM DTT, 0.5 mM 
each dNTP, and 20 U SUPERase-In (Invitrogen). For the sequencing reactions, 1 µl of 
100 mM ddNTP (TriLink Biotechnologies) was also added to the appropriate reaction. 
Reactions were incubated at 55ºC for 30 minutes, stopped with 20 µl of formamide 
loading dye (95% formamide, 20 mM EDTA [pH 8.0], 0.05% bromophenol blue, 0.05% 
xylene cyanol), and 8 µl of each sample was separated by 10% denaturing PAGE. Prior 
to loading, samples were heated at 75ºC for 4 minutes and then cooled on ice for 2 
minutes. Gels were dried, exposed to phosphor screens for 48-72 hours, and imaged 
using a Typhoon FLA 9500 scanner (GE Life Sciences) (modified from (Britton et al. 
2007)). Primer extension reactions were performed on RNA extracted from three or 
more independent biological replicates of each strain, grown to log phase at both 37ºC 
and 15ºC. Representative gels are shown. 		
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3.4.9 Ribosome sedimentation profiles 
 B. subtilis 168 strains were grown from single colonies in 2 mL 2XYT (+ 0.5 
µg/mL erythromycin for recombinant strains) for approximately 16-18 hours at 37ºC with 
shaking (225 rpm). These cultures were used to inoculate 250 mL 2XYT (+ 0.5 µg/mL 
erythromycin for recombinant strains) cultures to a starting OD600 ~0.05 in sterile 1L 
flasks. Flasks were incubated at 15ºC with shaking (225 rpm) until an OD600 ~0.3-0.4 
was reached. Samples were prepared as previously described (Li et al. 2014). Briefly, 
cells were harvested by rapid filtration using BioTrace NT pure nitrocellulose 0.2 µm 
membrane filters (Pall Life Sciences) and flash frozen in liquid nitrogen. Cell pellets were 
combined with 550 µl of frozen droplets of lysis buffer (20 mM Tris [pH 8.0], 100 mM 
NH4Cl, 10 mM MgCl2, 0.4% Triton X-100, 0.1% NP-40, 1 mM chloramphenicol, 100 
U/mL DNase I) in 10 mL canisters (Retsch) pre-chilled in liquid nitrogen and pulverized 
by mixer milling (Qiagen Tissuelyzer II). The resulting lysates were thawed and clarified 
by centrifugation, and 200 µl of the supernatants were layered onto 10-55% (w/v) 
sucrose gradients prepared in 20 mM Tris [pH 8.0], 100 mM NH4Cl, 10 mM MgCl2, and 1 
mM chloramphenicol. Gradients were centrifuged at 35000 rpm at 4ºC for 2.5 hours 
(Beckman Coulter) and then analyzed at 254 nm using a Biocomp Gradient Station iP, 
Bio-Rad Econo UV Monitor, and Gradient Profiler software. 
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Table 3.1. Oligonucleotides used in this study.  
For each primer pair, the forward primer is listed first and the reverse primer is listed second. 
 
Name Sequence (5'-3') Notes 
1349 
 
GGCCCGAATTCTATGGAGGTGGCTCA
TGATTAGCAAAGATC 
Primer for cloning infC-rpmI-rplT 
operon into pYH213 protein 
overexpression vector (Yakhnin et 
al. 2015); EcoRI restriction site in 
bold; ATT to ATG is underlined 
1351 
 
GCCGGCTGCAGTTACTTGTTTAATTGA
G 
 
Primer for cloning infC-rpmI-rplT 
operon into pYH213 protein 
overexpression vector (Yakhnin et 
al. 2015); PstI restriction site in 
bold 
1357 GTTGATCAGTCAACTTATCTGTATAG Primer for PCR checks and 
sequencing of pYH213 protein 
overexpression constructs 
1358 CGTTTAAGGGCACCAATAACTG Primer for PCR checks and 
sequencing of pYH213 protein 
overexpression constructs 
866 CGCGCGAATTCTTGACTAAAGATCCG
GTATTGTGTAG 
Primer for cloning L20-interacting 
RNA into modified pDG1728 
reporter vector (Babina et al. 
2017); EcoRI restriction site in 
bold 
867 GCGCGGATCCATTAACCAATTGATCTT
TGCTAATCAT 
Primer for cloning L20-interacting 
RNA into modified pDG1728 
reporter vector (Babina et al. 
2017); BamHI restriction site in 
bold; ATT to ATG is underlined 
204 TATCTCTTGCCAGTCACGTTACG Primer for PCR checks and 
sequencing of pDG1728 reporter 
constructs 
122 GGGGACGACGACAGTATCGGCCTC Primer for PCR checks and 
sequencing of pDG1728 reporter 
constructs 
691 
 
CGAGGATCCTCGCTTTCTGCTCTTTTT
GGATTG 
Primer for amplifying 5'-500 bp 
region of L20-interacting RNA 
recombinant construct; BamHI 
restriction site in bold, if needed 
692 
 
CTTTAGGGTTATCGAATTCGATAAGCT
TCTAGGACGACTTATCCGGAACAACTT
TTACATTG 
Primer for amplifying 5'-500 bp 
region of L20-interacting RNA 
recombinant construct 
693 
 
CCCTAGCGCCTACGGGGAATTTGTAT
CGCGGCCGCTTGACTAAAGATCCGGT
ATTGTGTAG 
Primer for amplifying 3'-500 bp 
region of L20-interacting RNA 
recombinant construct 
774 GCTCAAATCGGAACTTACCGTAG 
 
Primer for amplifying 3'-500 bp 
region of L20-interacting RNA 
recombinant construct 
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681 TAGAAGCTTATCGAATTCGATAACCCT
AAAG 
Primer for amplifying erythromycin 
resistance cassette from 
pDG1663 (Guérout-Fleury et al. 
1996) 
682 GCGGCCGCGATACAAATTAAAAGTAG
GCG 
Primer for amplifying erythromycin 
resistance cassette from 
pDG1663 (Guérout-Fleury et al. 
1996) 
720 
 
CGTCATCAGGAAGCTCTGAAGCTG 
 
Primer for confirming genomic 
integration of recombinant 
constructs 
775 
 
GAATTTAATCGCATTGCGCAATTTCGT
G 
 
Primer for confirming genomic 
integration of recombinant 
constructs 
745 GCAATGAAACACGCCAAAGTAAAC Primer for PCR checks, 
sequencing recombinant L20-
interacting RNA constructs 
1081 
 
GAATTGAATATAAATCACTTGCAGAAG
CACCCGCTTC 
Mutagenesis primer for M1, 
protein-binding mutation  
1082 
 
GAAGCGGGTGCTTCTGCAAGTGATTT
ATATTCAATTC 
Mutagenesis primer for M1, 
protein-binding mutation 
746 
 
GAAGCACCCGCTTCTCAGGTGATTGA
CACATGC 
Mutagenesis primer for M2, 
protein-binding mutation 
747 
 
GCATGTGTCAATCACCTGAGAAGCGG
GTGCTTC 
Mutagenesis primer for M2, 
protein-binding mutation 
1294 
 
GACCGTACATTTTTACCGATACAGATG
TTCGTAG 
Mutagenesis primer for M3, 
control mutation 
1295 
 
CTACGAACATCTGTATCGGTAAAAATG
TACGGTC 
Mutagenesis primer for M3, 
control mutation 
1412 
 
GGGTGTTTTATAATGCGGTGCATTTTT
GTTTGCCTGC 
Mutagenesis primer for M4, 
terminator mutation 
1413 
 
GCAGGCAAACAAAAATGCACCGCATT
ATAAAACACCC 
Mutagenesis primer for M4, 
terminator mutation 
1692 GGAAACTATGCTTTCCGTGACC Primer for qRT-PCR targeting the 
rplT coding region 
1693 TAAGAAAGGCCGTTCATGCG Primer for qRT-PCR targeting the 
rplT coding region 
1546 TTTTACTTCGTGACGGCGGT Primer for qRT-PCR targeting 
nifU, the normalization control 
1547 TTGTTGAACTTGGGCAGCTG Primer for qRT-PCR targeting 
nifU, the normalization control 
8 TAATACGACTCACTATAGG T7 promoter primer for generating 
5’-RACE RNA-linker 
7 TTTCTACTCCTTCAGTCCATGTCAGTG
TCCTCGTGCTCCAGTCGCCTATAGTG
AGTCGTATTA 
Primer for generating 5’-RACE 
RNA-linker 
1401 CAGATAGATGTCAGACGCATGGC 
 
Erythromycin resistance cassette 
outer reverse primer for cDNA 
synthesis (RT) 
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9 GACTGGAGCACGAGGACACTGA 5’-RACE RNA-linker forward 
primer for PCR 
1400 GCCAGTTTCGTCGTTAAATGCCC 
 
Erythromycin resistance cassette 
nested reverse primer for PCR 
1107 
 
GCGGGTGCTTCTGCTTGTGATTTATAT 
 
Northern blot probe for L20-
interacting RNA (Choonee et al. 
2007); hybridize and wash at 42ºC 
1402 GTTTACTTTGGCGTGTTTCATTGC Northern blot probe for 
erythromycin resistance cassette 
coding sequence; hybridize and 
wash at 37ºC 
1448 CTTTAGGGTTATCGAATTCGATAAGCT
TCTAGAGAGAAAAAGAAAATCTTTCAT
CCCCAC 
Primer for amplifying 5'-500 bp 
region of L20-interacting RNA re-
designed recombinant construct; 
use with 691 
1449 
 
CGCCTACGGGGAATTTGTATCGTTTAA
ACTTGCGCTCATAGAAAACCCATGTTA
CAATG 
Primer for amplifying 3'-500 bp 
region of L20-interacting RNA re-
designed recombinant construct; 
use with 774 
1444 CTGACAGCTTCCAAGGAGCTAAAGAG
GTCTCCTGTTGATAGATCCAGTAATGA
CC 
 
Primer for amplifying double 
terminator construct from pYH213 
(Yakhnin et al. 2015) for 
appending onto 3’ end of 
erythromycin resistance cassette 
from pDG1663 for re-designed 
recombinant constructs 
1445 
 
GGTCATTACTGGATCTATCAACAGGA
GACCTCTTTAGCTCCTTGGAAGCTGTC
AG 
Primer for amplifying double 
terminator construct from pYH213 
(Yakhnin et al. 2015) for 
appending onto 3’ end of 
erythromycin resistance cassette 
from pDG1663 for re-designed 
recombinant constructs 
1446 
 
GTTTAAACGATACAAATTCCCCGTAGG
CGCTAGGGAAAAAAATTACGCCCCGC
CCTGCC 
Primer for appending double 
terminator construct onto 3’ end of 
erythromycin resistance cassette 
from pDG1663 for re-designed 
recombinant constructs; use with 
primer 681 
1109 
 
CCAAGTAATACGACTCACTATAGGAAT
TGAATATAAATCACAAGCAGAAG 
 
T7 in vitro transcription primer for 
infC operon transcription start; T7 
promoter sequence is underlined 
1110 
 
GAATGCATTTTGCAGGC 
 
T7 in vitro transcription primer for 
terminated infC operon transcript 
1296 
 
GTTGCCTCATCCTTTATATAG 
 
T7 in vitro transcription primer for 
full-length infC operon transcript 	 	
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1621 CCAAGTAATACGACTCACTATAGGCTT
TAACAAAGCGGACAAACAAAATGATC 
T7 in vitro transcription primer for 
16S rRNA sequencing reaction 
template (modified from (Britton et 
al. 2007)); T7 promoter sequence 
is underlined 
1432 CAGCGTTCGTCCTGAGCCAG Primer for 16S rRNA sequencing 
reaction template, primer 
extension reactions (modified from 
(Britton et al. 2007)) 
1623 CCAAGTAATACGACTCACTATAGGACC
TTGGGTCTTATAAACAGAACG 
T7 in vitro transcription primer for 
23S rRNA sequencing reaction 
template (modified from (Redko et 
al. 2008)); T7 promoter sequence 
is underlined 
1434 CATCGGCTCCTAGTGCCAAGGCATC Primer for 23S rRNA sequencing 
reaction template, primer 
extension reactions (modified from 
(Redko et al. 2008)) 
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4.1 Introduction 
The glycine riboswitch regulates the expression of glycine metabolic and 
transport genes in bacteria. It was among the first riboswitches discovered, and since 
then, more than 7000 homologs have been identified across numerous bacterial species 
(Mandal et al. 2004; Ruff et al. 2016). Many examples of the glycine riboswitch, including 
those found in B. subtilis and Vibrio cholerae, are composed of two tandem glycine-
binding aptamers followed by a single expression platform. Currently, the glutamine 
riboswitch is the only other known tandem riboswitch in which two or more separate 
homologous metabolite-sensing aptamers are proposed to act together on a single 
expression platform (Ames and Breaker 2011). Other examples of tandem riboswitches 
typically consist of two or more complete and functionally independent riboswitches 
(Welz and Breaker 2007; Poiata et al. 2009; Zhou et al. 2016). 
Due to its unique architecture, the structure and molecular dynamics of the 
tandem glycine riboswitch have been the subject of numerous biochemical and 
biophysical studies (Mandal et al. 2004; Lipfert et al. 2007; Kwon and Strobel 2008; 
Lipfert et al. 2010; Huang et al. 2010; Erion and Strobel 2011; Butler et al. 2011; 
Kladwang et al. 2011; Sherman et al. 2012; Baird and Ferré-D’Amaré 2013; Esquiaqui et 
al. 2014; Ruff and Strobel 2014; Ruff et al. 2016). Initial experiments demonstrated 
cooperative glycine-binding behavior between the two homologous aptamers in vitro 
(Mandal et al. 2004; Kwon and Strobel 2008; Erion and Strobel 2011), and subsequent 
work proposed a model of sequential glycine binding and asymmetrical cooperativity 
(Lipfert et al. 2007; Kwon and Strobel 2008; Lipfert et al. 2010; Huang et al. 2010; Erion 
and Strobel 2011; Butler et al. 2011). Later studies identified a highly conserved leader-
linker kink-turn interaction that promotes riboswitch folding and glycine binding 
(Kladwang et al. 2011; Sherman et al. 2012; Baird and Ferré-D’Amaré 2013; Esquiaqui 
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et al. 2014). These results suggested that the full-length tandem glycine riboswitch did 
not demonstrate cooperative binding and the observed cooperativity was an artifact of 
the truncated constructs utilized for in vitro characterization. The current model for 
tandem glycine riboswitch function is based on extensive analysis of the glycine-binding 
and dimerization affinities of the two aptamers and proposes that aptamer dimerization 
and ligand binding are linked equilibria; dimerization interactions promote glycine binding 
and subsequent glycine binding further stabilizes riboswitch tertiary structure to allow for 
gene control (Ruff and Strobel 2014). Furthermore, recent work with naturally occurring 
“singlet” glycine riboswitches (one aptamer followed by a single expression platform) 
demonstrated that singlet riboswitches bind glycine with affinities comparable to those 
with the tandem aptamer architecture. However, singlet glycine riboswitches still require 
interactions between the aptamer domain and a flanking stem-loop “ghost aptamer” for 
proper folding and ligand-binding activity (Ruff et al. 2016). 
While the in vitro techniques applied to the tandem glycine riboswitch provide 
invaluable insight into structure and mechanism of action, such experiments do not 
always accurately reflect behavior within the cell. Therefore, to examine the tandem 
glycine riboswitch in a more biologically relevant context, we characterized the 
expression changes resulting from a panel of B. subtilis glycine riboswitch mutants 
designed to probe aspects of the in vitro folding models using β-galactosidase reporter 
assays. To understand the impact such changes have on organism fitness, we 
introduced these mutations into the native locus of the tandem glycine riboswitch 
preceding the gcvT glycine cleavage operon within the B. subtilis genome and examined 
organism phenotype under a variety of conditions.  
Our data suggest that mutations disrupting first aptamer tertiary structure have 
the greatest impact on tandem glycine riboswitch regulation and gene expression. We 
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find that glycine-induced expression of the gcvT operon is necessary for B. subtilis 
growth, swarming motility, and biofilm formation in high glycine environments. However, 
constitutive expression of the gcvT operon in the absence of glycine also has adverse 
effects on growth, emphasizing the importance of the tandem glycine riboswitch function 
as a genetic “on” switch in response to excess glycine.   
 
4.2 Results 
4.2.1 Double ligand occupancy is not necessary to elicit a regulatory response  
To investigate the impacts of disruptions to glycine-binding and inter-aptamer 
interactions on glycine riboswitch in vivo regulation, we examined a number of mutations 
to the tandem riboswitch structure using β-galactosidase reporter assays in B. subtilis 
(Figure 4.1A). Each mutant riboswitch sequence, including the first nine codons of gcvT, 
was cloned in-frame as a translational fusion with a lacZ reporter under the control of the 
native gcvT operon promoter, and then stably integrated as a single copy into the amyE 
locus of the B. subtilis 168 genome. The regulatory properties of each riboswitch mutant 
were then assessed by measuring β-galactosidase activity of reporter strains grown in 
varying glycine concentrations. As expected, the wild-type riboswitch construct behaved 
as a genetic “on” switch in the presence of glycine (Figure 4.1B). The β-galactosidase 
activity of the wild-type riboswitch reporter strain increased approximately 17-fold upon 
the addition of 0.25% glycine to the medium, and this activity level was maintained for all 
subsequent glycine concentrations tested.  
Mutations M1 and M2 target the glycine-binding domains on the first and second 
aptamer, respectively (Figure 4.1A). These bases have been shown to be important for 
glycine binding via inline probing experiments with both the B. subtilis and V. cholerae 
riboswitches and are in close proximity to the ligand in the crystal structure of the 
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Fusobacterium nucleatum RNA (Mandal et al. 2004; Kwon and Strobel 2008; Erion and 
Strobel 2011; Butler et al. 2011). Additionally, previous in vitro work with homologous V. 
cholerae glycine riboswitch mutants demonstrated that each binding-site mutation 
disrupts glycine binding independently and that the ability of one aptamer to bind glycine 
only has a small effect on the glycine-binding affinity of the other aptamer (Ruff and 
Strobel 2014). 
We find that mutation M1 significantly reduced, but did not completely abolish 
riboswitch responsiveness to glycine and downstream gene expression. The maximum 
Miller Units measured with the M1 construct were approximately one-tenth of those 
obtained with the wild-type construct (0.7 ± 0.06 Miller Units versus 5.9 ± 0.52 Miller 
Units, respectively, in 1% glycine). Surprisingly, the M2 mutation to the glycine-binding 
pocket on the second aptamer did not affect riboswitch regulation in response to glycine  
 
 
Figure 4.1. Regulatory activity of glycine riboswitch mutations. (A) Secondary structure of the 
B. subtilis glycine riboswitch with mutations M1-M8. Nucleotides are numbered from the transcript 
start site, +1 (Irnov et al. 2010). Gray shading highlights nucleotides that base pair to form the 
transcription terminator stem when the riboswitch is in the “off” conformation. (B) β-galactosidase 
activity (in Miller Units) of riboswitch mutant constructs in the presence of increasing glycine 
concentrations. The values reported represent the mean of three or more independent 
experimental replicates; error bars represent standard error of the mean across biological 
replicates. WT, wild-type reporter. 	
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or maximum gene expression levels (6.9 ± 0.33 Miller Units compared to 5.9 ± 0.52 
Miller Units from wild type in 1% glycine) (Figure 4.1B).  
This is in contrast to previous in vitro studies with the V. cholerae riboswitch that 
demonstrate disruptions to the glycine-binding site on the second aptamer have the 
greatest impact on the binding affinity of the first aptamer (Ruff and Strobel 2014). The 
M2 single mutation also resulted in higher basal β-galactosidase activity in comparison 
to the wild-type construct at 0% glycine. The proximity of the M2 mutation to the adjacent 
terminator stem may affect terminator stability, resulting in the elevated basal 
constitutive expression. In agreement with published findings, the M1+M2 double 
glycine-binding mutant construct abrogated regulation (Ruff and Strobel 2014).  
Finally, to determine if mutations to the glycine-binding domain on one aptamer 
influence the glycine-binding sensitivity and dynamic range of the other aptamer, we 
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Figure 4.2. Sensitivity and dynamic 
range of the M1 and M2 glycine 
riboswitch reporter constructs. (A) β-
galactosidase activity (in Miller Units) of the 
glycine-binding mutant riboswitch reporter 
constructs in the presence of increasing 
glycine concentrations. (B) Data in A 
normalized to represent fraction of β-
galactosidase activity for the glycine 
riboswitch reporter constructs at each 
glycine concentration tested. The values 
reported represent the mean of two or 
more independent experimental replicates. 
Error bars represent standard error of the 
mean across biological replicates; some 
error bars may be smaller than the data 
points. For both A and B, the x-axis is 
graphed on a log10 scale. WT, wild-type 
reporter. 	
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measured β-galactosidase activity from the wild-type, M1, and M2 glycine riboswitch 
reporter strains grown in range of additional glycine concentrations (Figure 4.2). Apart 
from the high basal β-galactosidase activity characteristic of the M2 mutation at low 
glycine concentrations, the M2 mutant construct behaved similarly to the wild-type 
riboswitch under all conditions tested. This indicates that the glycine-binding sensitivity 
of the first aptamer is comparable to that of a tandem glycine riboswitch construct in 
which both glycine-binding domains remain intact. Basal β-galactosidase activity was 
recorded with the M1 construct for the majority of the glycine concentrations tested 
during this experiment. The modest regulatory response previously measured for the M1 
reporter was observed only for glycine concentrations greater than 0.1%. Thus, the 
glycine-binding ability of the second aptamer does not appear to have the same range of 
sensitivity as the first aptamer. Altogether, based on the behavior of the M1 and M2 
single and double mutant constructs, glycine must bind to at least one aptamer to 
promote a regulatory response. However, glycine binding to the first aptamer is 
necessary to drive maximum downstream gene expression and allows for a more 
sensitive regulatory response to subtle changes in glycine concentration. 
 
4.2.2 Inter-aptamer interactions are important for tandem glycine riboswitch 
regulation 
 The M3 and M4 mutations were designed based on the structural data of the 
homologous F. nucleatum riboswitch and target the U-A γ inter-aptamer contacts that are 
proposed to play a crucial role in communicating the status of glycine binding between 
the two aptamers (Figure 4.1A) (Butler et al. 2011). Mutating this dimerization interface 
on the first aptamer (M3) resulted in a complete loss of regulation. However, the M4 
mutation to the second aptamer retained regulatory activity in response to glycine, 
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although the maximum Miller Units obtained were about one-third of those measured 
with the wild-type riboswitch construct (Figure 4.1B).  
This finding is the reverse of what has been reported with previous in vitro 
mutational analyses of the dimerization interface. A point mutation homologous to M4 on 
the V. cholerae riboswitch was found to have the most severe impact on aptamer 
dimerization via trans gel-shift assays (Ruff and Strobel 2014). Mutating the γ 
dimerization interface on both aptamers (M3+M4) abrogated glycine riboswitch function 
and yielded basal expression levels that were slightly higher than those measured for 
the M3 single mutant construct (0.27 ± 0.06 Miller Units for the M3+M4 construct 
compared to 0.12 ± 0.02 Miller Units for the M3 construct at 1% glycine).  
To examine the importance of inter-aptamer interactions for glycine binding and 
consequent regulation, we combined each dimerization mutant with the mutation to the 
glycine-binding pocket on the opposite aptamer (M1+M4 and M2+M3). The M1+M4 
mutant displayed total loss of regulation and downstream expression, whereas the 
M2+M3 double mutant retained regulatory activity and modest downstream expression. 
Similar to the single dimerization mutants (M3, M4), the behavior of the M1+M4 and 
M2+M3 double mutant constructs was the opposite of what has been previously 
observed. Equilibrium dialysis assays with a V. cholerae glycine riboswitch construct 
homologous to our M2+M3 construct resulted in the greatest reduction in glycine-binding 
affinity (Ruff and Strobel 2014). Taken together, we find that although regulation can 
occur with a disrupted dimerization interface (M4) and in combination with loss of 
glycine-binding to the second aptamer (M2+M3), proper tandem glycine riboswitch 
function and maximum gene expression appear to depend on the stabilization provided 
by inter-aptamer interactions and glycine binding to the first aptamer.  
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4.2.3 The leader-linker kink-turn is required for tandem glycine riboswitch 
function 
To investigate the impact of the leader-linker interaction, the M5 mutation 
disrupts the kink-turn that forms the P0 helix found in over 90% of tandem glycine 
riboswitches (Figure 4.1A) (Kladwang et al. 2011; Sherman et al. 2012). Previous inline 
probing, native gel analysis, small-angle X-ray scattering, and isothermal titration 
calorimetry experiments showed that this leader-linker interaction is formed independent 
of glycine and results in a more stable and compact structure that enhances glycine-
binding and inter-aptamer interactions (Kladwang et al. 2011; Sherman et al. 2012; Baird 
and Ferré-D’Amaré 2013; Esquiaqui et al. 2014). Truncations of the 5’ leader and 
mutations to the linker region that disrupt the formation of the P0 helix in the V. cholerae 
riboswitch significantly reduced the ligand-binding affinity of the RNA in vitro. The M5 
mutation disrupting the kink-turn resulted in a complete loss of regulation. Combining the 
M5 mutation with the glycine-binding mutation on the second aptamer (M2+M5) also 
resulted in loss of regulation and yielded Miller Units similar to that of the M5 single 
mutant construct and the M1+M4 double mutant (Figure 4.1B). This supports previous 
findings indicating that the leader-linker kink-turn plays a key role in riboswitch-mediated 
regulation and is important for glycine binding to the first aptamer. 
 
4.2.4 Control mutations to the glycine riboswitch behave as anticipated  
The M6 mutation destabilizes the base of the Rho-independent terminator stem 
that forms when the riboswitch is in the “off” conformation in the absence of glycine. As 
expected, this mutation allowed constitutive expression of the lacZ reporter (Figure 4.1). 
The slight increase in β-galactosidase activity in the presence of glycine (~2-fold 
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increase) can be attributed to further destabilization of the terminator upon glycine 
binding and aptamer dimerization, as these domains remain intact. 
We designed mutations M7 and M8 as controls that target regions on the first 
and second aptamer, respectively, in which RNA structure is conserved, but nucleotide 
composition varies (Figure 4.1) (Mandal et al. 2004). Riboswitch regulation remained 
intact for both of these mutant constructs with Miller Units comparable to that of the wild-
type riboswitch under all glycine concentrations tested. The basal β-galactosidase 
activity of the M8 mutant construct in the absence of glycine was modestly higher than 
that of the wild-type and M7 mutant riboswitch constructs. Like the M2 single mutation, 
this mutation may also result in a slight change in the conformation of the second 
aptamer, possibly affecting its glycine-binding affinity, dimerization interactions, or the 
stability of the adjacent terminator stem when in the “off” conformation.  
 
4.2.5 gcvT expression of native locus recombinant strains reflects  
β-galactosidase assay data 
In B. subtilis, the tandem glycine riboswitch turns on expression of the gcvT 
operon (encoding components of the glycine cleavage system, gcvT, gcvPA, and gcvPB, 
that catabolize glycine to ammonia, carbon dioxide, and one carbon units utilized via the 
folate pool) in response to glycine (Mandal et al. 2004; Kikuchi et al. 2008; Tezuka and 
Ohnishi 2014). To explore the physiological role of the glycine riboswitch and determine 
whether gcvT operon expression changes resulting from mutations to the riboswitch 
impact B. subtilis fitness and growth, we replaced the native copy of the glycine 
riboswitch within the B. subtilis NCIB 3610 genome with either a wild-type or mutant 
recombinant version (Figure 4.3A). A recombinant strain in which the entire gcvT-gcvPB 
locus was deleted was also generated to serve as a negative control (ΔgcvT-gcvPB). To 
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confirm our β-galactosidase assay results accurately represent changes in glycine 
riboswitch regulation and gene expression in the NCIB 3610 mutant recombinant strains, 
we performed quantitative RT-PCR (qRT-PCR) using primers within the gcvT coding 
region on log phase total RNA from each of the recombinant strains grown in M9 
minimal medium +/- 0.25% glycine (Figure 4.3B).  
These results are generally in good agreement with our reporter assay data 
(Figure 4.1B) and further confirm the behavior of the B. subtilis tandem glycine 
riboswitch as an “on” switch that regulates gcvT operon expression via a transcription 
terminator in response to glycine. The mutations that retained riboswitch function in the 
β-galactosidase assays (M1, M2, M4, M2+M3) exhibited similar trends in regulatory 
activity and expression as measured by qRT-PCR. Likewise, mutations M3, M5, M1+M4, 
		
Figure 4.3. Construction and confirmation of recombinant glycine riboswitch B. subtilis 
strains. (A) Schematic of the strategy used to generate the recombinant B. subtilis NCIB 3610 
strains. The gcvT operon promoter (PgcvT), glycine riboswitch, and two ~500 bp regions flanking 
the promoter and riboswitch locus were PCR-amplified from B. subtilis 168 genomic DNA. A PCR 
product in which an erythromycin resistance cassette (erm) was introduced into the intergenic 
region immediately upstream from the gcvT operon promoter was generated. Transformation of 
cloned PCR products into B. subtilis NCIB 3610 replaced the native copy of the glycine riboswitch 
with either a wild-type or mutant recombinant version via double-crossover homologous 
recombination. (B) qRT-PCR quantification of the native gcvT transcript from each of the 
recombinant glycine riboswitch strains grown in M9 minimal medium +/- 0.25% glycine. For each 
strain/condition, gcvT expression was normalized to expression of the nifU control transcript. 
Graph depicts relative gcvT expression from each strain compared to gcvT expression from the 
wild-type recombinant (WT) grown in the absence of glycine (0% glycine). Error bars represent 
standard error of the mean across three technical replicates. NCIB 3610, parental strain. 	
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and M2+M5 abrogated glycine riboswitch regulation and resulted in gcvT transcript 
expression levels comparable to that of the ΔgcvT-gcvPB operon deletion recombinant 
strain. The recombinant strain carrying the M6 mutation to the terminator exhibited 
elevated constitutive expression of the gcvT transcript regardless of the presence or 
absence of glycine. Also consistent with our previous data, the presence of the M1+M2 
double mutation removed riboswitch regulation and resulted in basal gcvT transcript 
expression.  
 The only major discrepancy between the qRT-PCR results and our β-
galactosidase assays is the behavior of the M3+M4 mutant. While the β-galactosidase 
assays suggest the M3+M4 mutation resulted in loss of riboswitch function and slightly 
elevated basal expression, our qRT-PCR data indicate that riboswitch regulation is 
retained in the corresponding mutant recombinant strain.  Additionally, the control 
recombinant strains containing mutations M7 and M8 exhibited gcvT transcript levels 
approximately 4 to 5-fold higher than that of the wild-type recombinant strain when 
grown in 0.25% glycine. This increase in expression is not represented in the reporter 
assay data where the M7 and M8 mutant constructs yielded Miller Units comparable to 
that of the wild-type construct in the presence of glycine. These discrepancies may be 
attributable to differences between B. subtilis strains 168 and NCIB 3610, to the 
increased sensitivity of qRT-PCR relative to β-galactosidase assays, or to the 
measurement of the native transcript rather than a translational reporter that does not 
include the entire transcript. 
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4.2.6 gcvT operon expression affects glycine sensitivity and doubling time 
during planktonic growth 
Once the behavior of the glycine riboswitch mutations was confirmed in the 
recombinant B. subtilis NCIB 3610 strains, growth curves were performed with all 
recombinant strains in M9 minimal medium with increasing glycine concentrations (Table 
4.1). High glycine concentrations are known to inhibit bacterial growth, as excess glycine 
interferes with cell wall biosynthesis (Snell and Guirard 1943; Gordon et al. 1951; 
Hishinuma et al. 1969, 1971; Hammes et al. 1973; Tezuka and Ohnishi 2014). In 
agreement with these observations, we observed a reduction in maximum growth for all 
recombinant strains in the presence of glycine, and the doubling times increased for 
nearly all strains as the glycine concentration in the medium was increased (Table 4.1). 
Prolonged lag phase and abnormal or little to no cell growth was also observed for most 
strains in 1% glycine; this is reflected in the high standard error reported for this glycine 
concentration (Hishinuma et al. 1969). 
Strikingly, the strain harboring the M6 mutation to the terminator stem grew 
approximately 1.3 times slower than the wild-type recombinant strain in medium lacking 
glycine. Furthermore, its doubling time decreased upon the addition of 0.25% glycine to 
the medium  (101 min to 88 min), and growth was comparable to that of the wild-type 
recombinant strain in all glycine-supplemented conditions.  As the M6 mutation results in 
constitutive expression of the gcvT operon, unnecessary expression of the glycine 
cleavage system in the absence of glycine appears to have adverse effects on cell 
growth, and this defect is rescued in the presence of glycine.  
As expected, the ΔgcvT-gcvPB recombinant strain grew comparably to the wild-
type recombinant in medium lacking glycine and demonstrated a significant increase in 
doubling time upon the addition of glycine to the medium, growing approximately 1.3 
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times slower than wild-type recombinant in all glycine concentrations tested. This 
suggests that the gcvT glycine cleavage operon is important for glycine detoxification in 
B. subtilis. The M5, M1+M4, and M2+M5 mutant recombinant strains also displayed a 
modest increase in doubling time relative to the wild-type recombinant upon the addition 
of glycine to the medium. The increase in glycine sensitivity of these mutant recombinant 
strains during planktonic growth can be attributed to extremely low expression of the 
gcvT operon (Figure 4.1B, 4.3B), further supporting the role the gcvT operon plays in 
glycine detoxification. 
No increase in glycine sensitivity was observed for the majority of the glycine 
riboswitch mutant recombinant strains that retained regulatory activity (M1, M2, M4, M7, 
M8, M2+M3). The doubling times of these strains remained consistent relative to that of 
Table 4.1. Doubling times (min) of recombinant glycine riboswitch B. subtilis strains 
grown in increasing glycine concentrations. Strains were grown in M9 minimal medium 
with increasing glycine concentrations at 37ºC with shaking (225 rpm) for 24 hours. Values 
reported are the mean of three or more independent experimental replicates; ± indicates the 
standard error of the mean across biological replicates. Numbers in parentheses denote strain 
doubling time relative to that of the wild-type recombinant (WT) strain. Asterisks (*) indicate 
strains that grew significantly worse than the wild-type recombinant strain at the corresponding 
glycine concentration (p<0.05). NCIB 3610, parental strain. 
 
Strain 0% Glycine 0.25% Glycine 0.5% Glycine 1% Glycine 
NCIB 3610  70.0 ± 2.6 80.0 ± 2.7 82.8 ± 1.7 108.9 ± 5.8 
WT 76.2 ± 2.3 87.9 ± 2.1 90.3 ± 3.9 110.6 ± 4.4 
ΔgcvT-gcvPB 73.7 ± 2.7 (1.0) *110.1 ± 4.8 (1.3) *118.8 ± 5.1 (1.3) 127.7 ± 9.8 (1.2) 
M1 81.7 ± 5.2 (1.1) 98.7 ± 7.5 (1.1) 98.7 ± 11.0 (1.1) 116.5 ± 11.6 (1.1) 
M2 69.3 ± 3.2 (0.9) 77.9 ± 4.5 (0.9) 84.1 ± 3.8 (0.9) 116.3 ± 12.5 (1.1) 
M3 *116.8 ± 7.8 (1.5) *143.6 ± 4.0 (1.6) *143.4 ± 0.0 (1.6) *153.4 ± 5.0 (1.4) 
M4 76.7 ± 2.8 (1.0) 92.3 ± 2.5 (1.0) 94.3 ± 3.4 (1.0) 110.6 ± 5.0 (1.0) 
M5 *84.6 ± 2.8 (1.1) *115.3 ± 7.8 (1.3) *122.8 ± 7.0 (1.4) 123.8 ± 13.8 (1.1) 
M6 *101.4 ± 7.4 (1.3) 87.8 ± 1.7 (1.0) 96.1 ± 1.0 (1.1) 106.1 ± 7.7 (1.0) 
M7 80.0 ± 5.7 (1.1) 91.9 ± 5.6 (1.1) 91.2 ± 6.3 (1.0) 106.7 ± 4.8 (1.0) 
M8 78.2 ± 3.5 (1.0) 90.6 ± 3.5 (1.0) 97.3 ± 3.0 (1.1) 110.6 ± 10.3 (1.0) 
M1+M2 80.0 ± 1.9 (1.1) 95.5 ± 4.5 (1.1) 103.1 ± 5.0 (1.1) *133.5 ± 6.8 (1.2) 
M1+M4 76.1 ± 6.1 (1.0) *107.2 ± 4.9 (1.2) *106.7 ± 2.3 (1.2) 126.9 ± 7.8 (1.2) 
M2+M3 80.8 ± 2.8 (1.1) 89.6 ± 3.1 (1.0) 96.4 ± 3.8 (1.1) 116.1 ± 4.3 (1.1) 
M2+M5 78.6 ± 1.8 (1.0) *100.4 ± 1.9 (1.1) *112.3 ± 6.7 (1.2) 126.8 ± 9.7 (1.2) 
M3+M4 *137.4 ± 6.5 (1.8) *143.6 ± 4.0 (1.6) *148.1 ± 2.4 (1.6) *148.1 ± 2.4 (1.3) 
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the wild-type recombinant strain at all glycine concentrations (Table 4.1). The 
recombinant strain carrying the M1+M2 double mutation also grew comparably to the 
wild-type recombinant under all conditions. The basal expression from the M1+M2 
construct appears sufficient for normal planktonic growth in high glycine environments. 
Interestingly, the strains carrying the M3 and M3+M4 mutations exhibited the 
longest doubling times, growing approximately 1.6 times slower than the wild-type 
recombinant strain in the presence and absence of glycine. This growth defect does not 
correlate well with gene expression as measured by β-galactosidase activity and qRT-
PCR. Each of the recombinant strains was created independently from the parental 
strain, thus it is unlikely that this defect is due to some other common mutation. It is 
possible that components of the gcvT operon are important for metabolic processes not 
directly related to glycine and that the M3 and M3+M4 mutations further interfere with 
translation of the native operon transcript. Therefore, the glycine-independent planktonic 
growth defects observed for these strains may be due to disruptions to other 
fundamental biochemical processes important for growth.  
While inhibition of cell growth was observed for all strains in increasing glycine 
concentrations as previously reported, only strains with mutations that completely 
abolish riboswitch function and result in extremely low gcvT operon expression appear to 
have heightened glycine sensitivity during planktonic growth in minimal medium 
compared to the wild-type recombinant strain. The majority of these glycine-sensitive 
recombinant strains carry mutations that disrupt glycine binding to the first aptamer 
and/or first aptamer tertiary structure.  
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Figure 4.4. B. subtilis growth using glucose and glycine as carbon sources. (A) Growth curves 
of B. subtilis NCIB 3610 (parental strain) in M9 minimal medium +/- 0.25% glycine with varying 
concentrations of glucose. Cultures were incubated at 37ºC with shaking (225 rpm) for 
approximately 24 hours and OD600 measurements were recorded at time points indicated. (B) M9 
minimal medium patch plates of select B. subtilis NCIB 3610 strains with various carbon sources. 
Plates were incubated at 37ºC for one week and photographed. Photographs after 48 hours of 
incubation are shown, however, no significant changes were observed on all plates after one week. 
WT, wild-type recombinant. 	
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4.2.7 Glycine cannot be utilized as a sole carbon source by B. subtilis NCIB 3610 
 Others have demonstrated that the tandem glycine riboswitch-regulated operons 
gcvT-gcvH and gcvP facilitate use of glycine as a carbon source in Streptomyces 
griseus (Tezuka and Ohnishi 2014). To examine whether B. subtilis could similarly 
metabolize glycine and assess whether this phenotype is sensitive to changes in gcvT 
operon expression resulting from glycine riboswitch mutations, we performed growth 
experiments in both solid and liquid minimal media in the presence and absence of 
glycine with limiting glucose. We found that in contrast to S. griseus, B. subtilis NCIB 
3610 is not able to grow on glycine as a sole carbon source (Figure 4.4). Of note, gcvT-
gcvH and gcvP exist as separate operons and are under the control of separate tandem 
glycine riboswitches in S. griseus, whereas gcvT and gcvPA-gcvPB (two genes 
encoding separate subunits of the glycine decarboxylase GcvP) are co-located in the B. 
subtilis genome and are under the regulation of a single tandem glycine riboswitch. The 
predicted B. subtilis homolog to gcvH (also known as yusH) occurs elsewhere in the 
genome and does not appear to be glycine riboswitch controlled.  
 
4.2.8 Glycine riboswitch mutants have reduced swarming motility in high glycine 
environments 
To assess whether more complex B. subtilis phenotypes might be more sensitive 
readouts of glycine toxicity than planktonic growth doubling times, we next investigated 
the impact of riboswitch mutations and aberrant regulation of the glycine cleavage 
operon on swarming motility in the presence of glycine. Swarming motility is highly 
dependent on cellular differentiation into a swarming proficient state and cellular 
contacts with surfaces and neighboring cells, all of which are at least partially mediated 
by peptidoglycan remodeling and cell wall synthesis and structural integrity  
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(Kearns and Losick 2003; Copeland and Weibel 2009). Excess glycine can be mis-
incorporated into bacterial cell walls and high glycine concentrations inhibit the enzymes 
responsible for the addition of L-alanine into peptidoglycan precursors, resulting in 
weakened cell walls and premature lysis (Gordon et al. 1951; Hishinuma et al. 1969, 
1971; Hammes et al. 1973).  
 
 
Figure 4.5. Swarming motility of recombinant glycine riboswitch B. subtilis strains in 
increasing glycine concentrations. M9 minimal medium swarm agar plates with varying glycine 
concentrations were inoculated with each strain and incubated at 37ºC for 48 hours. (A) Swarm 
diameters of recombinant glycine riboswitch B. subtilis strains. Three measurements were taken 
for each plate and averaged. The values reported represent the mean of three independent 
experimental replicates; error bars represent the standard error of the mean. Asterisks (*) indicate 
mutant recombinant strains that grew significantly worse than the wild-type recombinant (WT) in 
the corresponding glycine concentration. Daggers (†) indicate mutant recombinant strains that 
grew significantly better than the wild-type recombinant in the corresponding glycine concentration 
(p<0.05). Significance was not determined for measurements recorded at 1% glycine.  
(B) Representative photographs of swarming motility assays. NCIB 3610, parental strain. 	
 86 
 No significant difference in swarm diameter was observed for all strains in the 
absence of glycine.  Similar to cell growth rate, swarm diameter decreased for all strains 
as glycine concentration in the medium was increased (Figure 4.5). Little to no migration 
was observed at 1% glycine for all strains. The large degree of variation in swarm 
diameter at this concentration can be attributed to the prevalence of escape motile or 
flare mutants, which resulted in swarms with non-uniform diameters and is indicative of 
glycine toxicity. Consequently, significance was not determined for swarm diameter 
measurements at 1% glycine. Apart from differences in migration diameter, no other 
strain-specific or glycine concentration-dependent trends were noted in swarm 
morphology. 
Strains with mutations that abolish riboswitch regulation and result in low 
downstream expression (M3, M5, M1+M2, M1+M4, M2+M5) demonstrated a significant 
reduction in swarming motility in the presence of glycine compared to the NCIB 3610 
parental and wild-type recombinant strains (Figure 4.5). The M1+M2, M1+M4, and 
M2+M5 double mutant recombinant strains exhibited the most severe glycine-sensitive 
swarm phenotypes that were comparable to those of the ΔgcvT-gcvPB recombinant 
strain. Strains that retain riboswitch function and/or result in elevated constitutive operon 
expression (M1, M2, M4, M6, M7, M8, M2+M3, M3+M4) all behaved similar to the wild-
type recombinant and NCIB 3610 parental strains under all assay conditions.  
It is unlikely that the defects observed during planktonic growth play a role in 
swarm migration distance. While the M3 mutant recombinant strain showed a significant 
swarm migration defect, the migration distance of the M3+M4 double mutant 
recombinant strain was comparable to the wild-type recombinant and the NCIB 3610 
parental strains at all glycine concentrations. Similarly, while the doubling times of the 
M1+M2 mutant recombinant strain did not significantly differ from those of the wild-type 
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recombinant strain during planktonic growth, the M1+M2 recombinant strain 
demonstrated significant glycine-sensitivity during the swarming motility assays. Defects 
observed during planktonic cell growth can be distinct from those observed during static 
growth.  
 
4.2.9 Mutations to the glycine riboswitch inhibit biofilm formation in high glycine 
environments 
To further assess the effects of disruptions to glycine riboswitch function and 
gcvT operon regulation on B. subtilis fitness in the presence of excess glycine, we 
analyzed mutant recombinant strain biofilm formation on solid medium as well as the 
development of floating biofilms formed at the air-liquid interface (pellicle), as B. subtilis 
is a robust model organism for the study of biofilm development (for review see: (Cairns 
et al. 2014)). A recent study demonstrated that interfering with cell wall composition 
greatly disrupts B. subtilis biofilm formation (Bucher et al. 2015) and excess glycine has 
been shown to inhibit Streptoccocus sobrinus aggregation by way of reduced glucan-
binding ability and weakened cell wall integrity (Luengpailin and Doyle 2000). 
Extent of biofilm assembly on both solid and liquid media was reduced for all 
strains as glycine concentration was increased. Little to no pellicle development was 
observed for all strains at 1% glycine; the pellicles that did form were very fragile and 
had a smooth surface (Figure 4.6A,B). Consequently, significance is not reported for the 
crystal violet staining assays at this concentration. Similarly, biofilms that developed on 
solid medium with 1% glycine were small in diameter and lacked the wrinkled phenotype 
characteristic of robust B. subtilis biofilms (Figure 4.6C).  
The M3 and M5 single mutant recombinant strains as well as the M1+M2, 
M1+M4, and M2+M5 double mutant recombinant strains exhibited the greatest defects in 
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Figure 4.6.  Biofilm formation of recombinant glycine riboswitch B. subtilis strains in 
increasing glycine concentrations. (A) Crystal violet staining of recombinant glycine riboswitch 
B. subtilis strain pellicle formation. The values reported represent the mean of six or more 
independent experimental replicates; error bars represent standard error of the mean across 
biological replicates. Asterisks (*) indicate mutant recombinant strains that grew significantly worse 
than the wild-type recombinant (WT) in the corresponding glycine concentration (p<0.05). 
Significance was not determined for measurements recorded at 1% glycine. (B) Representative 
photographs of recombinant strain pellicle formation after 24 hours incubation at 37ºC.  
(C) Representative photographs of recombinant strain colony biofilm formation on solid medium 
after 5 days incubation at 30ºC. NCIB 3610, parental strain. 	
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biofilm formation in the presence of glycine on both solid and liquid media (Figure 4.6). 
Pellicles were thinner and had significantly reduced or no surface wrinkling in 
comparison to the other strains. The solid-surface biofilms also displayed defects in 
colony wrinkling and were often dark brown in color in the presence of glycine, indicating 
sporulation or cell death due to harsh environmental conditions (Sandman et al. 1988). 
The biofilms formed by these mutant recombinant strains were comparable to those of 
the ΔgcvT-gcvPB recombinant strain under all conditions.  
The recombinant strains in which glycine riboswitch function remains intact 
and/or the gcvT operon is constitutively expressed (M1, M2, M4, M6, M7, M8, M2+M3, 
M3+M4) generated robust biofilms on both media types with morphologies similar to 
those produced by the wild-type recombinant and NCIB 3610 parental strains. It should 
be noted that while crystal violet staining is a simple and high-throughput method for 
quantifying pellicle biofilm formation, assay results are highly sensitive to minor changes 
in protocol or conditions and often yield a great range of variation between replicates (Li 
et al. 2003; Kwasny and Opperman 2010), as demonstrated by the high standard error 
reported. Nevertheless, these biofilm assay results and observed trends in glycine 
sensitivity are consistent with those from our swarming motility experiments. 
 
4.3 Discussion 
 Since the initial discovery of the tandem glycine riboswitch, numerous studies 
have sought to elucidate the structure, dynamics, and selective advantages of the dual 
aptamer architecture. While informative, the vast majority of these investigations was 
limited to in vitro techniques and often yielded conflicting results. In this study, we 
examined the proposed models of tandem glycine riboswitch regulation in the context of 
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its native locus within the B. subtilis genome and assessed how previously described 
interactions contribute to riboswitch function in vivo and overall cell fitness.  
We find that mutations to the first aptamer (M1, M3, M5) resulted in the greatest 
reduction in downstream gene expression. All of these mutations directly or indirectly 
affect the structural stability and/or ligand-binding affinity of the first aptamer (Mandal et 
al. 2004; Kwon and Strobel 2008; Erion and Strobel 2011; Butler et al. 2011; Kladwang 
et al. 2011; Sherman et al. 2012; Baird and Ferré-D’Amaré 2013; Esquiaqui et al. 2014; 
Ruff and Strobel 2014). The M1 mutation to the glycine-binding domain on the first 
aptamer retained regulatory activity in response to glycine, although induced 
downstream expression was about one-tenth of that observed with the wild-type 
riboswitch. This suggests that glycine solely binding to the second aptamer can yield a 
regulatory response, but that glycine binding to the first aptamer is required for robust 
downstream gene expression. The first aptamer dimerization (M3) and leader-linker 
kink-turn (M5) mutations both completely abolished regulation and gcvT operon 
expression. This supports recent in vitro findings suggesting that aptamer dimerization is 
energetically linked to glycine binding in the first aptamer and that the ligand-binding 
affinity of the first aptamer is more sensitive to disruptions to the dimerization interface. 
These results also corroborate the importance of the P0/P1 helices for riboswitch 
dimerization and pre-organization of the ligand-binding pockets (Sherman et al. 2012; 
Ruff and Strobel 2014). 
Mutations to the second aptamer had varying effects. Surprisingly, the M2 
mutation to the glycine-binding domain on the second aptamer retained regulatory 
activity and expression levels comparable to that of the wild-type riboswitch. This 
reinforces the importance of glycine binding to the first aptamer for proper glycine 
riboswitch regulation and maximum downstream gene expression. Similarly, the M4 
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mutation to the dimerization domain on the second aptamer also retained regulatory 
function in response to glycine, although the resulting downstream gene expression was 
slightly less than that of the wild-type riboswitch. This finding supports previous studies 
suggesting that the second aptamer is capable of binding glycine despite disruptions to 
the dimerization interface (Ruff and Strobel 2014).  While differences in behavior 
between the M3 and M4 dimerization mutants may be due to the asymmetrical nature of 
the γ dimerization interface (different nucleotide mutations are required to disrupt the 
interaction for each aptamer), our other mutations corroborate a model where changes 
to the first aptamer have a bigger impact on gene expression. 
Taken together, our results indicate that double ligand occupancy is not required 
and glycine can bind to either aptamer to elicit a regulatory response in vivo. However, 
glycine binding to the first aptamer in combination with the leader-linker kink-turn and 
inter-aptamer interactions is necessary for optimal tandem glycine riboswitch-mediated 
regulation, maximum gcvT operon expression, and subsequent B. subtilis survival in 
high glycine environments. These findings offer new physiological insights into the 
decade-old dual aptamer debate and reinforce the hypothesis that the tandem 
architecture has been conserved against evolution not necessarily for enhanced ligand 
specificity and/or more digital gene control, but because the complex tertiary structure 
mediated by the presence of and interactions between the two aptamers is important for 
promoting glycine binding and conformational changes of the expression platform 
(Sherman et al. 2012; Ruff and Strobel 2014; Ruff et al. 2016). The recently proposed 
models of singlet glycine riboswitch regulation further support this theory. These single 
aptamer riboswitches bind glycine with affinities comparable to those with the dual 
aptamer structure, however, they are not true structural “singlets.” Interactions with 
stem-loop “ghost aptamers” are required for singlet riboswitch structural stability and 
 92 
regulation, although these interactions may be less complex and/or distinct from those 
found with the tandem aptamer architecture (Ruff et al. 2016). 
While we demonstrate that glycine binding to the second aptamer is not 
necessary to elicit the maximum regulatory response in vivo, previous bioinformatic 
analyses indicate that the glycine-binding domains on both aptamers are equally well-
conserved (Barrick and Breaker 2007). This suggests that maintaining two functional 
ligand-binding domains may confer some evolutionary advantage over the singlet 
aptamer conformation. Despite the fact that our study does not directly suggest a 
cooperative mechanism of ligand binding, as this behavior is difficult to discern in vivo, 
the possibility that the tandem glycine riboswitch acts cooperatively within the cell cannot 
be precluded.  
Although our overall conclusions are in agreement with the current model for 
tandem glycine riboswitch function, some of our data do not directly align with those from 
previous reports. Namely, we find that disruptions to the glycine-binding pocket on the 
second aptamer (M2) do not compromise riboswitch function or downstream expression 
in vivo, whereas in vitro studies with the V. cholerae riboswitch report that homologous 
mutations to the second aptamer have a more severe impact on tandem riboswitch 
ligand-binding affinity (Ruff and Strobel 2014). A similar trend is observed with our 
dimerization mutations. Our data suggest that mutations to the γ dimerization interface 
on the first aptamer (M3) completely abrogate riboswitch function, while mutations to the 
dimerization interface on the second aptamer (M4) still retain regulatory activity, albeit 
with reduced downstream expression. Past work with homologous V. cholerae 
riboswitch mutant constructs demonstrate that disrupting the γ dimerization domain on 
the second aptamer results in the greatest reduction in dimerization affinity between the 
two aptamers (Ruff and Strobel 2014).   
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The discrepancies between our results and those obtained with the V. cholerae 
riboswitch are most likely due to differences between in vitro and in vivo experimental 
conditions. Our experiments utilize the full-length B. subtilis tandem glycine riboswitch 
and our conclusions are based on in vivo gene expression and reporter enzyme activity 
levels, whereas previous investigations directly measured glycine-binding and 
dimerization affinities in vitro using both cis (full-length) and trans V. cholerae tandem 
glycine riboswitch constructs (Ruff and Strobel 2014). Additionally, though the tandem 
glycine riboswitches found in B. subtilis and V. cholerae are homologous, they are not 
identical and thus may not behave in the same manner in both in vivo and in vitro 
environments. For example, the B. subtilis tandem glycine riboswitch is followed by a 
Rho-independent terminator and its regulatory mechanism of action is well-
characterized; the expression platform and mechanism by which the V. cholerae tandem 
glycine riboswitch regulates gene expression in vivo has not been characterized in detail 
(Mandal et al. 2004). Consequently, while general conclusions can be drawn across 
studies, direct comparisons may not be applicable.  
Using B. subtilis as a model organism, we validate the current model of tandem 
glycine riboswitch folding in vivo and demonstrate the importance of proper tandem 
glycine riboswitch function as a genetic “on” switch for gcvT operon expression and 
optimal cell growth in both the presence and absence of glycine. The effects subtle point 
mutations to the tandem glycine riboswitch have on regulation, gene expression, and 
communal bacterial behaviors such as swarming and biofilm formation reinforce the 
potential of riboswitches as antimicrobial drug targets. Knowledge of how cells respond 
to the loss of riboswitch regulation allows for a more informed and directed approach to 
the design of riboswitch-targeting antibiotics and provides insight into how resistance to 
such compounds may evolve in the future. 
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4.4 Materials and Methods 
4.4.1 β-galactosidase activity assay plasmid and strain construction 
B. subtilis integration vector pDG1728 was modified to allow for a translational 
fusion between the glycine riboswitch constructs and lacZ (Guérout-Fleury et al. 1996). 
Briefly, the region containing the spoVG ribosome-binding site and the lacZ start codon 
was removed using the EcoRI and BamHI restriction sites and replaced with a cassette 
that allowed for a translational fusion with the lacZ reporter when cloning with BamHI: 
 5’-GAATTCTACGACAAATTGCAAAAATAATGTTGTCCTTTTAAATAAGATCTGATAAA 
ATGTGAACTAAGCTTCTAGGATCC-3’; underlining denotes EcoRI and BamHI 
restriction sites, respectively. 
To generate the glycine riboswitch-lacZ translational fusion constructs, the region 
containing the gcvT operon promoter, wild-type glycine riboswitch, and ribosome-binding 
site and first nine codons of gcvT was PCR-amplified from B. subtilis 168 genomic DNA 
(GenBank: AL009126; complement of 2549307-2549704 (Kunst et al. 1997)) with 
primers containing EcoRI and BamHI restriction sites (Table 4.2). After digestion, the 
PCR product was cloned into the modified pDG1728 vector digested with the same 
enzymes. Mutations to the glycine riboswitch were obtained by site-directed 
mutagenesis or PCR assembly (Table 4.2). All plasmids were verified via Sanger 
sequencing. 
Reporter constructs were transformed into B. subtilis 168 as described previously 
(Yasbin et al. 1975; Jarmer et al. 2002). Transformants were screened for resistance to 
spectinomycin (100 µg/mL), sensitivity to erythromycin (0.5 µg/mL), and loss of amylase 
activity (plating on TBAB + 1% starch and staining with Gram’s iodine solution, Sigma-
Aldrich) to ensure proper integration of the lacZ reporter constructs into the amyE locus.  
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4.4.2 β-galactosidase activity assays 
B. subtilis 168 lacZ reporter strains were grown from single colonies in 2 mL M9 
minimal medium + 1% glucose + 50 µg/mL tryptophan + 100 µg/mL spectinomycin for 
approximately 24 hours at 37ºC with shaking (225 rpm). These cultures were diluted 
1:10 into 2 mL M9 minimal medium + 1% glucose + 50 µg/mL tryptophan + 100 µg/mL 
spectinomycin with varying glycine concentrations (0, 0.25, 0.5, and 1% w/v glycine, or 
approximately 0, 33.3, 66.6, and 133.2 mM glycine) and grown for approximately 10 
hours at 37ºC with shaking (225 rpm). Cells (1.5 mL) were harvested and re-suspended 
in 1 mL Z buffer (50 mM Na2HPO4, 40 mM NaH2PO4, 10 mM KCl, 1 mM MgSO4, 50 mM 
2-Mercaptoethanol) + 100 µg/mL spectinomycin. OD600 values were measured as 1:10 
dilutions of cell suspensions in Z buffer. Samples with a final OD600 reading less than 0.5 
were discarded. β-galactosidase activity assays were performed as previously described 
using 0.5 mL of cell suspensions and Miller Units were calculated as follows (Miller 
1992): 
Miller Units = 1000 ∗  !!"#∆! !"#  ∗ !!"" ∗ !"#.(!") 
The values reported represent three or more independent replicates; error bars 
represent standard error of the mean across biological replicates. 
 To assess the sensitivity of the M1 and M2 glycine-binding mutant riboswitch 
constructs relative to that of the wild-type glycine riboswitch, additional β-galactosidase 
activity assays were performed with these reporter strains as described above using the 
following glycine concentrations: 0.0025, 0.005, 0.01. 0.025, 0.05, and 0.1% w/v glycine, 
or approximately 0.33, 0.67, 1.33, 3.33, 6.66, and 13.32 mM glycine.  The fraction of β-
galactosidase activity for each riboswitch reporter construct at each glycine 
concentration tested was calculated as follows: 
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Fraction of activity = !"#$% !"##$% !"#$% !!"#.  !"#$% (!"##$% !"#$% !" !% !"#$%&')!"#.  !"#$% !"##$% !"#$% !" !% !"#$%&' !!"#.  !"#$% (!"##$% !"#$% !" !% !"#$%&') 
The values reported for these experiments represent two or more independent 
replicates; error bars represent standard error of the mean across biological replicates. 
 
4.4.3 Native locus recombinant glycine riboswitch strain construction 
To generate the recombinant strains for the growth curve, swarming motility, and 
biofilm assays, the gcvT operon promoter, wild-type glycine riboswitch, and two ~500 bp 
regions of homology flanking either side of the promoter and riboswitch region were 
PCR-amplified from B. subtilis 168 genomic DNA (GenBank: AL009126; complement of 
2549705-2550291 for the 5’ flanking ~500 bp region of homology, complement of 
2549075-2549704 for the region containing the promoter, riboswitch, and 3’ flanking 
~500 bp region of homology). An erythromycin resistance cassette was PCR-amplified 
from B. subtilis integration vector pDG1663 (GenBank: U46200; 3930-5160) (Guérout-
Fleury et al. 1996). PCR assembly with Phusion High-Fidelity DNA polymerase 
(ThermoFisher Scientific) was then used to generate recombinant PCR products in 
which the erythromycin resistance cassette was inserted immediately upstream from the 
gcvT operon promoter, in between the two regions of homology amplified from B. subtilis 
genomic DNA (Table 4.2). To generate the ΔgcvT-gcvPB construct, ~500 bp 
immediately downstream from the gcvPB coding region was PCR-amplified from B. 
subtilis 168 genomic DNA for the 3’ region of homology (GenBank: AL009126; 
complement of 2544924-2545409). A double Rho-independent terminator construct was 
PCR-amplified from pYH213 (Yakhnin et al. 2015) (sequence the same as GenBank: 
AY599227; 631-768 (Choi et al. 2005)) and appended onto the 3’ end of the 
erythromycin resistance cassette to prevent any read-through from the resistance 
cassette promoter. The complete ΔgcvT-gcvPB recombinant construct was then 
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assembled as described above. All assembly PCR constructs were poly-adenylated 
using Taq DNA polymerase (NEB), gel-purified, and cloned into pCR2.1 or pCR4 TOPO-
TA vector (Invitrogen). Mutations to the glycine riboswitch were obtained by site-directed 
mutagenesis or PCR assembly (Table 4.2). All plasmids were verified via Sanger 
sequencing.  
Recombinant pCR2.1 or pCR4 constructs were transformed into B. subtilis NCIB 
3610 as described previously (Yasbin et al. 1975; Jarmer et al. 2002). Transformants 
were screened for resistance to erythromycin (0.5 µg/mL). Integration of the complete 
recombinant construct within the gcvT locus and the presence of the riboswitch 
mutations of interest were verified via PCR and Sanger sequencing. 
 
4.4.4 Quantitative RT-PCR 
Total RNA was extracted from early-to-mid log phase (OD600 ~0.4-0.6) B. subtilis 
NCIB 3610 strains grown in M9 minimal medium + 1% glucose +/- 0.25% glycine (+ 0.5 
µg/mL erythromycin for recombinant strains) at 37ºC with shaking (225 rpm). To remove 
genomic DNA, 5 µg of total RNA was treated with RQ1 DNase (Promega) at 37ºC for 40 
minutes followed by incubation at 98ºC for 2 minutes to heat-inactivate the enzyme, 
phenol-chloroform extraction, and ethanol precipitation. Reverse transcription was 
performed with random hexamers and SuperScript III according to the manufacturer’s 
protocol (Invitrogen) and the resulting cDNA served as template for qPCR using an ABI 
7500 Fast Real-Time PCR System (ThermoFisher Scientific) with SYBR Green 
detection. Glycine cleavage operon transcript levels were quantified using primers 
targeting the gcvT coding region and quantification of nifU was used as a normalization 
control (Table 4.2) (Reiter et al. 2011). To confirm effective removal of contaminating 
DNA, experiments were also conducted using reactions lacking reverse transcriptase. 
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Error bars represent standard error of the mean across three technical replicates 
propagated using standard calculations (Taylor 1997). 
 
4.4.5 Growth curves with varying glycine concentrations 
B. subtilis NCIB 3610 strains were grown from single colonies in 2 mL M9 
minimal medium + 1% glucose (+ 0.5 µg/mL erythromycin for recombinant strains) for 
approximately 16 hours at 37ºC with shaking (225 rpm). These starter cultures were 
used to inoculate 0.5 mL M9 minimal medium + 1% glucose (+ 0.5 µg/mL erythromycin 
for recombinant strains) cultures with varying glycine concentrations (0, 0.25, 0.5, and 
1% w/v glycine or approximately 0, 33.3, 66.6, and 133.2 mM glycine) in sterile non-
treated 24-well cell culture plates to a starting OD600 reading of approximately 0.2. Plates 
were incubated at 37ºC with shaking (225 rpm) for 24 hours. OD600 values were 
recorded at one-hour intervals using a SpectraMax M3 Multi-Mode Microplate Reader 
(Molecular Devices). Doubling times were calculated as previously described, by taking 
the inverse of the slope of ln(OD600) in exponential phase readings (Rubinow 1975). The 
values reported represent three or more independent replicates; error bars represent the 
standard error of the mean across biological replicates. To determine the significance, 
mutant recombinant strain doubling times were compared to those of the wild-type 
recombinant strain at each glycine concentration using a Welch’s single-tailed T-test in 
Microsoft Excel. Values were considered significantly different if p<0.05. 
 
4.4.6 Growth assays with various carbon sources 
B. subtilis NCIB 3610 starter cultures were prepared as described above and 
used to inoculate 0.5 mL M9 minimal medium +/- 0.25% glycine cultures with varying 
glucose concentrations (0, 0.2, 0.4, 0.6, 0.8, and 1% w/v glucose) in sterile non-treated 
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24-well cell culture plates to a starting OD600 reading of approximately 0.2. Plates were 
incubated at 37ºC with shaking (225 rpm) for approximately 24 hours. OD600 values were 
recorded at time points indicated using a SpectraMax M3 Multi-Mode Microplate Reader 
(Molecular Devices). For further analysis, select B. subtilis NCIB 3610 strains were 
patched onto the following plates (1.5% agar): M9 minimal medium + no carbon source, 
M9 minimal medium + 1% glucose, M9 minimal medium + 0.25% glycine, and M9 
minimal medium + 1% glucose + 0.25% glycine. Plates were incubated at 37ºC for one 
week and photographs were taken using a Samsung WB380F digital camera. 
 
4.4.7 Swarming motility assays 
B. subtilis NCIB 3610 starter cultures were prepared as described above and 
grown to similar stationary phase OD600 values, and 5 µL of each culture was spotted 
onto the center of M9 minimal medium + 1% glucose + 0.7% agar swarming motility 
plates with the above glycine concentrations (Kearns and Losick 2003; Copeland and 
Weibel 2009). Plates were incubated at 37ºC for 48 hours and then photographed using 
a Samsung WB380F digital camera. The diameter of swarm motility growth was 
measured and recorded for each sample using FIJI software (Schindelin et al. 2012); 
three measurements were taken for each plate and averaged. The values reported 
represent three independent replicates; error bars represent standard error of the mean 
across biological replicates. To determine the significance, mutant recombinant strain 
swarm diameters were compared to those of the wild-type recombinant strain at each 
glycine concentration using a Welch’s single-tailed T-test in Microsoft Excel. Values 
were considered significantly different if p<0.05. Representative photographs are shown. 
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4.4.8 Crystal violet staining 
B. subtilis NCIB 3610 starter cultures were prepared as described above and 
grown to similar stationary phase OD600 values,  and 1 µL of each starter culture was 
used to inoculate 100 µL MSgg minimal medium (5 mM potassium phosphate [pH 7], 
100 mM MOPS [pH 7], 2 mM MgCl2, 700 µM CaCl2, 50 µM MnCl2, 50 µM FeCl3, 1 µM 
ZnCl2, 2 µM thiamine, 0.5% glycerol, 0.5% glutamate, 50 µg/mL tryptophan, 50 µg/mL 
phenylalanine; + 0.5 µg/mL erythromycin for recombinant strains) cultures with the 
above glycine concentrations in sterile non-treated 96-well cell culture plates (Branda et 
al. 2001). Plates were incubated at 37ºC without agitation for 30 hours. Following 
incubation, culture supernatant was removed and discarded and the wells were washed 
twice with 100 µL 1X phosphate-buffered saline (137 mM NaCl, 2.7 mM KCl, 10 mM 
Na2HPO4, 1.8 mM KH2PO4, pH 7.4). Plates were air-dried for 20 minutes and the 
remaining surface-attached cells were stained with 100 µL 0.1% Gram’s crystal violet 
(BD Biosciences) for 20 minutes. Stain was then removed and plates were washed three 
times with 100 µL sterile water and allowed to air-dry for at least 30 minutes. Biofilm-
associated crystal violet was then resolubilized in 100 µL 96% ethanol and incubated at 
room temperature for 10 minutes. For quantification, resolubilized samples were diluted 
1:10 into 96% ethanol and OD570 measurements were recorded using a SpectraMax M3 
Multi-Mode Microplate Reader (Molecular Devices). Wells incubated with cell-free 
medium were washed and stained as above to serve as a negative control and blank; 
the OD570 values from the cell-free wells were averaged and subtracted from the OD570 
values for each sample (modified from (Kayumov et al. 2015)). The values reported 
represent six or more independent replicates; error bars represent standard error of the 
mean across biological replicates. To determine the significance, mutant recombinant 
strain crystal violet OD570 values were compared to those of the wild-type recombinant 
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strain at each glycine concentration using a Welch’s single-tailed T-test in Microsoft 
Excel. Values were considered significantly different if p<0.05. 
 
4.4.9 Pellicle assays 
B. subtilis NCIB 3610 starter cultures were prepared as described above and 
grown to similar stationary phase OD600 values, and 1 µL of each culture was used to 
inoculate 0.5 mL MSgg minimal medium cultures (+ 0.5 µg/mL erythromycin for 
recombinant strains) with the above glycine concentrations in sterile non-treated 24-well 
cell culture plates (Branda et al. 2001). Plates were incubated at 37ºC without agitation 
for 40 hours. Wells were photographed at 24, 26, 28, 30, and 40 hours post-inoculation 
using a Samsung WB380F digital camera. This assay was repeated three independent 
times for each strain; representative photographs at 24 hours post-inoculation are 
shown. 
 
4.4.10 Colony biofilm assays 
B. subtilis NCIB 3610 starter cultures were prepared as described above and 
grown to similar stationary phase OD600 values, and 10 µL of each culture was spotted 
onto the center of  MSgg minimal medium + 1.5% agar plates with the above glycine 
concentrations (Branda et al. 2001). Plates were incubated at 30ºC for 5 days and then 
photographed using a Samsung WB380F digital camera. This assay was repeated two 
independent times for each strain; representative photographs are shown. 
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Name Sequence (5'-3') Notes 
1018 GGGCCCGAATTCCTGTTGCCCAGCATA
TAGTGATGATGGTA 
Primer for cloning glycine 
riboswitch into modified 
pDG1728 reporter vector; EcoRI 
restriction site in bold 
1019 CCGGCCGGATCCGTCAAATAACGGCG
TTCTTTTCAGCAT 
Primer for cloning glycine 
riboswitch into modified 
pDG1728 reporter vector; 
BamHI restriction site in bold 
204 TATCTCTTGCCAGTCACGTTACG Primer for PCR checks and 
sequencing of pDG1728 
reporter constructs 
122 GGGGACGACGACAGTATCGGCCTC Primer for PCR checks and 
sequencing of pDG1728 
reporter constructs 
1014 TGACAAGATCATATGGGATAGACAG Primer for amplifying 5'-500 bp 
region of glycine riboswitch 
recombinant construct 
1015 CTTTAGGGTTATCGAATTCGATAAGCTT
CTACAATTTGGGCAGATTTTTCTTATAT
TATTCATC 
Primer for amplifying 5'-500 bp 
region of glycine riboswitch 
recombinant construct 
1016 TAGCGCCTACGGGGAATTTGTATCGCG
GCCGCCTGTTGCCCAGCATATAGTGAT
GATGGTAGG 
Primer for amplifying 3'-500 bp 
region of glycine riboswitch 
recombinant construct 
1017 TCGCTGTATATTGAGCACGGCCTGG Primer for amplifying 3'-500 bp 
region of glycine riboswitch 
recombinant construct 
681 TAGAAGCTTATCGAATTCGATAACCCTA
AAG 
Primer for amplifying 
erythromycin resistance cassette 
from pDG1663 
682 GCGGCCGCGATACAAATTAAAAGTAGG
CG 
Primer for amplifying 
erythromycin resistance cassette 
from pDG1663 
1046 CGAGCTTCCGGACAAATTCATAGTTC Primer for confirming genomic 
integration of recombinant 
constructs 
1047 GAAGCATTAATGACAAGCAGATAGCG Primer for confirming genomic 
integration of recombinant 
constructs 
745 GCAATGAAACACGCCAAAGTAAAC Primer for PCR checks, 
sequencing recombinant glycine 
riboswitch constructs 	 	
Table 4.2. Oligonucleotides used in this study.  
For each primer pair, the forward primer is listed first and the reverse primer is listed second. 
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1648 CTGCGGAGTGAATCTCACAGGCAAAAG
AACTC 
 
Mutagenesis primer for M1, 
glycine-binding mutation to first 
aptamer 
1649 GAGTTCTTTTGCCTGTGAGATTCACTC
CGCAG 
Mutagenesis primer for M1, 
glycine-binding mutation to first 
aptamer 
1650 GCAAAGTAAACTTACAGGTGCCAGGAC
AGAG 
 
Mutagenesis primer for M2, 
glycine-binding mutation to 
second aptamer 
1651 CTCTGTCCTGGCACCTGTAAGTTTACTT
TGC 
 
Mutagenesis primer for M2, 
glycine-binding mutation to 
second aptamer 
1263 GCAAACTGCGGAGTGAACCTCTCAGG
CAAAAGAAC 
Mutagenesis primer for M3, 
dimerization mutation to first 
aptamer 
1264 GTTCTTTTGCCTGAGAGGTTCACTCCG
CAGTTTGC 
Mutagenesis primer for M3, 
dimerization mutation to first 
aptamer 
1265 GCGTATGCAAAGTAAGCTTTCAGGTGC
CAGG 
Mutagenesis primer for M4, 
dimerization mutation to second 
aptamer 
1266 CCTGGCACCTGAAAGCTTACTTTGCAT
ACGC 
Mutagenesis primer for M4, 
dimerization mutation to second 
aptamer 
1526 CATGAAAATATGAGCGAATCCCAGCAA
GGGGAGAGAC 
Mutagenesis primer for M5, 
leader-linker kink-turn mutation 
1527 GTCTCTCCCCTTGCTGGGATTCGCTCA
TATTTTCATG 
Mutagenesis primer for M5, 
leader-linker kink-turn mutation 
1284 GGTGTTTCTCTGTAATTTTTTGTATG Mutagenesis primer for M6, 
terminator mutation 
1285 CATACAAAAAATTACAGAGAAACACC Mutagenesis primer for M6, 
terminator mutation 
1528 GACCTGACCGAAAATTTCGGGATACAG
GCGC 
Mutagenesis primer for M7, 
control mutation to first aptamer 
1529 GCGCCTGTATCCCGAAATTTTCGGTCA
GGTC 
Mutagenesis primer for M7, 
control mutation to first aptamer 
1530 GAGTGTTTGTGCGGAAGCGCAAACCAC
CAAAGG 
Mutagenesis primer for M8, 
control mutation to second 
aptamer 
1531 CCTTTGGTGGTTTGCGCTTCCGCACAA
ACACTC 
Mutagenesis primer for M8, 
control mutation to second 
aptamer 
1444 CTGACAGCTTCCAAGGAGCTAAAGAGG
TCTCCTGTTGATAGATCCAGTAATGAC
C 
 
Primer for amplifying double 
terminator construct from 
pYH213 for appending onto 3’ 
end of erythromycin resistance 
cassette from pDG1663 for 
ΔgcvT-gcvPB recombinant 
construct 
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1445 
 
GGTCATTACTGGATCTATCAACAGGAG
ACCTCTTTAGCTCCTTGGAAGCTGTCA
G 
Primer for amplifying double 
terminator construct from 
pYH213 for appending onto 3’ 
end of erythromycin resistance 
cassette from pDG1663 for 
ΔgcvT-gcvPB recombinant 
construct 
1446 
 
GTTTAAACGATACAAATTCCCCGTAGG
CGCTAGGGAAAAAAATTACGCCCCGCC
CTGCC 
Primer for appending double 
terminator construct onto 3’ end 
of erythromycin resistance 
cassette from pDG1663 for 
ΔgcvT-gcvPB recombinant 
construct; use with primer 681 
1652 CCCTAGCGCCTACGGGGAATTTGTATC
GTTTAAACATAAAAACAGCTGTCTACCA
GACAG 
Primer for amplifying 3'-500 bp 
region of ΔgcvT-gcvPB 
recombinant construct 
1653 CGAAAACGGCTCTATGACCTTG 
 
Primer for amplifying 3'-500 bp 
region of ΔgcvT-gcvPB 
recombinant construct 
1654 GAATCAGTTTATCAAACTGTCGGG 
 
Primer for confirming genomic 
integration of ΔgcvT-gcvPB 
recombinant construct; use with 
primer 1046 
1671 AAAGGAGAGAACCGCTATCTGC 
 
Primer for qRT-PCR targeting 
the gcvT coding region 
1672  AATCTGCACATCACCTGCTG 
 
Primer for qRT-PCR targeting 
the gcvT coding region 
1546 TTTTACTTCGTGACGGCGGT Primer for qRT-PCR targeting 
nifU, the normalization control 
1547 TTGTTGAACTTGGGCAGCTG Primer for qRT-PCR targeting 
nifU, the normalization control 
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Chapter 5 
Discussion 
5.1 Summary and significance 
This thesis offers novel insights into the in vivo behavior of RNA cis-regulators 
within the context of their native loci and highlights the advantages of combining 
computational, in vitro, and in vivo experimental approaches to obtain a more 
comprehensive understanding of regulatory RNA function from biochemical, biophysical, 
physiological, and evolutionary perspectives. 
 
5.1.1 A conserved S6:S18-interacting RNA cis-regulator inhibits translation of 
Escherichia coli rpsF 
In Chapter 2, I experimentally verify the in vivo regulatory activity of a conserved 
ribosomal protein-interacting mRNA structure that was computationally predicted by my 
group (and others) and previously shown to demonstrate robust interaction with the 
S6:S18 heterodimer in vitro (Matelska et al. 2013; Fu et al. 2014). I show that 
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overexpression of both S6 and S18 is required for regulation in vivo, I demonstrate that 
this RNA structure regulates gene expression at the translational level, and I confirm the 
predicted secondary structure and sites of RNA-protein interaction necessary for 
regulatory activity. 
The S6:S18-interacting RNA cis-regulator presents a unique example of 
ribosomal protein autogenous regulation. The broad distribution of this RNA structure 
across many bacterial phyla is the exception, rather than the rule for such regulatory 
RNAs, as the majority of RNA cis-regulators identified to date are narrowly distributed to 
select subsets of bacteria. Furthermore, the S6:S18-interacting RNA regulates gene 
expression in response to interactions with a heterodimer composed of two secondary 
rRNA-binding proteins, whereas most known ribosomal protein RNA structures respond 
to interactions with a single primary rRNA-binding protein. The biological 
characterization of the S6:S18-interacting RNA allows us to fill in some of the existing 
gaps in our knowledge of ribosomal protein operon regulation in bacteria. Yet, it also 
reminds us that much remains to be discovered regarding this type of regulation, not 
only in non-model species of bacteria, but in the well-characterized model organism E. 
coli as well.  
With that said, the work presented in Chapter 2 and the Appendix of this thesis 
emphasizes the importance of experimentally validating computationally predicted RNA 
structures. Over the past decade, advancements in bioinformatics and high-throughput 
sequencing methods have lead to the identification of many putative structured RNA 
motifs, yet few have been assigned actual biological function. The confirmation of the 
regulatory activity of the S6:S18-interacting RNA (Chapter 2) and the ongoing validation 
efforts for the putative L21-interacting RNA (Appendix) demonstrate the power of using 
computational tools for structured RNA discovery. However, the lack of apparent 
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regulatory function of the predicted L19 RNA leader in B. subtilis (Appendix) reveals the 
limitations that still exist with such in silico approaches. Making a more concerted effort 
to combine computational discovery with experimental validation will not only promote 
the development of improved prediction tools and subsequently expand existing RNA 
structural databases, but it will allow for more accurate discovery of novel, biologically 
relevant regulatory RNA structures. Structural and biophysical characterization of new 
regulatory RNA motifs will enable us to better compare RNA structures across diverse 
organisms to ultimately gain insight into the evolution of regulatory RNA structures in 
bacteria and how they co-evolve with their protein-binding partners. 
 
5.1.2 Fitness advantages conferred by the L20-interacting RNA cis-regulator of 
ribosomal protein synthesis in Bacillus subtilis 
 The work presented in Chapter 3 takes the functional characterization of 
ribosomal protein RNA cis-regulators a step beyond the standard in vitro and in vivo 
validation techniques detailed in Chapters 1 and 2 to explore regulatory RNA behavior in 
its native context within the cell. It is well understood that these cis-regulatory RNA 
structures help ensure the stoichiometric production of ribosomal proteins for proper 
ribosome assembly. However, relatively little work has examined how the loss of RNA-
mediated regulation of ribosomal protein operons affects ribosome assembly and cell 
fitness. In this Chapter, I use information from previous structural and functional studies 
to generate recombinant B. subtilis strains that harbor mutations designed to disrupt the 
regulatory activity of the L20-interacting RNA cis-regulator of the infC ribosomal protein 
operon. I examine how different mutations impact the regulation and expression of the 
infC operon within the recombinant strains and demonstrate that compromising the 
regulatory activity of the L20-interacting RNA causes cold temperature-sensitive defects 
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in growth, rRNA processing, and ribosomal subunit sedimentation. I find that point 
mutations to the L20-interacting RNA structure in the 5’-UTR of the infC ribosomal 
protein operon result in mutant phenotypes similar to those observed with bacterial 
strains carrying severe ribosomal protein mutations or deletions. My findings reinforce 
the sensitivity and cooperativity of ribosome assembly; even seemingly minute 
perturbations to the ribosome biosynthesis pathway can have detrimental effects on 
overall cell viability. 
From an evolutionary perspective, this work improves our understanding of the 
forces that govern the evolution of RNA-based gene regulation in bacteria and the 
fitness advantages this type of regulation confers to bacteria. While this study examines 
only one example of a regulatory RNA structure that is narrowly distributed to Firmicutes, 
it is anticipated that most ribosomal protein RNA cis-regulators measurably contribute to 
bacterial fitness in some way. However, the extent of the fitness advantages these cis-
regulatory RNAs confer to an organism may vary depending on the bacterial species, 
the RNA regulatory element itself, and/or the ribosomal protein operon it controls. 
Further analysis of both widely distributed and narrowly distributed examples of RNA cis-
regulators in B. subtilis and other bacteria will allow us to better assess the evolutionary 
origins of and relationships between different RNA structures and the bacterial phyla in 
which they are found. In particular, such comparative studies will help elucidate whether 
the diverse regulatory structures we observe in nature originate from a distant common 
ancestor or are the result of multiple instances of independent evolution.  
 
5.1.3 In vivo behavior of the tandem glycine riboswitch in Bacillus subtilis 
In Chapter 4, I apply the same approach described in Chapter 3 to investigate 
the in vivo behavior of another, somewhat controversial, cis-regulatory RNA found in B. 
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subtilis: the tandem glycine riboswitch. Over the past decade, dozens of in vitro studies 
have examined the structural dynamics of the tandem glycine riboswitch in an effort to 
elucidate the evolutionary benefits of its unique dual aptamer composition. However, 
conflicting results stemming from differences in the conditions and constructs used for in 
vitro characterization have reopened the debate over the behavior and purpose of the 
tandem aptamer arrangement.  
To shed some light on this controversy from a physiological perspective, I 
investigated the function and fitness contributions of the tandem glycine riboswitch within 
its native context in B. subtilis. I demonstrate that glycine binding to the first aptamer and 
first aptamer tertiary structure are required for proper glycine riboswitch function and 
maximum gene expression in vivo and that glycine riboswitch-mediated regulation is 
important for B. subtilis survival in high glycine environments. Although previous 
bioinformatics studies indicate that the ligand-binding domains on both aptamers are 
equally well conserved (Barrick and Breaker 2007), my results suggest that the 
conservation of the second aptamer may primarily be driven by the role its structure 
plays in mediating inter-aptamer contacts and conformational changes of the adjacent 
expression platform. The fact that glycine does not need to bind to the second aptamer 
to elicit the maximum regulatory response in vivo leads us to speculate that the ligand-
binding activity of the second aptamer is potentially a vestigial function from the 
hypothesized duplication event that generated the tandem glycine riboswitch 
architecture (Ruff et al. 2016). Nevertheless, these hypotheses need to be examined in 
greater detail.   
Overall, my conclusions biologically validate the in vitro folding model currently 
proposed for the tandem glycine riboswitch, however, some of my data differ from 
previous reports. These discrepancies are most likely due to differences between in vitro 
 110 
and in vivo experimental methods and reinforce the necessity of characterizing 
riboswitch function and behavior using a combination of in vitro and in vivo approaches. 
My study is the first to examine the behavior of the tandem glycine riboswitch within its 
biological context, and while much remains to be elucidated regarding the origins, 
conservation, and selective advantages of its dual aptamer architecture, this project lays 
the necessary groundwork for such future investigations.  
 
5.2 Broader impacts and future directions 
5.2.1 Novel approach for studying RNA behavior and evolution in vivo 
The methods employed in Chapters 3 and 4 offer a novel approach for 
investigating cis-regulatory RNAs within the context of their native loci. Apart from select 
regulatory assays (Chapter 2) and drug discovery efforts (see below), little work has 
examined how the results of in vitro and in vivo validation studies translate to actual 
physiological behavior of RNA cis-regulators within the cell or how the function of these 
regulatory RNA structures impact organism fitness. Using data obtained from previous 
characterization studies, I combine extensive mutational analyses of each candidate 
RNA, a knockout strategy in which the native locus of the regulatory RNA is replaced 
with a mutant version, and various phenotypic assays. This approach allows me to 
comprehensively examine the fitness costs associated with removing each RNA 
regulator as well as what RNA motifs are most essential for regulatory function and 
overall organismal viability. Examining regulatory RNA structure and function in this 
manner offers insight into the factors that drive RNA-ligand specificity and interactions, 
RNA structural diversity and conservation, and the selective advantages this type of 
RNA-based regulation confers to an organism. While mutant recombinant bacterial 
strains are widely used in the microbiology and molecular biology fields, most studies 
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utilize strains harboring gene deletions or mutations to protein coding regions. To my 
knowledge, I am the first to use native locus recombinant bacterial strains to assess how 
disruptions to regulatory RNA secondary structure impact gene regulation and cell 
fitness.  
My approach also provides a suitable platform for studying the evolution of RNA 
structure in vivo, in real time. Although RNA is a common model “system” for 
evolutionary studies, most investigations are limited to in vitro selection methods, 
computational models, and RNA virus passaging studies. Very little work has explored 
how regulatory RNA structures actively emerge and co-evolve with their binding partners 
in a biological context. Compensatory evolution experiments conducted with RNA cis-
regulator native locus mutant bacterial strains exhibiting significant fitness defects can 
improve our understanding of the balance required between sequence and structure 
conservation for biological function and how RNA structures explore sequence space in 
vivo. Moreover, the multiple distinct cis-regulatory RNA structures that interact with 
homologous ribosomal protein-binding partners (i.e. the S15- and L20-interacting RNAs) 
or the same small target molecule (i.e. the SAM, preQ1, c-di-GMP, guanine, and 2’-dG 
riboswitches) are excellent systems for examining how ligand specificity shapes RNA 
evolution in vivo, as the interactions between each unique RNA structure and its 
corresponding binding partner are often distinct for each RNA-ligand pair.  
 
5.2.2 RNA cis-regulators as antimicrobial targets 
Antibiotic resistance is emerging at an alarming rate within bacterial pathogens, 
thus limiting the use of once commonplace and clinically effective antibiotics (Andersson 
and Hughes 2010). Consequently, there is a growing need for the development of novel 
antimicrobial therapies that address new bacterial targets and use new modes of action, 
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while exhibiting little to no toxicity or cross-reactivity with targets within the patients they 
are meant to treat. Riboswitches and ribosomal protein RNA cis-regulators are both 
attractive targets for such new antibiotics, as they are mostly unique to bacteria, 
associated with genes essential for survival or pathogenesis, and interact with their 
binding partners with high specificity. Depending on their phylogenetic distribution, 
substances targeting certain cis-regulatory RNA structures can be used as broad-
spectrum antibacterial drugs or as more selective antibiotics meant to target only specific 
bacterial phyla. My work reinforces this potential, as I show that removing cis-regulatory 
RNA-mediated gene regulation in B. subtilis results in severe defects in cell growth, 
ribosome assembly, and social behaviors such as swarming motility and biofilm 
formation; the latter two phenotypes in particular play key roles in protecting certain 
bacterial pathogens from antibiotics (Lai et al. 2009; Van Acker et al. 2014). 
Riboswitches have been the focus of drug development efforts since their 
discovery almost 20 years ago and a handful of compounds have been identified and/or 
designed that interfere with riboswitch function and inhibit bacterial growth (for review 
see: (Blount and Breaker 2006; Deigan and Ferré-D’Amaré 2011)). An analog of 
thiamine, pyrithiamine, inhibits the growth of several bacterial and fungal species by 
targeting the TPP riboswitch and repressing genes involved in thiamine biosynthesis 
(Sudarsan et al. 2005). Two lysine analogs, L-aminoethylcysteine and DL-4-oxalysine, 
have been found to inhibit the growth of select Gram-positive bacteria through interfering 
with lysine riboswitch-mediated regulation of the lysine biosynthesis pathway (Blount et 
al. 2007). Roseoflavin, a riboflavin analog that is naturally produced by Streptomyces 
davawensis, and the synthetic FMN analog ribocil inhibit the growth of certain bacterial 
species by mechanisms involving the FMN riboswitch (Lee et al. 2009; Howe et al. 2015, 
2016; Wang et al. 2017). Several compounds that bind guanine riboswitches and inhibit 
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bacterial growth have been developed (Kim et al. 2009; Mulhbacher et al. 2010) and the 
antibacterial activity of carba-α-D-glucosamine, a rationally designed GlcN6P analog that 
targets the glmS riboswitch, has recently been reported (Schüller et al. 2017). 
In contrast, little to no research has explored the potential of ribosomal protein 
cis-regulatory RNAs as targets for novel antibiotics. However, given the similarities 
between these regulatory RNA structures and riboswitches, it is not difficult to apply the 
techniques used for riboswitch drug development to obtain antimicrobial compounds that 
interfere with the RNA-based regulation of ribosomal protein synthesis in bacteria. The 
prokaryotic ribosome is already a major antibiotic target and I, and others, have 
demonstrated that disruptions to ribosomal protein operon regulation, ribosomal protein 
overexpression, and/or alterations in ribosome composition have detrimental effects on 
bacterial fitness. Compounds that directly target or mimic these cis-regulatory RNA 
structures to either irreversibly repress ribosomal protein synthesis or allow for the de-
regulation and subsequent uncontrolled synthesis of targeted ribosomal proteins can be 
developed. Such molecules would disrupt the stoichiometric production of ribosomal 
components required for proper ribosome assembly and ultimately inhibit bacterial 
growth.  
My work assessing the in vivo behavior and fitness contributions of bacterial RNA 
cis-regulators provides a foundation for the future development of antimicrobials that 
target regulatory RNA structures. Knowledge of the fitness costs associated with the loss 
of RNA cis-regulator function as well as what RNA motifs are most essential for ligand 
binding and subsequent regulation in vivo allows for improved rational design of 
regulatory RNA-targeting compounds. Combining my approach with the evolution 
experiments described above enables us to investigate how bacteria evolve to 
 114 
compensate for the loss of RNA cis-regulator-mediated gene control and informs us of 
how resistance to these novel antibiotics may eventually arise. 
 
5.3 Concluding remarks 
The computational discovery of structured RNA is a rapidly advancing field. 
Consequently, many regulatory RNA motifs have been predicted in bacterial genomes, 
yet relatively few have been biologically validated. Furthermore, a disconnect often 
exists between the data obtained from the in vitro and in vivo techniques used to 
characterize such RNAs; how an RNA structure folds and functions within a test tube or 
reporter construct does not necessarily reflect how it behaves within its biological 
context. This thesis reinforces the need to make a continued effort to experimentally 
verify the ever-growing pool of computationally predicted RNA cis-regulator candidates 
and demonstrates the benefits of examining cis-regulatory RNA behavior within its native 
context in the cell. I present an approach that not only allows for a more comprehensive 
characterization of RNA cis-regulator function in vivo, but also informs us about the 
selective forces that drive the emergence, evolution, and maintenance of structured RNA 
regulators in bacterial genomes. A greater understanding of the in vivo function and 
fitness contributions of different cis-regulatory RNAs in bacteria will significantly improve 
the existing models of structured RNA folding and evolution and aid the development of 
novel antimicrobials that target RNA regulators.	  
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Appendix 
Identification of putative RNA cis-regulator transcription 
start sites in Bacillus subtilis 
 
A.1 Introduction 
 In 2007, Yao and colleagues published a computational tool for the de novo 
discovery of cis-regulatory RNAs in prokaryotic genomes. The pipeline integrates RNA 
motif prediction with RNA homology searches and genomic context. In a test with 
available sequenced Firmicute genomes, the method successfully recovered previously 
characterized regulatory RNA structures and predicted a number of additional RNA 
motifs that are promising candidates for novel regulatory elements. Of these candidates, 
three putative structured mRNA motifs preceding the genes encoding ribosomal proteins 
L13, L19, and L21 were reported in B. subtilis (Yao et al. 2007). Although this study was 
conducted almost a decade ago, the functions of these RNA elements remain 
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uncharacterized. Given the proximity of these predicted structures to ribosomal protein 
genes, it is hypothesized that these candidate RNAs are involved in the autogenous 
regulation of the ribosomal protein operons they precede. In an effort to validate the 
biological activity of the putative L13, L19, and L21 RNA leaders, we sought to confirm 
the transcription of each of these RNA elements in B. subtilis using 5’- and 3’-RACE and 
RT-PCR. 
 
A.2 Results and Discussion 
A.2.1 L13 leader 
 The L13 leader is a large bulged stem-loop that is predicted to precede the rplM–
rpsI operon in B. subtilis, which encodes ribosomal proteins L13 and S9, respectively 
(Figure A.1A). Although L13 is a primary rRNA-binding protein that directly interacts with 
23S rRNA during ribosome assembly, there is no homology between the L13-binding 
	
 
Figure A.1. Consensus sequences and secondary structures of the predicted B. subtilis 
ribosomal protein autoregulatory RNA motifs derived from (Yao et al. 2007). The genomic 
context of each putative RNA (indicated with a red arrow) is shown below its predicted structure. 
(A) The L13 RNA leader. (B) The L19 RNA leader. (C) The L21 RNA leader. 	
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site on the 23S rRNA and the predicted mRNA leader. Alternate pairings for this RNA 
structure that overlap the rplM start codon suggest a potential translational mechanism 
of regulation (Yao et al. 2007). Previous RNA-seq data confirms transcription of this 
putative RNA structure (Irnov et al. 2010) and we also verified transcription of the RNA 
leader region via RT-PCR. However, we were unable to recover transcription start sites 
for the rplM-rpsI operon using 5’-RACE with both log and stationary phase total RNA 
from B. subtilis 168. Additional RT-PCR analysis indicates that the predicted rplM 
promoter is co-transcribed with the putative L13 RNA leader and the rplM coding region, 
suggesting that the rplM–rpsI operon may be under the control of multiple promoters or 
that the 5’-UTR of this operon transcript may be longer than previously reported (Figure 
A.2A). 
 
A.2.2 L19 leader 
 This putative RNA element is found upstream of the rplS gene, encoding 
ribosomal protein L19, which binds to the 23S rRNA at the interface between the 50S 
and 30S ribosomal subunits. This predicted structure consists of a small hairpin with an 
internal bulge and it is often found in close proximity to the Shine-Dalgarno sequence of 
the rplS open reading frame, indicating a potential translational regulatory mechanism 
(Figure A.1B). No sequence or structural similarities were identified between the putative 
regulatory mRNA structure and the 23S rRNA (Yao et al. 2007). 
We recovered two transcription start sites for the rplS coding region: one 
approximately 7 nucleotides downstream from the predicted promoter sequence that 
includes the putative RNA leader region, and one immediately upstream from the rplS 
Shine-Dalgarno sequence (Figure A.2B). The regulatory potential of this RNA structure 
was assessed using β-galactosidase reporter assays similar to those described in 
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Chapter 3. Briefly, a construct containing the predicted L19 leader sequence originating 
from the 5’-most transcription start site recovered was cloned as a translational fusion 
with a lacZ reporter under the control of an IPTG-inducible promoter, and subsequently 
transformed into B. subtilis 168. No repression of reporter strain β-galactosidase activity 
was observed upon overexpression of ribosomal protein L19, suggesting that this 
putative RNA structure does not autogenously regulate rplS in response to L19 (Daniel 
Beringer, unpublished data). Finally, although rplS is predicted to be expressed as an 
independent transcriptional unit in Firmicutes, we were unable to confirm this with both 
RT-PCR and 3’-RACE (Yao et al. 2007). 
 
A.2.3 L21 leader 
 The predicted L21 mRNA leader precedes the rplU-ysxB-rpmA operon (encoding 
ribosomal protein L21, hypothetical protein ysxB, and ribosomal protein L27, 
respectively) in B. subtilis and is composed of a large stem-loop with two highly 
conserved bulged adenosines (Figure A.1C). Both L21 and L27 are secondary rRNA-
binding proteins during ribosome assembly; L21 interacts with L20 and the 23S rRNA, 
and L27 associates with L15 and the 5S rRNA. There is no apparent conservation 
between the putative mRNA structure and the 23S and 5S rRNAs (Yao et al. 2007). 
 Using 5’-RACE, we identified a transcription start site for the rplU-ysxB-rpmA 
operon approximately 8 nucleotides downstream from the predicted promoter sequence 
that contains the potential mRNA regulatory motif (Figure A.2C). We also confirmed that 
the L21 RNA leader, rplU, ysxB, and rpmA are co-transcribed in B. subtilis via RT-PCR 
(Figure A.2D). Moreover, β-galactosidase activity of a L21 RNA leader-lacZ translational 
fusion (as described above and in Chapter 3) is repressed approximately 2-fold upon 
overexpression of L21. No repression of β-galactosidase activity is observed in response  
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Figure A.2. Identification of predicted RNA leader transcription start sites in B. subtilis 
using 5’-RACE and RT-PCR. (A) Agarose gel electrophoresis (1%) of RT-PCR products from 
B. subtilis 168 log phase total RNA indicating that the predicted rplM promoter sequence, the 
putative L13 RNA leader, and rplM coding region are co-transcribed. (B) Transcription start sites 
recovered for the predicted L19 RNA leader. (C) Transcription start sites recovered for the 
predicted L21 RNA leader. Putative promoter sequences are underlined; putative Shine-
Dalgarno sequences are in bold (Yao et al. 2007). The number of times each transcription start 
site was recovered is indicated above each arrow. The transcription start site used for 
subsequent analysis is in green. The sequences complementary to the reverse primers used for 
5’-RACE are highlighted in magenta and red. (D) Agarose gel electrophoresis (1%) of RT-PCR 
products from B. subtilis 168 log phase total RNA demonstrating that the predicted L21 RNA 
leader, rplU, ysxB, and rpmA are co-transcribed. 	
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to L27 overexpression. This suggests that the predicted L21 RNA leader is a regulatory 
element that inhibits downstream expression in response to L21 binding. Preliminary 
filter-binding assays confirm binding interactions between L21 and the RNA leader 
(Elizabeth Gray and Carolyn Larkins, unpublished data). Additional studies to further 
characterize the structure, sites of RNA-protein interaction, and regulatory mechanism of 
the L21 RNA motif are currently underway. 
 
A.3 Materials and Methods 
A.3.1 RT-PCR 
 B. subtilis 168 total RNA was extracted from log (OD600~0.4-0.8) and stationary 
(OD600~2.0+) phase cultures grown in 2XYT medium at 37ºC with shaking (225 rpm) as 
previously described. Genomic DNA was removed from 5 µg of total RNA by RQ1 
DNase (Promega) digestion at 37ºC for 40 minutes, followed by heat-inactivation of the 
enzyme at 98ºC for 2 minutes, phenol-chloroform extraction, and ethanol precipitation. 
The DNase-treated RNA was reverse transcribed using SuperScript III and random 
hexamers according to the manufacturer’s protocol (Invitrogen).  PCR was conducted 
using this cDNA as template and gene-specific primers (Table A.1). To serve as 
controls, experiments were repeated with B. subtilis 168 genomic DNA and reverse 
transcription reactions lacking reverse transcriptase. 
 
A.3.2 RACE 
B. subtilis 168 total RNA was extracted from log and stationary phase cultures as 
described above and 5’-RLM-RACE was performed following the Invitrogen GeneRacer 
protocol with a homemade RNA-linker (Weinberg et al. 2009). First strands were 
synthesized using gene-specific primers and SuperScript III (Invitrogen) and the 
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reactions served as template for PCR using a forward primer corresponding to the 5’-
linker and nested gene-specific reverse primers (Table A.1). PCR products were cloned 
into pCR2.1 TOPO-TA vector (Invitrogen) and sequenced to identify the 5’ ends of the 
transcripts. 
3’-RACE was conducted on log and stationary phase B. subtilis 168 total RNA 
according to the Invitrogen GeneRacer manual. B. subtilis 168 total RNA was 
polyadenylated and then reverse-transcribed using SuperScript III (Invitrogen) and a dT 
reverse primer. PCR was performed using the resulting cDNA as template with forward 
gene-specific primers and a nested dT reverse primer (Table A.1). PCR products were 
cloned into pCR2.1 TOPO-TA vector (Invitrogen) and sequenced to identify the 3’ ends 
of the transcripts.			 	
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Name Sequence (5'-3') Notes 
8 TAATACGACTCACTATAGG T7 promoter primer for generating 
5’-RACE RNA-linker 
7 TTTCTACTCCTTCAGTCCATGTCAGT
GTCCTCGTGCTCCAGTCGCCTATAGT
GAGTCGTATTA 
Primer for generating 5’-RACE 
RNA-linker 
9 GACTGGAGCACGAGGACACTGA 5’-RACE RNA-linker forward primer 
for PCR 
604 GATCTCCAGTATCAACGTGTGGTGTG
TAAGTTG 
L13 RNA leader 5’-RACE outer 
reverse primer for RT 
603 AGACGACCTAAAGTCTTGCCAGCAGC L13 RNA leader 5’-RACE nested 
reverse primer for PCR; use with 9 
650 GCCTGGATGTTGAGTGTGACGGTAG L13 RNA leader 5’-RACE outer 
reverse primer 2 for RT 
648 GTAAGTTGGTTTGTGTTTTCCGCGAA
GG 
L13 RNA leader 5’-RACE nested 
reverse primer 2 for PCR; use with 
9 
649 CCGCGAAGGATAGCTGCAACTTCTG L13 RNA leader 5’-RACE nested 
reverse primer 3 for PCR; use with 
9 
291 CCCCAAGCTTATGGTATGTATTTCAA
CCCCACGATAAGCCCCGG 
L13 RNA leader forward primer for 
RT-PCR 
247 CCCCAAGCTTATGGTATGTATTTCAA
CCCCACGATAAG 
L13 RNA leader forward primer 2 
for RT-PCR 
139 GGAATTCCTATGACAACTAAACCAGG
TGTATAAT 
rplM putative promoter forward 
primer for RT-PCR 
263 GGACTAGTATGACCAAAGGAATCTTA
GGAAGAAAAATTGG 
rplM coding region forward primer 
for RT-PCR 
264 CCGCGGATCCTTATTTAGATTTAACA
GCACTTTTAACAGTG 
rplM coding region reverse primer 
for RT-PCR 
606 GTGCACGACGAGCGCCTTTAAGACC
GTA 
rpsI reverse primer for RT-PCR; 
use with 291 or 247 
598 TTCCACCACCACGACGCTTAATCACA
ACACCTTCA 
L19 RNA leader 5’-RACE outer 
reverse primer for RT 
597 TAACGTGTACACGTAAAGTGTCACCA
GGACGG 
L19 RNA leader 5’-RACE nested 
reverse primer for PCR; use with 9 
599 ACGATGTTCCGCTGTGCCGGTTT L19 RNA leader forward primer for 
RT-PCR 
600 ATGACAGCCTGCCGAACTTTTCAGTG
CG 
rbgA reverse primer for RT-PCR; 
use with 599 
601 GGAGCGAAAGTTTTGCGGTGCAATTC
AGTTG 
rnhB reverse primer for RT-PCR; 
use with 599 	 	
Table A.1. Oligonucleotides used in this study. 
For primer pairs, the forward primer is listed first and the reverse primer is listed second. 
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602 CTGTATTCGTCGGAGAAGGTGCTTTC
GTA 
ylgG reverse primer for RT-PCR; 
use with 599 
10 GCGGTCACGCTTACTTAGCCCTCACT
GAAATTTTTTTTTTTTTTTTT 
3’-RACE outer dT reverse primer 
for RT 
674 CTTACGGTGTTGGCGTTGAACGTAC L19 RNA leader 3’-RACE forward 
primer for PCR; use with 11 
141 GGAATTCTAGATTTTATTGCATAGGCT
ATGAAATTGTGATA 
rplS putative promoter 3’-RACE 
forward primer for PCR; use with 
11 
220 GACTAGTATGCAAAAACTAATTGAAG
ATATCAC 
rplS coding region 3’-RACE 
forward primer for PCR; use with 
11 
11 GCGGTCACGCTTACTTAGCCCTCACT
GAA 
3’-RACE nested dT reverse primer 
for PCR 
608 GTTGCCGACTTTCACGTTGTCTCCGC
C 
L21 RNA leader 5’-RACE outer 
reverse primer for RT 
607 GCAAGTTTTTCGATGTAAACAGTTTG
GCC 
L21 RNA leader 5’-RACE nested 
reverse primer for PCR; use with 9 
609 CCATTGCTACAACCGCTCAGTACAG L21 RNA leader forward primer for 
RT-PCR 
610 TAATCCCGTTCGATTGTCTCCAGCGA
AAC 
ysxB reverse primer for RT-PCR; 
use with 609 
611 TTGCGGTCACGGCCGAAACGTTCGA
AT 
rpmA reverse primer for RT-PCR; 
use with 609 
651 CGTGACTCGTGATTTCAAAACGCATG spo0B reverse primer for RT-PCR; 
use with 609 	 	
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